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Abstract
Site-specific incorporation of fluorescent probes into proteins enhances the ability of researchers to study
protein folding and structural dynamics. Currently, the most common fluorescent probe for proteins is green
fluorescent protein (GFP). However, the use of GFP, a 28 kDa protein, requires its covalent attachment to a
protein of interest. Additionally, this attachment is restricted to either the N- or C-terminus of the protein,
drastically limiting the scope of experiments possible. Alternative technologies for the addition of novel
fluorescence properties to proteins exist, however they are also limited by the probe size or its method of
attachment. Since many proteins of interest are less than or equal to the size of these fluorescent auxiliaries, it
is likely that the covalent fusion of the fluorescent apparatus will significantly perturb the native fold or
function of the molecule of interest. As such, the development of minimalistic probes for protein functional
studies is of great interest to the biochemical community. Acridon-2-ylalanine (Acd) is a minimalistic
fluorescent unnatural amino acid (flUAA) that possess a long lifetime, resistance to photobleaching, a near
unity quantum yield, and visible wavelength emissions. While there existed literature precedent for the
synthesis of Acd, these methods required harsh conditions and reagents that precluded a high-yielding,
scalable synthesis of the flUAA. To this end, we have devised an efficient, scalable 5-step synthesis utilizing
Tyr that yields Acd in 87 % overall yield. Recently, we have shown that Acd can be incorporated into proteins
in vivo and can be a valuable probe of protein-peptide interactions and protein conformational change due to
its blue-wavelength excitation, unique solvatochromic properties, and ability to participate in energy transfer
with endogenous amino acids (Trp and Tyr), exogenous fluorophores (methoxycoumarin), and the
lanthanide ion Eu3+. Furthermore, as the need for minimalistic probes is not limited to fluorescence
applications, we have collaborated with the Deutsch laboratory to develop methods for the synthesis of
unnatural amino acids capable of probing the interaction between the ribosomal exit tunnel and nascent
peptides.
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ABSTRACT 
 
MINIMALISTIC PROBES FOR PROTEIN FOLDING AND STRUCTURE STUDIES 
Lee Colyer Speight 
Professor E. James Petersson 
Site-specific incorporation of fluorescent probes into proteins enhances the ability of 
researchers to study protein folding and structural dynamics. Currently, the most common 
fluorescent probe for proteins is green fluorescent protein (GFP). However, the use of 
GFP, a 28 kDa protein, requires its covalent attachment to a protein of interest. 
Additionally, this attachment is restricted to either the N- or C-terminus of the protein, 
drastically limiting the scope of experiments possible. Alternative technologies for the 
addition of novel fluorescence properties to proteins exist, however they are also limited 
by the probe size or its method of attachment. Since many proteins of interest are less 
than or equal to the size of these fluorescent auxiliaries, it is likely that the covalent 
fusion of the fluorescent apparatus will significantly perturb the native fold or function of 
the molecule of interest. As such, the development of minimalistic probes for protein 
functional studies is of great interest to the biochemical community. Acridon-2-ylalanine 
(Acd) is a minimalistic fluorescent unnatural amino acid (flUAA) that possess a long 
lifetime (τ = 16 ns), resistance to photobleaching, a near unity quantum yield (Φ = 0.95), 
and visible wavelength emissions. While there existed literature precedent for the 
synthesis of Acd, these methods required harsh conditions and reagents that precluded a 
high-yielding, scalable synthesis of the flUAA. To this end, we have devised an efficient, 
scalable 5-step synthesis utilizing Tyr that yields Acd in 87 % overall yield. Recently, we 
have shown that Acd can be incorporated into proteins in vivo and can be a valuable 
vii 
probe of protein-peptide interactions and protein conformational change due to its blue-
wavelength excitation, unique solvatochromic properties, and ability to participate in 
energy transfer with endogenous amino acids (Trp and Tyr), exogenous fluorophores 
(methoxycoumarin), and the lanthanide ion Eu3+. Furthermore, as the need for 
minimalistic probes is not limited to fluorescence applications, we have collaborated with 
the Deutsch laboratory to develop methods for the synthesis of unnatural amino acids 
capable of probing the interaction between the ribosomal exit tunnel and nascent 
peptides.  
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BACKGROUND 
As postulated by C. B. Anfinsen, the classical thermodynamic hypothesis of protein 
folding states that “the three-dimensional structure of a native protein in its normal 
physiological milieu … is the one in which the Gibbs free energy of the whole system is 
lowest; that is, that the native conformation is determined by the totality of inter-atomic 
interactions and hence by the amino acid sequence, in a given environment1.”  Multitudes 
of literature reports have corroborated this hypothesis since its inception in 1973 leading 
to it commonly being referred to as “Anfinsen’s Hypothesis2.”  Thus, as the environment 
of a protein dictates how its monomeric components interact, studies of these interactions 
and the overall protein structural architecture should mimic the native state of the protein 
as closely as can be reasonably achieved. Advances in protein imaging technologies, 
chiefly x-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, have 
enabled protein scientists worldwide to decipher, model, and publish the atomic 
resolution structures of over 98,000 proteins and protein complexes as of February 20143.  
While these technologies have unquestionably aided the investigations of all biological 
researchers, many intricacies of the folding pathways, enzymatic activities, and overall 
structural dynamics of proteins remain elusive. As with any technique, both x-ray 
crystallography and NMR spectroscopy have limitations and impose constraints on the 
analytes to ensure successful imaging at useful resolutions. Such constraints inherent to 
these methods include the use of nonnative conditions such as salts, pH, solvent, and 
concentration, all of which can possibly affect the inter-atomic interactions of a protein 
under analysis4. For example, intrinsic to protein structure elucidation by X-ray 
crystallography is the caveat that the protein being studied must pack orderly into a 
3 
crystal lattice, which itself is a significant perturbation of the protein’s solution-phase 
dynamics.   
 While there have been recent reports of crystallographic and NMR techniques being 
applied to proteins in vivo where the protein is in its native environment, these analyses 
are still respectively limited by a protein’s ability to crystallize or be isotopically labeled 
at close to millimolar concentrations5.  Furthermore, the data retrieved from such 
experiments is also respectively limited to fixed states in a crystal lattice and the 
microsecond timescale just as the analogous in vitro experiments6. Efforts towards 
providing better image and temporal resolution of these analyses are ongoing; however 
they are still relatively new technologies7.  Fluorescence spectroscopic analysis of 
proteins, on the other hand, is not limited by these same constraints and is a generally 
well understood method for analyzing both monomeric and polymeric biological 
compounds. Experiments with intrinsically fluorescent or fluorescently labeled proteins 
are routinely done at micromolar concentrations or lower and the data can be acquired in 
time intervals as low as fractions of nanoseconds. This enables the facile and accurate 
observation of changes in fluorescence of either purified analytes or dilute components of 
complex mixtures. In fact, fluorescence based imaging of proteins has been done in vivo 
since the 1990s and detailed in vitro work dates to the 1970s8.  While fluorescence 
experiments have the tremendous benefit of being able to be conducted readily in the 
native context of a protein, the technology does have its own limitations. The use of 
intrinsic fluorescent probes, such as the amino acids tryptophan (Trp) and tyrosine (Tyr), 
is complicated by to the abundance of these residues and other moieties in cells that are 
excited by similar wavelengths of light. Additionally, the accuracy of the measurements 
4 
is often constrained by the chemistry necessary to install a fluorescent probe, the size of 
the probe, or the location of the probe’s installation on the protein.  Development of 
fluorescent modifications for proteins has yielded a broad suite of probes and methods 
that are as structurally and spectroscopically diverse as the applications for which they 
were designed.  
 
FLUORESCENCE AS A MINIMALLY PERTURBING METHOD FOR 
MONITORING PROTEIN DYNAMICS 
 
Figure 1.1: Chromophore Size. Space-filling renderings of several chromophores, based on either crystal 
structures or ab initio calculations. The green fluorescent protein (GFP) was rendered from PDB ID 1GFL9. 
The benzylated SNAP tag protein was rendered from PDB ID 3L00 (S. Schmitt, B. Mollwitz, F. Pojer, M. 
5 
Bannwarth, M. Schiltz, K. Johnsson, unpublished results). The geometry of tetracysteine-bound FlAsH was 
optimized at the HF/6-31G level, all others were optimized at the AM1 level.   
Numerous aspects of protein dynamics, such as folding, conformational changes, binding 
to other proteins or molecules, and proteolysis, can be examined with fluorescently 
labeled proteins.  Protein folding and conformational changes can be monitored by 
observation of changes in the fluorescence of a probe relative to a defined starting state. 
For example, solvatochromic fluorescent probes change their relative fluorescence 
intensity through a change in the molar absorptivity of the fluorophore(ε), absorption 
maxima(λabs), emission maxima (λem), or quantum yield (Φ) in response to changes in 
their local environment. This has been used to monitor the movement of a protein domain 
or amino acid residue between environments of differing hydrophobicity such as the 
movement of a probe from the nonpolar interior of a protein to the exterior where it is 
exposed to bulk polar solvent, typically water. The binding of other molecules to a 
fluorescently labeled protein of interest can also be observed by solvatochromic effects 
but more commonly the change in fluorescence due to a change in intramolecular 
distances between two probes is used. Proteolysis and biomolecular disassociations 
benefit from being monitored by such a fluorescence technique as the possibility to 
conduct fluorescence experiments under extremely dilute conditions allows for a robust 
change in fluorescence due to rapid diffusion of fluorophores.   
Two types of energy transfer experiments are commonly used to ascertain the change in 
distance between two fluorescent probes: Fӧrster resonance energy transfer (FRET) and 
photoinduced electron transfer (PET) (Figure 1.2). FRET experiments rely on the 
interaction between two probes whose spectral properties are matched such that one 
6 
probe, the ‘donor’ has an appreciable fluorescence emission that overlaps with the 
absorption spectrum of the other probe, the ‘acceptor.’ Two facets of this process are 
important to consider. First, FRET is not the result of a trivial emission-reabsorption 
process, but rather the result of the coupling of the electronic transition dipoles of the 
donor and acceptor species that enables the transfer of energy from one to the other. As 
such, it is not necessary for the acceptor chromophore to have emission properties of its 
own; these types of acceptor probes are referred to as quenchers because their effects are 
observed by a decrease in donor emission rather an appearance of novel longer 
wavelength emissions. All FRET interactions have a quantitative 1/(R6) distance 
dependence that allows for straight-forward time-dependent structural information to be 
derived (where R is the intermolecular distance between the donor and acceptor).  PET 
experiments solely rely on the quenching of donor fluorescence. However the distance 
dependence of PET, roughly e-R, often is too dependent on the pathway between the 
fluorophore and quencher to interpret accurately. The mechanism of PET quenching can 
be either through a static or dynamic electron transfer. These two mechanisms differ with 
regard to whether or not the excited state of the donor is populated, yet the outcome is the 
same; a decrease in the probability that the fluorophore will emit light. Static PET 
quenchers form a ground-state complex with the fluorophore that prevents the transition 
to the excited state by an absorption of a photon while dynamic PET quenchers undergo a 
coupled reduction or oxidation reaction with the excited state of the fluorophore that 
causes the fluorophore to return to the ground state by a non-emissive pathway.  PET 
quenchers of utility for biophysical applications are capable of being restored to their 
original oxidation state under the conditions of the experiment so that the process can 
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occur repeatedly. On this note, as PET is a redox process, the redox active amino acids 
Met, His, Lys, Trp, Tyr, and Cys can be valuable PET probes when matched with the 
appropriate fluorophore. Additionally, some research groups have seen modulation of a 
fluorophore’s fluorescence due to the N-terminal amine of proteins and peptides10.  
In addition to solvatochromism, it is prudent to consider PET quenching by endogenous 
biological components of a system, such as the amino acids Trp and Tyr, as another type 
of environmental effect. Mutagenesis of these residues to avoid these interactions would 
likely be perturbing to the system and can be avoided by the use of careful controls if a 
chosen fluorescent probe interacts with these endogenous moieties.  Such considerations 
must be made when any fluorophore is used in a new system, as the native environment 
of a protein can be quite different from the conditions in which fluorophores are typically 
characterized (i.e. in pure solvent). However it is within these unique environments that 
the dynamics of fluorophores can report in ways that other techniques cannot. For 
example, Lakowicz and others observed that the x-ray structures of proteins reveal that 
they are tightly packed with a density far too great to allow for the free diffusion of small 
molecules such as molecular oxygen11. However, the fluorescence of Trp residues buried 
within a variety of proteins’ hydrophobic cores is quenched by oxygen, albeit at a 
significantly decreased extent when compared to that of surface exposed residues. These 
observations imply that protein structural vibrations must occur on the nanosecond 
timescale in order for oxygen diffusion to occur and subsequent Trp fluorescence 
quenching to be observed. While these findings do provide useful information, they also 
highlight the need for careful probe selection and diligent design of control experiments. 
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Figure 1.2: Common Protein Fluorescence Experiments. Protein conformational changes, protein-protein 
interactions, and proteolytic cleavage can be monitored by changes in the intra- or intermolecular distance 
between two FRET (Fӧrster resonance energy transfer) probes. Similar experiments can be conducted with 
a fluorophore/PET quencher or a single, environmentally sensitive dye. 
Technology for the installation of fluorescence moieties to proteins is an area of intense 
research. The fluorescent probe toolbox available to biophysical researchers is ever 
expanding and includes probes whose size varies from a single atom substitution made by 
chemical synthesis to 28 kDa proteins with an internal fluorophore that forms upon 
protein folding. Methodology for the attachment of these probes varies from co-
translational incorporation via genetic fusion of a fluorescent protein to a protein of 
interest, ribosomal incorporation of a fluorescent amino acid, or post-translational 
modification, which can either be chemoenzymatic or rely on bioorthogonal chemical 
reactions. Of most interest to protein folding biophysicists are highly site-specific 
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methods which do not require extensive synthetic chemical post-translation modification. 
However, owing to their robust nucleophilicity, lysine (Lys) and cysteine (Cys) residues 
have been used for the installation of fluorophores possessing the appropriate reactive 
partners. Unfortunately, since the respective amine and thiol groups of these residues are 
frequently found in other biomolecules, these methods are largely restricted to in vitro 
applications and single Lys or Cys mutants. To overcome these limitations, several 
unique bioorthogonal reactive handles, such as azides and alkynes, have been site-
specifically installed into proteins for subsequent labeling with appropriately 
functionalized fluorophores. The chemistry involved and/or the scaffolds necessary for 
their incorporation of these reactive handles are significantly more likely to perturb the 
native fold or function of a protein rather than a single amino acid substitution12. Co-
translational incorporation allows one to place fluorophores on the interior of a protein, 
whereas post-translational attachment is either limited to surface residues or requires that 
the protein be capable of unfolding and then refolding after modification. Therefore the 
pursuit of such minimalistic fluorescent probes amenable to site-specific ribosomal 
installation is the most prudent endeavor for those wishing to image proteins as close to 
their native state as possible.   
 
FLUORESCENT PROTEINS 
First isolated from the jellyfish Aequorea victoria in 1962, green fluorescent protein 
(GFP) has substantively changed biochemical research by allowing straightforward 
genetic reporting of in vivo gene expression and, via fusion to a protein of interest, 
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cellular protein localization and trafficking (Figure 1.1) 13. GFP has subsequently been 
optimized for enhancing folding (eGFP) as well as derivatized to yield several colored 
variants14. While the utility of these 28 kDa β-barrel proteins may initially seem limited 
to passive applications such as using fluorescence to determine the cellular fate of a 
protein target, the multi-colored library of fluorescent proteins (FPs) has been used for a 
variety of complex applications, the most exciting of which rely on FRET15.  Using 
carefully selected FP pairs with significant spectral overlap, FRET probes have been 
designed for examining diverse biochemical processes such as protease activity, protein-
protein interactions, and metal ion homeostasis both in vitro and in vivo14, 15. Typically, 
these studies are designed such that one colored FP (the donor) is appended to one 
terminus of a linker, which has been designed as the ‘reporter’ sequence, and the other 
colored FP (the acceptor) is attached to the other terminus. As this is readily done on the 
DNA level and cloned into a protein expression vector, studies can easily be done in vivo, 
or in vitro following purification of the fusion protein product.  
One such example of this methodology being used for an in vivo experiment was 
conducted by the laboratories of G. A. Rutter and M. Merkx. Previously, the Merkx 
group had developed a genetically encoded FRET-based sensor for the in vivo detection 
of Cu(I) ions by combining copper-binding domains from proteins involved in human 
copper homeostasis Atox1 and ATP7B and fusing this reporter sequence to two FPs16. 
Mutation of the copper-binding domains to the zinc-binding domains found in ZntA, a 
zinc transporter protein, and fine tuning of linker lengths allowed for pico- and 
femtomolar detection of Zn(II) in a subsequent report17. However, the emission ratio 
change upon Zn(II) binding was minimal (a decrease of 15%). By changing the FPs from 
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eCFP and eYFP to Cerulean FP and Citrine FP and adding mutations to the FPs to 
promote contacts between the donor and acceptor,  the combined groups of Merkx and 
Rutter were able to enhance the dynamic range from their sensor to a 2.4-fold decrease in 
emission ratios18. These optimizations show that FPs can be used to in FRET-based 
assays in vivo, however, spectral optimizations aside, it is important to account for the 
large size of the FPs and how this effects their interactions in the system; it is possible 
that the FP-fusion disrupts the native functions of the protein of interest.  
 
PROTEIN BASED CHEMICAL-TAGGING SYSTEMS 
While research into GFP and its colored derivatives has allowed for the development of 
variants suitable for most spectral applications, others have developed alternative 
strategies where the fluorophore can be enzymatically attached post-translationally. A 
product of the Promega Corporation, the HaloTag is a mutated bacterial haloalkane 
dehalogenase that, when attached to a protein of interest via genetic fusion, creates a 
covalent ester linkage between the protein and a synthetic ligand19. As the fluorescent 
moiety, or any desired ‘cargo,’ is part of the unreactive portion of the synthetic ligand, 
these probes can be changed by varying the ligand while keeping the same fusion protein, 
saving a significant amount of time if a particular fluorophore is shown to be suboptimal 
for an application. This methodology, frequently referred to as ‘protein based chemical-
tagging’ has proven to be fairly general and has been used for an array of applications: 
labeling proteins with fluorescent probes and quantum dots, as well as providing a 
platform to protein purification. Other protein based chemical-tagging systems that have 
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been developed include SNAP-tag (based on the human DNA repair protein O6-
alkylguanine-DNA alkyltransferase (hAGT) (Figure 1.1))20, CLIP-tag (a derivative of 
SNAP-tag that recognizes O6-benzylcytosine derivatives)21, and TMP-tag (E. coli 
dihydrofolate reductase (eDHFR) that recognizes trimethoprim(TMP)-based tags)22. 
These strategies do not reduce the steric cost of fluorescent labeling with FPs, as the 
fusion of one of the tagging domains typically adds ~30kDa to the protein of interest. 
However, they do offer unique applications such as fluorogenic tagging reactions. 
V. W. Cornish’s laboratory, which developed the TMP-tag methodology, recently 
reported the use of dual functionalized TMP ligands that enabled fluorogenic labeling of 
proteins in living cells23. Consistent with the TMP moiety’s previous role as a 
therapeutic, synthetic ligands containing TMP have been shown to have high water 
solubility and cell permeability. These parameters, combined with the high affinity of 
eDHFR for TMP-ligands (KD ~ 1 nM), make the TMP chemical tag methodology well 
suited for high resolution live cell imaging. However, the need to wash out excess probe 
or labeling reagent is always an issue with chemical based fluorescent labeling. To 
circumvent this issue, Cornish and coworkers redesigned the TMP ligands to contain both 
a fluorophore and a quencher.  The quencher was specifically anchored on the ‘leaving 
group’ portion of ligand such that upon reaction with a Cys residue in a mutant eDHFR, 
the TMP-fluorophore conjugate would be covalently attached to the fusion protein of 
interest and the quencher would diffuse away, dramatically increasing the signal from the 
fluorophore upon excitation. Using the ATTO520 and BHQ1 as the respective 
fluorophore and quencher in their fluorogenic TMP-tag, the experimenters were able to 
specifically label the nuclear protein histone 2B with significantly higher resolution and 
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precision than with previous generation TMP-tags. Additionally, the Cornish group was 
able to label three distinct cytosolic proteins (TOMM20, α-actinin, and MLC) in two 
different cell lines (HEK 293T and MEF) showing that there is no intrinsic localization of 
the TMP-ligands. Furthermore, the modular design of these ligands allows for future 
refinement and/or selection of fluorophores and quenchers to meet experimental needs.  
 
SMALL MOLECULE FLUORESCENCE PROBES 
Despite the fact that protein based chemical-tagging strategies allow experimenters to 
readily change fluorophores and utilize fluorogenic labels, there is still a significant steric 
cost; the required protein fusions are several hundred amino acids in size, rendering them 
as sterically perturbing as FP based systems. Well aware of this, R. Tsien, whose work 
with GFP brought its use to the forefront of biochemistry, developed a drastically more 
minimalistic protein tag. Requiring no more than the specific six amino acid sequence 
CCPGCC, Tsien and coworkers identified a bisarsenical fluorescein derivative (FlAsH) 
that binds this tetracysteine motif with high affinity and negligible toxicity when 
administered with a 10-fold excess of a small vicinal diol such as 1,2-ethanedithiol 
(Figure 1.1)24. The probe had the added, and unexpected, benefit of achieving a 5000-
fold increase in fluorescence upon binding of the CCPGCC motif, making this system 
both fluorogenic and tremendously less stericly perturbing than FP or protein based 
chemical-tag methods. It is also important to note that several research groups have 
corroborated these claims25.  Subsequent refinement by the Tsien lab led to the 
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development of other bisarsenical probes that responds to the CCPGCC motif including 
the popular ReAsH, based on the resorufin fluorophore26.   
Aside from simply using the FlAsH or ReAsH probes to label proteins in vivo and in 
vitro, several groups have devised clever methods of using the turn-on fluorescence 
properties of these probes as a diagnostic of protein dynamics. The Schepartz laboratory 
used both FlAsH and ReAsH in conjunction with bipartite Cys-Cys motifs to study 
intramolecular domain interactions as well as intermolecular protein-protein dimerization 
interactions27. It was hypothesized that the space created by the PG section of the 
CCPGCC motif could be replaced with the space between two protein domains or 
polypeptide strands; thus binding of the bisarsenical probes would be an indicator of the 
proximity between two Cys-Cys sequences. With proof-of-principle experiments for 
successful intramolecular (with aPP and Zip4) and intermolecular (GCN4 and Jun) 
FlAsH/ReAsH binding, the group further showed that they were able to detect defects in 
protein structure both in vitro and in vivo. By inducing mutations in GCN4 and Jun that 
are known to destabilize helix formation and protein dimerization, the Shepartz group 
found that FlAsH and ReAsH fluorescence intensity was greatly decreased in response to 
these mutants in vivo. These experiments highlight the ability of these probes to 
selectively bind to the tetracysteine motif and thus diagnose disruptions in the orientation 
of the four cysteine residues and polypeptide structure in complex environments.  
The Schepartz report on the use of FlAsH and ReAsH to study intramolecular and 
intermolecular protein dynamics concludes with the assertion that their methodology 
would be well suited to study the misfolding and aggregation of proteins involved in 
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protein aggregation pathologies such as Alzheimer’s disease and Parkinson’s disease. 
Just a few years later, J. Kelly and coworkers were successful in using the methodology 
to monitor the formation of early stage oligomers of Aβ1-40, which are unresponsive to 
typical aggregation dyes that detect only later stage fibrils such as thioflavin T (Figure 
1.3)28. By installing Cys-Cys motifs at the N-terminus of Aβ1-40 monomers synthesized 
using Fmoc-based solid phase peptide synthesis, the group was able to monitor the 
formation of early stage oligomers within minutes of beginning aggregation experiments. 
Thioflavin T, for comparison, takes 12 hours before there is a significant increase in 
fluorescence indicating fibril formation. Interestingly, the group was also able to observe 
thioflavin T to FlAsH FRET at early stages during the experiments, corroborating others 
reports that thioflavin T weakly binds to oligomers. Combined with traditional thioflavin 
T assays, the Kelly lab was able to use their split-FlAsH methodology to study the 
aggregation of Aβ1-40 in vitro in more detail than had previously been done. Their 
experiments led them to the conclusion that Aβ1-40 aggregation is not a nucleated 
polymerization, but rather a nucleated conformational change, a finding which highlights 
the advantage of the small size and minimal perturbation of the FlAsH methodology to 
study protein dynamics.  
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Figure 1.3: Monitoring Aβ1-40 Oligomer Formation with FlAsH. FlAsH can bind to both oligomers and 
fibrils, unlike thioflavin T (ThT), which only binds fibrils. FlAsH fluorescence from the Cys2 mutants of 
Aβ1-40 monomers indicates the assembly of oligomers before fibrillization. Adapted figure reproduced from 
Lee et al. with permission from Nature Publishing Group28. 
While the FlAsh methodology allows for the installation of a fluorophore into proteins 
dependent only on a short peptide tag, it is still an imperfect solution to the problems of 
FP and chemical-based protein fusion protocols for the fluorescent labeling of proteins. 
Aside from the cellular toxicity of FlAsH and the related dyes due to their arsenic 
moieties, the requirement of complex washout procedures, and low specificity owing to 
reactivity with monothiols and Cys rich proteins pose significant limitations for 
biophysical investigators26, 29. Thus A. Ting and coworkers sought to combine the utility 
of small peptide tagging protocols with the absolute specificity of genetic FP fusions. The 
group’s first success in this area came with their discovery of the permissivity of the E. 
coli biotinylation enzyme BirA30. BirA, previously known to react precisely with a Lys 
Oligomers 
Fibrils 
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residue in a 15 residue ‘acceptor protein’ (AP) sequence, has been shown to have only 
one substrate in E. coli and none in mammalian cells31. Ting’s group found that wild-type 
BirA is capable of using an analog of biotin in which the urea functionality has been 
replaced with a ketone, allowing for a reaction with a fluorescent probe bearing a 
hydrazide handle. This resulted in a two step procedure for the labeling of proteins in 
mammalian cell lysate or on the surface of live cells: First, BirA, ATP, and the ketone 
biotin analog are added to the cell lysate or cell growth medium, allowing for the specific 
attachment of the biotin analog to the lysine with the AP sequence. Following washout of 
the ketone compound for in vivo applications, the fluorescent hydrazide-containing probe 
is added and allowed to react with the ketone moiety. This method, while specific, is 
limited to cell lysate and cell surface applications due to the possibility of hydrazide 
cross-reactivity with the ketone and aldehyde containing compounds typically found in 
the cytosol.  
Subsequent work within the Ting laboratory with other enzymatic tagging methods 
suffered from similar limitations. Specifically in their use of a transglutaminase based 
system, intracellular labeling proved elusive due to several off target labeling events and 
calcium concentrations that were suboptimal for activity32. However, through structure-
based evolution of the E. coli lipoic acid ligase, Ting’s group was able to create an 
enzymatic one-step fluorophore ligation method applicable to intracellular tagging of 
proteins inside live cells33. Coined ‘PRIME’ (PRobe Incorporation Mediated by 
Enzymes), the method involves the mutant lipoic acid ligase, or fluorophore ligase, 
specifically appending a carboxylic acid derivative of 7-hydroxycoumarin onto a lysine 
residue within a 13 residue recognition sequence34. The experimenters were able to show 
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robust labeling of proteins in the nucleus and cytosol in various mammalian cell lines that 
proceeded faster and with significantly less background fluorescence and cytotoxicity 
than the analogous labeling with FlAsH. However, the system still required the 
expression of the fluorophore ligase in the cells in which proteins are to be labeled.  At 
high plasmid loading, this led to some background, nonspecific labeling. These 
limitations aside, Ting and coworkers have used both the BirA and PRIME 
methodologies to study protein-protein interactions inside living cells35. 
 
TRYPTOPHAN ISOSTERES AS MINIMALISTIC FLUORESCENCE PROBES 
Although the endogenous amino acids Tyr and Trp are both fluorescent, with Trp 
typically dominating the emissions spectra of proteins, it is difficult to selectively excite 
either fluorophore in proteins containing a single Tyr or Trp residue and impossible in 
proteins containing multiple Tyr or Trp. Despite these limitations, Trp fluorescence has 
been used to probe the structure, folding, and interactions of proteins due to its low 
abundance (1%) relative to other residues36. Thus, the ideal minimalistic fluorescent 
probe would be an isosteric analog of Trp with superior spectral properties. Such an 
endeavor is possible, since it was shown that as early as 1956 that the bacterial translation 
machinery could use the Trp analogs 7-azaTrp and 2-azaTrp37  (Note: subsequent 
publications have yet to reproduce the incorporation of 2-azaTrp)38. Additionally, several 
indole derivatives have been shown to be superior to the parent molecule in the context of 
biological fluorescence studies; these features include red-shifted absorbance and 
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fluorescence maxima, enhanced Stoke’s shifts, greater environmental sensitivity, and 
longer fluorescence life-times (Figure 1.4)38-42.  
The most commonly used Trp analogs for biophysical studies are 7-azaTrp and 5-
hydroxyTrp. These analogs have been shown to be well suited to use for site-specific 
genetic incorporation through the use of E. coli Trp auxotrophic strains by several 
research groups, with the first incorporation of 5-hydroxyTrp by A. G. Szabo in 1992 and 
proof of its minimal perturbing status by J. B. Alexander Ross et al in the same year43. In 
2002, H. Hu and coworkers installed both 7-azaTrp and 5-hydroxyTrp into the sole Trp 
position of protein G from Streptococcus (residue 43) and compared the resulting spectra 
to those of the wild-type protein44. As with the free amino acids, protein G mutants 
containing 7-azaTrp and 5-hydroxyTrp showed a red-shifted absorbance profile and a 
significant shoulder in the absorbance at 310 nm, respectively. These spectral 
enhancements are due to the changes in the separation of the 1La and 1Lb electron 
transition bands due to the altered electronics of the indole rings. Absorption at longer 
wavelengths allows the fluorophores to be selectively excited in the presence of 
endogenous Trp residues. However Hu and colleagues found that the analogs had 
drastically different environmental sensitivities; the 5-hydroxyTrp mutant was shown to 
be less sensitive to solvent exposure than Trp (which modestly increases in fluorescence 
intensity upon shielding the residue from solvent), while the 7-azaTrp mutant’s 
fluorescence increased significantly and blue-shifted slightly upon moving the residue 
away from solvent. In another example, Broos and coworkers studied the Lys motif 
(LysM), which is a peptidoglycan binding domain found in both prokaryotes and 
eukaryotes, and its ligand interactions using these Trp analogs45. While it proved to be a 
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valuable probe these in contexts, the intense sensitivity of 7-azaTrp to polar solvents 
often results in dramatic quenching of the fluorophore, which can make it too dim to be 
useful. 
N. Budisa has significantly contributed to the exploration of the photophysical properties 
and in vivo incorporation of Trp derivatives, specifically those containing additional 
endo- and exocyclic nitrogen atoms38-41. The intense quenching of 7-azaTrp is due to the 
ability of both endocyclic nitrogen atoms to participate in hydrogen bonding with 
separate water molecules. These interactions prevent tautomerization of the azaindole to a 
more fluorescent isomer and thus diminish the utility of the fluorophore41. In efforts to 
circumvent this problem, Budisa’s group has studied the regioisomers 4, 5, and 6-azaTrp. 
While 6-azaTrp is red-shifted by an additional 30 nm in its absorbance profile, its use has 
been shown to be problematic in the literature, with some claiming to have trouble 
reproducing its ribosomal incorporation40, 46. 4 and 5-azaTrp were shown to tautomerize 
only at high pH values (>10), making them resilient to environmental effects in the 
context of biological applications. Furthermore, Budisa’s group showed that 4 and 5-
azaindole were capable of being used as substrates by the Trp synthetase (TrpS) in E. 
coli, allowing for in situ stereospecific synthesis of the corresponding amino acids from 
the parent fluorophore40. After incorporating both of these Trp analogs, in addition to 7-
azaTrp, into human anxA5, Budisa’s group compared the changes of each mutant 
fluorescent protein in response to changes in environment. As in other experiments, the 
7-azaTrp mutant was weakly fluorescent when folded, and almost completely quenched 
upon denaturation and exposure of the residue to bulk solvent. Conversely, the 
fluorescence spectra of the 4 and 5-azaTrp mutants were largely unchanged in the same 
21 
experiment. Furthermore, the 4-azaTrp mutant proved to be the superior probe due to its 
broad absorbance band at 310 nm, a Stokes shift of 130 nm, and a higher quantum yield. 
Budisa’s work with indole and Trp analogs has also included N-methylated derivatives of 
the aforementioned compounds, those with exocyclic amine substituents, and the 
application of Trp analogs to the creation of optimized FPs38, 39, 41.   
 
Figure 1.4: Trp Analogue Fluorescence Emission. Fluorescence spectra of 4-AzaTrp, 5-AzaTrp, 6-AzaTrp, 
and 7-AzaTrp are all red-shifted relative to the Trp spectrum with 4-AzaTrp having the greatest 
bathochromic shift. Adapted figure reproduced from Merkel et al. with permission from Wiley-VCH41. 
 
SITE-SPECIFIC INCORPORATION OF UNNATURAL AMINO ACIDS 
Site-specific incorporation of exogenous fluorescent unnatural amino acids (flUAAs) into 
proteins is the best option for the most accurate fluorescent measurements of protein 
dynamics. Fortunately for protein biophysicists, the ribosome, nature’s polypeptide 
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synthesizer, has been shown to tolerate noncanonical mRNAs, tRNAs, and a suite of 
amino acids with diverse structures and functions. Several in vitro and in vivo methods 
for the site-specific incorporation of unnatural amino acids (UAAs) have been published 
in the last 25 years (with amber suppression and 4-base codon technologies being the 
most popular). However, all current methods are limited by the intrinsic size restraints of 
the ribosomal A, P, and E sites, nascent peptide exit tunnel, as well as the steric 
constraints of the trafficking protein/GTPase EF-Tu47-49.  
Fundamental studies that would later provide the basis for genetic code expansion were 
first conducted by S. Benzer and colleagues in the early 1960s, when a detailed 
understanding of the macromolecular components of translation was still lacking50. 
Following treatment of Cys-tRNA with the ‘cysteine activating enzyme’ in the presence 
of ATP, Benzer took the resulting Cys aminoacyl tRNA (aa-tRNA) and removed the thiol 
group via reduction with Raney-Ni. The resulting desulfurized aa-tRNA was then 
effectively alanine (Ala) tRNA. When this misacylated tRNA was used in a crude 
translation experiment, Ala was incorporated instead of Cys.  These results revealed that 
‘activating enzymes,’ later known as aminoacyl tRNA synthetases (aaRSs), know what 
amino acid to put onto what tRNA, however the macromolecular complex responsible for 
decoding mRNA only sees the codon on the tRNA, not what amino acid is esterified to 
its 3’ end. Such findings made it theoretically possible to expand the genetic code by 
intentional misacylation of tRNA molecules. Shortly over a decade later, S. Hecht’s 
laboratory was able to chemically aminoacylate a symmetrical phosphorylated adenosine 
derivative and subsequently enzymatically ligate it on to a truncated tRNA to yield a 
functional misacylated tRNA51.  As all tRNAs terminate in the same three nucleotides, 
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cytidine-cytidine-adenosine, this methodology was shown to be a general method for 
‘sense-reprogramming’ of the genetic code, that is, hijacking a normal coding codon by 
use of a misacylated corresponding tRNA.  
While ‘sense-reprogramming’ can yield site-specific mutants of proteins containing 
unnatural amino acids, this methodology requires the use of either auxotrophic cells lines 
or cell-free systems lacking the natural tRNA for the codon to ensure complete 
incorporation of the novel amino acid. P. G. Schultz was able to solve this problem and 
effectively add a 21st amino acid to the genetic code by the development of amber 
suppression technology52. The ‘UAG’ codon, commonly referred to as the amber codon, 
is the least used codon and had previously been shown to be efficiently suppressed by 
known suppressor tRNAs for the incorporation of endogenous, but rare, amino acids such 
as selenocysteine (Note: in the context of this document, suppression refers to the 
reprogramming of a ‘stop’ signal in translation into a coding codon). Thus, using a 
modified version of Hecht’s protocol for the production of semisynthetic tRNAs, Schultz 
and coworkers devised a method for the semisynthesis of full length misacylated tRNAs 
bearing the anticodon CUA. This new route, in which a dinucleotide, 
phosphodeoxycytidine-phosphoadenosine (pdCpA), is aminoacylated and then ligated 
onto a truncated tRNA missing the terminal C and A, dramatically improved the atom 
economy of Hecht’s method as all aminoacylated nucleotides are substrates for the 
chemoenzymatic ligation reaction (in Hecht’s method both ‘ends’ of the symmetrical 
phosphorylated adenosine derivative could be aminoacylated, but only one would be 
transferred in the ligation)53.  These misacylated amber suppressor tRNAs are then used 
in conjunction with mRNAs bearing the amber codon at the site of interest in an in vitro 
24 
translation reaction. A caveat of this methodology is that the UAG codon normally codes 
for a ‘stop,’ or termination, in translation and as such the suppressor tRNA competes with 
release factor 1 (RF 1). Thus, yields are diminished relative to the production of the 
corresponding wild-type protein due to any premature hydrolysis of the misacylated 
amber suppressor tRNA and production of truncated protein (where RF 1 outcompetes 
the suppressor tRNA and terminates translation).  Despite these limitations, this 
technology has proven to be incredibly enabling and a variety of groups have used it to 
incorporate novel amino acids into proteins in both in vitro reactions and by large cells 
(via micro-injection of the misacylated amber suppressor tRNA). Such endeavors opened 
the door for the incorporation of any amino acid that could be tolerated by the rest of the 
cellular translation system.  
M. Sisido and coworkers have conducted several studies aimed at mapping the size and 
geometric permissivity of the endogenous translation machinery in both prokaryotes and 
eukaryotes. In 1999, Sisido’s group unveiled the “honeycomb model” describing the 
regions where benzene groups could be attached to the β-carbon of an amino acid while 
still allowing for efficient translation (Figure 1.5)54. This model was the result of testing 
the in vitro incorporation efficiencies of 19 aromatic UAAs in both E. coli and rabbit 
reticulocyte lysate and comparing them to Tyr incorporation. It expanded upon a previous 
model from the group in which they studied the geometric restraints of 12 aromatic 
puramycin derivatives47. Their findings showed that polyaromatic UAAs are generally 
well tolerated in both systems (the rabbit reticulocyte system showed marginally more 
size permissivity) with only two tested positions found not to be tolerated. Sisido’s group 
used this information to guide their site-specific incorporation of several fluorescent 
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UAAs into streptavidin; L-2-anthrylalanine (antAla) and three coumarin derivatives of 
homoalanine, glutamic acid (Glu), and aspartic acid (Asp)55. The incorporation of these 
probes into streptavidin allowed the detection of biotin binding at nM concentrations by 
changes in FRET between an endogenous Trp residue and the flUAA, highlighting the 
utility of site-specific genetic incorporation of these probes. Several years later, Sisido’s 
group was able to incorporate flUAAs containing 7 different derivatives of the BODIPY 
fluorophore and, utilizing a 4 base codon methodology, incorporate two different flUAAs 
into the calcium binding protein calmodulin (CaM) concurrently56. This dual 
incorporation allowed the group to monitor peptide binding by calcium saturated CaM 
using FRET from one BODIPY UAA to the other, without the concern for background 
fluorescence from endogenous Tyr or Trp. Sisido’s continued work with flUAAs has 
includes L-2-acridonylalanine (Acd), a blue-wavelength fluorescent amino acid with a 
long fluorescence lifetime and resilience to photobleaching (Figure 1.1)57. A general 
limitation of UAA incorporation using semi-synthetic tRNAs is that the aa-tRNAs are 
labor intensive to fabricate and prone to hydrolysis. These factors constrain applications 
to in vitro work or micro-injections into large cells. Sisido has since published work 
utilizing a double alanine EF-Tu mutant (E215A and D216A in E. coli) capable of tighter 
binding to Acd and other polyaromatic UAAs to decrease hydrolysis rates, but this still 
requires the semi-synthesis of the UAA-tRNA prior to each application.  
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Figure 1.5: ‘Honeycomb’ Model of Ribosomal Permissivity. This model, based on Sisido’s work,54 shows 
where benzene rings can be attached to the β-carbon of an amino acid for successful ribosomal incorporation. 
A denotes well-tolerated positions, B denotes moderately tolerated positions, and X denotes forbidden 
positions.  
 
ORTHOGONAL AMINOACYL-tRNA SYNTHETASES 
Acknowledging the limitations of the use of semi-synthetic misacylated amber suppressor 
tRNAs for the production of large quantities of site-specific unnatural amino acid mutants 
of proteins, R. Furter pioneered the use of an orthogonal aaRS/amber suppressor tRNA 
pair (o-aaRS/tRNA pair) in vivo system (Figure 1.6)58. Using an E. coli strain resistant to 
the incorporation of phenylalanine (Phe) derivatives in conjunction with a permissive 
yeast Phe aaRS/amber suppressor tRNA pair, Furter was able to site-specifically 
incorporate p-fluorophenylalanine into proteins in vivo. The choice of this exogenous 
aminoacylation system for use in the analog resistant E. coli strain was crucial to Furter’s 
success; the yeast enzyme and tRNA are orthogonal to the E. coli’s aminoacylation 
machinery, that is, there is no cross reaction between the macromolecules from either 
organism. Explicitly, orthogonality in this context means that no E. coli aaRS is capable 
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of aminoacylating the yeast tRNA and the yeast Phe aaRS is incapable of aminoacylating 
any E. coli tRNA. This orthogonality allowed for the in vivo aminoacylation of the yeast 
amber suppressor tRNA exclusively by the permissive yeast Phe aaRS while the fidelity 
of the E. coli aaRSs and tRNAs remained robust. Aside from greatly reducing the 
synthetic burden of site-specifically incorporating an unnatural amino acid into a protein, 
Furter’s orthogonal aaRS/amber suppressor tRNA method allowed for production of 
mutant proteins at yields as high as two-thirds that of the analogous wild-type protein.  
In 2001, Schultz was able to tremendously expand upon Furter’s use of the o-aaRS/tRNA 
pair technology by devising protocols to evolve novel o-aaRS/tRNA pairs in vivo59. After 
some initial difficulty in crafting an o-aaRS/tRNA pair deriving from a human or yeast 
source for use in E. coli, Schultz’s group began examining the factors that could lead to 
complete orthogonality60. In addition to the parameters for orthogonality identified by 
Furter, Schultz and coworkers stressed the importance of picking an o-aaRS/tRNA pair 
that has a small dependence of tRNA recognition by the aaRS in the anticodon loop. Such 
a characteristic was seen as essential for effective amber suppression so that when the 
anticodon is mutated to CUA, the affinity for the tRNA by the aaRS is maintained. The 
tyrosyl aaRS/tRNA pair from the archea Methanococcus jannaschii had previously been 
shown to be orthogonal to the E. coli translation machinery in addition to a minimal 
recognition of the anticodon by the aaRS, and as such was selected for optimization by 
the Schultz group61. To ensure complete orthogonality, the group mutated 11 nucleotides 
of the tRNA randomly (in addition to mutating the anticodon to CUA) and the resulting 
o-tRNA was subjected to negative selection in E. coli. This negative selection involved 
inserting a UAG codon in the middle of the coding sequence of the toxic protein barnase, 
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and then transforming the resulting plasmids, along with a plasmid containing the mutant 
o-tRNA, into E. coli. If the E. coli cultures survived, then the candidate o-tRNA was 
mutated in such a way that its orthogonality was maintained and thus it was not 
aminoacylated by an endogenous E. coli aaRS, preventing production of full-length 
barnase.  
A similar strategy was used to create the mutant o-aaRS enzyme. Based on the crystal 
structure of a homologous tyrosyl aaRS from Bacillus stearothermophilus, the Schultz 
group identified five residues in the active site that were within close proximity of the 
hydroxyl group of Tyr. These residues were initially all mutated to Ala and then the 
resulting DNA construct was subjected to random mutagenesis as these sites. The group 
combined this library of mutant o-aaRS enzymes with the o-tRNA they had crafted, and 
used this pair in several rounds of positive selection. Unlike the negative selection used 
for the generation of the o-tRNA, this procedure involved inserting a TAG codon into the 
DNA sequence (corresponding to a UAG mRNA codon) of chloroamphenicol 
acetyltransferase (CAT) and growing E. coli cultures in the presence of chloroamphenicol 
and an unnatural amino acid. E. coli cultures that survived exposure to chloroamphenicol 
were hypothesized to insert either the UAA or an endogenous amino acid in response to 
the UAG codon to produce full-length CAT. As the probability of either scenario was 
equal, the surviving E. coli strains and their mutant o-aaRS/tRNA pairs were then 
subjected to the same negative selection used for the generation of the o-tRNA. Just as in 
the process for generating the o-tRNA, surviving E. coli cultures maintained 
orthogonality and did not produce the full-length toxic protein barnase. The Schultz 
group, among others, has continued to use this in vivo evolution method, or similar 
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strategies, to develop a broad suite of o-aaRS/tRNA pairs capable of utilizing a diverse 
catalog of unnatural amino acids bearing novel functional groups or possessing unique 
properties62. Furthermore, several refinements of the o-tRNA sequence have been 
published that lead to better recognition by components of the E. coli translation 
machinery such as elongation factor thermo unstable (EF-Tu)63. 
 
Figure 1.6: Schematic Diagram of Amber Suppression Technology Utilizing an O-aaRS/tRNA Pair.  
Since the technology for the development of o-aaRS/tRNA pairs relies on selecting 
against only endogenous components, it would be theoretically possible for an o-
aaRS/tRNA pair to have activity for other unnatural amino acids for which it was not 
evolved. R. Mehl, a former member of the Schultz laboratory, has pioneered the 
screening of o-aaRS/tRNA pairs for their permissivity64. Noting that it is labor intensive 
to craft an o-aaRS/tRNA pair de novo for each new unnatural amino acid that one may 
desire to utilize as well as the fact that many useful functional groups are essentially 
isosteric (for example the cyano, ethynyl, and azide moieties), Mehl’s group began 
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screening previously evolved o-aaRS/tRNA pairs for their ability to use unnatural amino 
acids structurally similar to the one for which they were evolved. Gratifyingly, this 
approach has been tremendously successful and the Mehl group has been able to 
incorporate many structurally similar unnatural amino acids using only a few mutant o-
aaRS/tRNA pairs. While modest mutants may eventually prove useful or necessary to 
improve the affinity of the pair for a given unnatural amino acid, this requires much less 
time and finesse than de novo generation of o-aaRS/tRNA pairs.  
 
SITE-SPECIFIC INCORPORATION OF NOVEL FLUORESCENT AMINO 
ACIDS 
 
Figure 1.7: Line Diagrams of Ribosomally Permissible flUAAs Discussed in This Section. 
While an o-aaRS/tRNA pair was first developed to incorporate p-cyanophenylalanine 
(pCNF) site-specifically into proteins as an IR probe, the molecule had previously been 
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used in synthetic peptides as a FRET donor to Trp65. With this in mind, R. Mehl and S. 
Brewer evolved a new o-aaRS/tRNA pair capable of utilizing both pCNF and the 
structurally similar flUAA 4-ethynylphenylalanine (pENF) which is also a FRET partner 
with Trp66. pCNF fluorescence has been shown to be extremely sensitive to its 
surrounding environment. Since the nitrile moiety is capable of hydrogen bonding with 
bulk water as well as other polar functionalities, D. Raleigh and I. Carrico advise that 
interpretation of fluorescence measurements in which pCNF changes environment to be 
done in conjunction with IR measurements67. Furthermore, it was found by these 
investigators that pCNF is also quenched by Tyr and His, albeit at shorter distances than 
Trp, making donor only controls crucial for interpreting pCNF FRET data10. However, 
with these proper controls, pCNF can be used effectively to measure distances in proteins 
with an appropriate FRET partner. Other work in the Petersson laboratory, both with 
synthetic peptides and semi-synthetic proteins, has shown that pCNF is capable of being 
quenched by backbone thioamides in the context of CaM and the Parkinson’s disease 
protein α-synuclein68.  
7-hydroxycoumarin is a small well known fluorophore possessing a high quantum yield, 
a large Stoke’s shift, and, due to the phenol moiety’s pKa of roughly 7.8, a pronounced 
sensitivity to environmental conditions. While the use of this fluorophore had previously 
been limited to semi-synthetic applications, P. G. Schultz and coworkers were able to 
evolve an o-aaRS/tRNA pair capable of selectively using an amino acid with the 7-
hydroxycoumarin moiety in the amino acid side-chain (Hco)69. The initial studies 
reported in conjunction with the identification of the o-aaRS/tRNA highlighted the 
environmental sensitivity of the fluorophore; urea chemical denaturation of myoglobin 
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containing a buried Hco residue showed a positive correlation between the fraction of 
protein unfolded and an increase in Hco fluorescence, in line with the solvatochromic 
properties of the fluorophore. The Schultz group continued to exploit the environmental 
sensitivity of Hco in another study where they incorporated Hco into an antibody and 
monitored binding of its antigen via changes in Hco fluorescence70. They noted that it 
would not have been possible to attach a fluorophore site-specifically using the common 
method of labeling Cys residues with a fluorophore-maleimide conjugate as several 
disulfide bonds are required for proper folding of the antibody. Another use of Hco’s 
environmental sensitivity that more explicitly relies on the dynamics of the fluorophore’s 
phenol and its acid/base activity was reported by L. Wang and colleagues71. Using the 
published o-aaRS/tRNA for Hco, the group site-specifically incorporated Hco into the 
homodimeric substrate protein signal transducer and activator of transcription 3 (STAT3) 
in order to study the dynamics of phosphorylation of a specific Tyr residue. When 
properly folded, STAT3 forms a SH2 domain where Trp564 of one monomer is proximal 
to Tyr705 of the other. Moreover, Trp564 is distal to the Tyr705 residue on the same 
monomer unit. Thus, by mutating Trp564 to Hco, L. Wang envisioned that the 
fluorophore’s emissions would change in response to the presence or absence of a 
negatively charged phosphate group on Tyr705 on the other subunit. Their results showed 
a 13-fold increase in Hco fluorescence upon phosphorylation of Tyr705. This 
fluorescence increase was shown to be reversible upon addition of the dephosphorylase 
CIP, highlighting the ability of this technique to truly monitor phosphorylation dynamics 
of a specific amino acid residue. Furthermore, the experimenters point out that Trp564 
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and the SH2 domain are well conserved in other STAT proteins, making this a general 
technique for studying phosphorylation of these substrate STAT proteins.  
E. Chapman, in collaboration with P. G. Schultz, has used Hco to monitor the in vivo 
localization of specific proteins in E. coli. Two extensively studied E. coli proteins, the 
chaperonin GroEL and the bacterial tubulin homolog FtsZ, have previously proven 
elusive to accurate visualization in fluorescence localization studies, as fusion to FPs 
renders these proteins nonfunctional72. Attempting to resolve the controversy73 over 
whether heat shock induces a change in GroEL cellular localization in conjunction with 
upregulation, the experimenters installed Hco at position 129 of GroEL and monitored 
fluorescence recovery after photobleaching (FRAP) with irradiation of a specific portion 
of single cells74. Under all tested stress and heat shock conditions, it was shown that 
GroEL distribution remained diffuse as there were no significant changes in FRAP 
relative to cells treated under normal conditions. Additionally, the Hco mutant GroEL 
was shown to be functional by both ATPase activity in a malachite green assay and its 
ability to refold and restore enzymatic activity to malate dehydrogenase. Chapman and 
Schultz’s study of FtsZ, done with the aid of the groups of C. Jacobs-Wagner and A. 
Løbner-Olesen revealed that site-specific Hco incorporation allowed the monitoring of 
cytoskeletal assembly in living E. coli cells with fluorescence microscopy75.  Mutating 
Ala10 to Hco with amber suppression technology yielded a FtsZ mutant that was shown 
to be functional by GTPase activity and subsequent induced polymerization. This 
functionality allowed the experimenters to knock out endogenous FtsZ and prepare E. 
coli cells containing exclusively Hco10 labled FtsZ to monitor the polymerization 
dynamics of the protein. As FP fusion mutants of FtsZ were nonfunctional, previous 
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experiments had required the co-expression of wild-type FtsZ and thus meant lower 
resolution in fluorescence images as not all FtsZ molecules were fluorescent.  
 
Figure 1.8: Tracking FtsZ Depolymerization in Cells Using Hco. FtsZ10CouAA (Hco = CouAA) shows a 
small (~20 %) decrease in polymerization ability (top left) while maintaining GTPase activity close to wild 
type wt (top right). A time-course depolymerization of FtsZ10CouAA at 0, 15, and 30 min following addition 
of GTP (bottom three panels). Adapted figure reproduced from Charbon et al. with permission from Wiley-
VCH75. 
7-hydroxycoumarin’s 464 nm emission is well suited to FRET interactions with other 
exogenous fluorophores such as the BODIPY dyes, making it a useful probe for 
quantitative binding measurements in biophysical assays. S. Shan’s research group used  
the Hco o-aaRS/tRNA system in vitro to generate ribosome-nascent chain complexes 
(RNCs) where the nacent peptide chain contained a Hco residue76. The experimenters 
noted that they chose to use the o-aaRS/tRNA method as opposed to chemically acylated 
semi-synthetic tRNA to reduce the amount of Hco used since the enzymatic method gives 
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higher yields with less material by regenerating hydrolyzed aa-tRNA. As the ribosome 
has been shown to nonspecifically bind hydrophobic compounds, such as polyaromatic 
fluorophores like Hco, Shan and coworkers had to keep free Hco concentrations at 50 µM 
or lower to yield RNCs with Hco only in the backbone of the nascent chain. With these 
fluorescent RNCs in hand, Shan’s group then mutated a nonconserved residue in the 
signal recognition particle (SRP) to Cys and labeled it with BODIPY-maleimide to create 
a FRET acceptor to test the functionality of the RNCs. Upon addition of BODIPY-SRP to 
a solution of RNCs with Hco in the nascent chain, energy transfer was observed with an 
efficiency of 0.8 at saturating concentrations of labeled SRP. This FRET assay was 
shown to be specific by a lack of energy transfer in BODIPY-SRP titrations with Hco-
RNCs containing a nascent chain engineered to not to be a substrate for SRP. Shan 
further demonstrated the functionality of the Hco-RNCs by using the calculated FRET 
efficiency and equilibrium titrations to calculate a Kd value that agreed with others 
reported previously for similar complexes. These experiments demonstrate the utility of 
genetically encoded amino acids to prepare site-specifically labeled complex 
biomolecules.  
The second UAA reported to be site-specifically incorporated in vivo in E. coli by the 
Schultz lab was the weakly fluorescent L-3-(2-napthyl)alanine (Nap)77. They also 
engineered an o-aaRS/tRNA pair derived from an E. coli LeuRS for incorporation of Nap 
in Saccharomyces cerevisiae. As the fluorescence properties of this UAA are not 
particularly useful, this report was more significant for the role of Nap in the 
development of o-aaRS/tRNA pairs containing large side-chains such as Hco and 3-(6-
acetylnaphthalen-2-ylamino)-2-aminopropanoic acid (ANAP). When initial evolution 
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experiments aimed at creating a o-aaRS/tRNA pair for ANAP failed, Schultz’s group 
attempted to use the pair evolved for Nap as a starting point and engineer specificity for 
the 6-acetyl group78. This strategy proved to be far more successful than their earlier 
trials and yielded an o-aaRS/tRNA pair for ANAP incorporation in S. cerevisiae. Like 
Hco, ANAP is extremely environmentally sensitive. To probe the utility of monitoring 
changes in ANAP fluorescence in response to changes in local environment the Schultz 
group incorporated ANAP into a glutamine-binding protein (QBP) from E. coli. This 
protein contains two globular domains which symmetrically surround a Gln binding site. 
By mutating a residue within this binding site, Asp160, it was envisioned that the 
movements of the two globular domains in response to Gln binding could be monitored 
by changes in ANAP fluorescence.  Their experiments showed a large shift in λemmax 
from 480 nm to 430 nm with fluorescence at 430 nm increasing 5 fold upon addition of 
Gln. There were no significant changes in fluorescence anisotrophy between the Gln 
bound and free forms of QBP, demonstrating that the change in ANAP fluorescence was 
due solely to changes in the local environment.  
Since the ANAP o-aaRS/tRNA was evolved from an E. coli LeuRS, it is orthogonal to all 
eukaryotic systems, including mammalian cells. In 2013, Schultz and coworkers reported 
the use of ANAP and its o-aaRS/tRNA in live HEK293 and CHO cells79. By designing 
mutants of several proteins whose cellular localizations were well known, the 
experimenters demonstrated the ability of site-specifically incorporated ANAP to reliably 
report on the cellular trafficking of proteins in vivo. Additionally, since ANAP is capable 
of two-photon excitation, the group used this technique to image ANAP containing 
proteins, rendering this technology applicable to use in situations where light penetration 
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or phototoxicity from conventional light sources is problematic.  A study published 
concurrently by the group of R. Blunck used the ANAP o-aaRS/tRNA system to site-
specifically label Kv channels in Xenopus oocytes80. While a flUAA has previously been 
incorporated site-specifically into an ion channel protein in Xenopus oocytes using 
chemically acylated semi-synthetic tRNA81, the Blunck group found that the use of the 
orthogonal enzymatic system allowed for higher expression levels. The most effective 
method for simultaneously monitoring the functional and structural dynamics of 
membrane ion channels is voltage-clamp fluorometry (VCF). Traditionally VCF is 
limited to the use with labeled Cys-mutant proteins, which are viable only when labeled 
at surface-accessible residues. This method is accurate because it gives fluorescence data 
in direct response to changes in voltages applied to cell membranes. However its 
resolution is limited by the sensitivity of the fluorophore, its proximity to the site of 
voltage-dependent movement, and perturbations to channel structure due to probe 
installation. Therefore, Blunck’s group used the ANAP o-aaRS/tRNA system to 
genetically incorporate ANAP at positions most crucial for monitoring the protein’s 
dynamics and not limited by solvent accessibility: V234 (S1 helix; proximal to lower S4 
helix), A359 (upper S4 helix), and H486 (lower S6 helix, near C-terminus). By installing 
ANAP at these positions, the experimenters were able to collect data on the entire gating 
event beginning with “pre-gating” closed state transitions and up to complete pore 
opening. Specifically, the group found that the early closed state transitions were only 
observed in the N-terminal region of the S4 helix and, despite identical voltage 
dependence, the N-terminal and C-terminal portions of S4 change conformation 
discontinously. Additionally, the group found three transitions in the voltage sensor 
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movements, in line with a hypothesized kinetic model generated from electrophysical 
measurements by Schoppa and Sigworth82.  Blunck’s work showed that the use of 
genetically incorporated flUAAs allow VCF measurements with higher temporal and 
structural resolution than those made with post-translationally labeled Cys mutants.  
 
Figure 1.9: Simultaneous Observation of Conformational Change and Conductance in a Kv Channel. Top 
left: cartoon of transmembrane sements S1-S6 of Kv1.2/2.1 chimera protein. Top right: Kv1.2/2.1 S4 
domain, residue Ala359 (location of ANAP installation) is marked in red and Arg residues are shown in 
blue. Bottom left: fluorescence (dF, red), gating charge (Q, black), and conductance (G, blue) as a function 
of membrane potential in the Ala359ANAP mutant. Gating currents and ANAP fluorescence responses after 
pulses from -90 mV to potentials between -180 and 50 mV. Adapted figure reproduced from Kalstrup et al. 
with permission © (2013) from the National Academy of Sciences80. 
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In similar experiments, the labs of L. Y. Jan and S. Boxer showed that a fluorophonre 
similar to ANAP, Aladan, was tolerated in the translation machinery of Xenopus oocytes 
and were able to create Kir2.1 and Shaker potassium channels containing Aladan at 
various sites83. Other work in the lab, with Aladan installed into the IgG-biding domain 
GB1 via solid phase peptide synthesis, replicated the work of A. R. Chamberlin and 
showed that the fluorescence maxima of the fluorophore is shifted in the context of a 
protein. By comparing the fluorescence spectra of Aladan at both buried and solvent 
accessible sites, and ensuring that the orientation of the fluorophore did not change by 
anisotropy experiments, the experimenters were able to show that changes in Aladan 
fluorescence can accurately be used to reflect changes in its local environment. 
Specifically they found that the more exposed Aladan was to bulk solvent (water) the 
greater the degree of a bathochromic shift and decrease in fluorescence intensity. 
The dansyl fluorophore has been site-specifically incorporated into proteins utilizing a 
variety of methods and on a variety of amino acid scaffolds. It was first shown to be 
ribosomally permissible by the lab of A. R. Chamberlin in 1996 when it was site-
specifically incorporated into β-galactosidase as ε-dansyllysine (ε-danLys) using semi-
synthetic tRNA methods84. ε-DanLys was shown to be directly excited at 280 and 295 
nm, along with endogenous Trp residues, and selectively excited at the lower energy 
absorption band of 340 nm. Excitation at 340 nm revealed a fluorescence emission 
maximum at roughly 500 nm, which is shifted from the spectrum of the fluorophore in 
water, but in good agreement with spectra of proteins labeled posttranslationally with 
dansyl chloride.  
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In 2006, P. G. Schultz and coworkers were able to develop an o-aaRS/tRNA pair, derived 
from the E. coli LeuRS for use in S. cerevisiae, capable of utilizing 3-(5-
(dimethylamino)naphthalene-1-sulfonamide)propanic acid (danAla), a flUAA containing 
the dansyl fluorophore on a unique scaffold85. In line with previous reports, Schultz’s 
group found that when danAla was installed at a buried location (Trp33) within the well 
folded protein human superoxide dismutase (hSOD) the fluorescence increased in 
intensity and its maxima was blue-shifted. When the protein was chemically denatured 
with guanidinium hydrochloride, the fluorescence of danAla at buried locations 
decreased in fluorescence intensity and its blue-shift was relieved. This was shown to be 
a useful measure of changes in the environment around position 30 in hSOD as the same 
experiments with the solvent exposed residue 16 (natively Gln) showed no change in 
response to chemical denaturation.  
Like the o-aaRS/tRNA pair for ANAP, the E. coli origin of the danAla pair allows its use 
in a broad suite of eukaryotic systems. L. Wang and coworkers used the technology to 
incorporate danAla at two sites in the voltage-sensitive domain (VSD) of Ciona 
intestinalis voltage-sensitive phosphatase (CiVSD)86. Since there have been reports of 
CiVSP having different movement speeds in response to the same gating charge between 
mammalian cells and Xenopus oocytes, L. Wang’s group conducted their experiments in 
the neuronal stem cell HCN-A94. Using the rat Shaker potassium channel as a model, 
they created an in silico model of CiVSD and picked residues Phe234 and Gln208 as sites 
to mutate to danAla as these sites are on opposite ends of helix S4 and thus could report 
on its voltage-dependent movement. As Phe234 is on the intracellular face of the protein 
and exposed to bulk cytosol, it had proven difficult to label with post-translational 
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techniques and thus was a prime candidate for study with a genetically incorporated 
flUAA. The group’s results showed that the Phe234danAla mutant showed an increase in 
fluorescence, indicating a movement of the fluorophore into a less polar environment, 
while the Gln208danAla mutant showed the opposite. These findings, including the first 
fluorescence measurement for a label at position 234, showed that the ends of S4 move in 
opposite directions in response to membrane depolarization. Furthermore, the fact that a 
slightly more positive membrane voltage was required to depolarize the Gln208danAla 
mutant relative to wild-type, suggests that the more hydrophobic fluorophore was buried 
in the hydrophobic lipid membrane, requiring a greater driving force to move. This result, 
while speculative, is entirely in line with the observed decrease in fluorescence intensity 
(movement from a hydrophobic to a hydrophilic environment) upon membrane 
depolarization in this mutant. L. Wang has continued to expand the use of the o-
aaRS/tRNA pair in complex systems, including a report of its use in Caenorhabditis 
elegans87.  
 
SITE-SPECIFIC INCORPORATION OF A FLUORESCENCE QUENCHING 
PROBE 
 The site-specific genetic incorporation of fluorescence probes is not limited to just 
fluorophores themselves. First used by M. Sisido as early as 1998, p-nitrophenylalanine 
(pNO2-F), a ribosomally permissible UAA, has been shown to efficiently accept electrons 
from the excited states of pyrenyl, β-anthraniloyl, and indole fluorophores, effectively 
quenching their fluorescence88. However early reports by Sisido used chemically acylated 
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semi-synthetic tRNA and, like early genetically incorporable flUAAs, suffered from low 
yields and limited applications. In 2006, P. G. Schultz’s group evolved an o-aaRS/tRNA 
pair for use in E. coli capable of using pNO2-F89. Using a model GCN4 leucine zipper 
protein that is known to spontaneously assemble into parallel coiled-coil homodimers, the 
group made both single pNO2-F and Trp mutants (GCN4 does not natively contain any 
Trp residues). By adding stoichiometric amounts of F22pNO2-F mutant GCN4 into 
solutions of various GCN4 Trp mutants, the experimenters were able to calculate 
distances between Trp residues and pNO2-F residues by changes in quenching efficiency. 
As pNO2-F has been shown to quench the fluorescence of both endogenous and 
exogenous fluorophores and an o-aaRS/tRNA has been developed for its genetic 
incorporation in E. coli, it serves as a compliment to the several genetically encodable 
flUAAs.  
 
TOWARDS MORE MINIMALISTIC PROBES FOR FLUORESCENCE AND 
FUNCTIONAL STUDIES  
Acknowledging the need for truly minimalist site-specific probes to more accurately 
study protein structure and dynamics, the Petersson lab strives to provide such tools to 
the biophysical community. We identified Acd as part of a robust study of the ability of 
red-shifted fluorophores to transfer energy to thioamides, a single atom substitution of the 
polypeptide backbone capable of quenching fluorescence through a variety of 
mechanisms. Acd is a ribosomally permissible fluorescent amino acid that possesses a 
long lifetime (τ = 16 ns), resilience to photobleaching, a near unity quantum yield (φ = 
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0.95), and visible wavelength emission. While previous literature reports relied on semi-
synthetic tRNA methodology and in vitro translation reactions to site-specifically install 
Acd into proteins, we, in conjunction with Professor R. A. Mehl of Oregon State 
University, have identified a permissive o-aaRS/tRNA pair capable of using Acd as a 
substrate. Furthermore, we have used this orthogonal enzymatic pair to site-specifically 
incorporate Acd into three proteins and characterize the dynamics of Acd with respect to 
changes in its local environment and proximity to both endogenous and exogenous 
fluorescent amino acids.  
In addition to work with Acd and other minimally perturbing fluorescent probes, we have 
collaborated extensively with the C. J. Deutsch laboratory in the Physiology Department 
of the Perelman School of Medicine at the University of Pennsylvania to study the 
traversal of nascent peptides through the ribosomal exit tunnel. Previous studies by the 
Deutsch group have probed the accessibility of Cys residues on a nascent peptide as a 
way of determining the contours of the exit tunnel as a function of the primary or second 
structure of a nascent peptide. The results of these studies have indicated that nascent 
peptides and/or the tunnel rearrange to accommodate sterically large side-chains. To 
expand upon this, we have worked with the group to explore the difference in transit time 
of nascent peptides bearing UAAs with unusually large side-chains. These new methods, 
which involve the probes being ribosomally incorporated as opposed to post-
translationally attached, are aimed at better elucidating effects of large sidechains on the 
time-course of protein elongation and folding in the exit tunnel. Thus, these methods 
represent a type of minimalistic chemical probe of protein folding, to complement 
minimalist fluorescent probes such as Acd and its derivatives. 
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CHAPTER 2: ACRIDON-2-YLALANINE: SYNTHESIS, IN VIVO 
INCORPORATION, AND BIOPHYSICAL STUDIES 
Adapted in part with permission from Goldberg, J. M.; Speight, L. C.; Fegley, M. W.; 
Petersson, E. J., Minimalist Probes for Studying Protein Dynamics: Thioamide 
Quenching of Selectively Excitable Fluorescent Amino Acids. Journal of the American 
Chemical Society 2012, 134 (14), 6088-6091. Copyright (2012) American Chemical 
Society and Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, 
R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and 
In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent Amino Acid for Lifetime 
and Forster Resonance Energy Transfer/Luminescence Resonance Energy Transfer 
Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-18814. 
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BACKGROUND: ACD PRIOR STUDIES AND PHOTOPHYSICS 
Acridon-2-ylalanine (Acd), a ribosomally permissible fluorescent unnatural amino acid 
(flUAA) with numerous robust photophysical characteristics, was chosen as a target 
unnatural amino acid (UAA) for the identification of an orthogonal aminoacyl tRNA 
synthetase/tRNA (o-aaRS/tRNA) pair to extend its use to in vivo applications. The Mehl 
group’s strategy of screening previously evolved mutant o-aaRS/tRNA pairs for their 
permissivity was chosen as the group had previously worked with UAAs of similar 
shapes and sizes such those with a benzophenone side-chain. Acd’s side-chain 
fluorophore, a linear fusion of three six-membered rings, is truly a minimalistic probe 
with a volume of 222 Å3 making it only modestly larger than Trp (47 % larger; for 
comparison, fluorescein is > 200 % larger). While this does infer a nontrivial increase in 
size when replacing a Trp or Tyr residue with Acd, the steric cost of such a substitution 
comes with several payoffs in terms of fluorescence properties. Acd is a blue wavelength 
fluorophore with its most useful λabs for excitation at 386 nm, λem  at 420 – 450 nm, a near 
unity quantum yield in water (Φ = 0.95), modest molar extinction coefficient (ε = 5700 
cm-1), resistance to photobleaching (< 5 % photobleaching after 3 hours of continuous 
irradiation), and an unusually long fluorescence lifetime (τ =16 ns)57, 90, 91. 
Initial investigations of Acd in the Petersson laboratory involved pairing it with a 
minimalistic fluorescence quenching probe studied by the group: the thioamide91. Our 
laboratory had previously disclosed our findings that a single atom substitution of an 
oxygen atom for sulfur in an amide renders the resulting moiety (a thioamide) capable of 
quenching the fluorescence of endogenous fluorophores such as Tyr and Trp as well as 
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exogenous probes such as pCNF92, 93. However these experiments were limited by the 
fact that it is difficult to selectively excite these probes in the context of a protein 
harboring more than one of these residues or in complex mixtures such as cell lysates. In 
our efforts to solve this problem, we investigated the ability of thioamides to quench 
more red shifted fluorescence probes with a particular emphasis on those capable of 
being installed as amino acid side-chains. Our initial studies focused on 7-azatryptophan 
(7-azaTrp), 7-methoxycourmarin (Mcm), and Acd (1) (Figure 2.1). Since both 7-azaTrp 
and Mcm are excited below 350 nm and thioamides absorb very strongly in this region of 
the spectrum, it was difficult to quantify the quenching effects in Stern-Volmer 
experiments. Acd fortunately did not display this issue as it is capable of direct excitation 
by irradiation at 386 nm which is significantly removed from the absorption spectrum of 
a thioamide. Additionally, Acd has the added benefit of its high quantum yield in water 
when compared to the other studied probes (φ7azaTrp = 0.01 and φMcm = 0.18). 
Additionally, it is important to note that the emission spectra of neither Acd nor 7-azaTrp 
or Mcm overlap with the absorption profile of a thioamide, making the mechanism of this 
quenching Photo-induced Electron Transfer (PET).  
 
Figure 2.1: Line Diagrams of Acd, Mcm, and 7-azaTrp. 
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Titration of a prototypical thioamide, thioacetamide, into solutions of Acd to create a 
Stern-Volmer plot revealed that the fluorescence of Acd varied inversely with 
thioacetamide concentration (Figure 2.2). Furthermore, the Stern-Volmer constant, KSV, 
increased with temperature suggesting that the observed quenching interaction may result 
from a dynamic electron transfer event. To further characterize the quenching, time-
correlated single photon counting (TCSPC) spectroscopy was used to examine the change 
in Acd fluorescence lifetimes in the presences of varying concentrations of 
thioacetamide. These experiments revealed a KSV that agreed well with the steady-state 
measurements and all lifetime data could be fit with a single exponential function 
(Figure 2.3). 
 
Figure 2.2: Steady-State Stern-Volmer Experiments with Acd and Thioacetamide. Left: Stern-Volmer plots 
of thioacetamide quenching Acd at several temperatures. Error bars are calculated from standard error. 
Right: Stern-Volmer constants and goodness-of-fit values for each temperature. Reprinted with permission 
from Goldberg, J. M.; Speight, L. C.; Fegley, M. W.; Petersson, E. J., Minimalist Probes for Studying 
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Protein Dynamics: Thioamide Quenching of Selectively Excitable Fluorescent Amino Acids. Journal of the 
American Chemical Society 2012, 134 (14), 6088-6091. Copyright (2012) American Chemical Society. 
 
Figure 2.3: Dynamic Stern-Volmer Quenching of Acd. Left: Fluorescence lifetime measurements of 2 µM 
Acd in 100 mM phosphate buffer, pH 7.00 at 25 °C in the presence of 50 mM acetamide (X, blue fit) or 50 
mM thioacetamide (O, red fit). Heavy lines are single exponential fits to the raw data. Right: Stern-Volmer 
plots of Acd fluorescence intensity (green circles) and lifetime (black triangles) as a function of 
thioacetamide concentration; error bars represent standard error. Reprinted with permission from Goldberg, 
J. M.; Speight, L. C.; Fegley, M. W.; Petersson, E. J., Minimalist Probes for Studying Protein Dynamics: 
Thioamide Quenching of Selectively Excitable Fluorescent Amino Acids. Journal of the American 
Chemical Society 2012, 134 (14), 6088-6091. Copyright (2012) American Chemical Society. 
To demonstrate the practical utility of the Acd/thioamide fluorescence probe pair we 
synthesized the well characterized short peptide, the villin headpiece subdomain (or 
HP35). This polypeptide has been shown by our own laboratory and others to fold into a 
compact structure where the N- and C-termini are within 20 Å of one another. Previously, 
this construct has been used in our laboratory to examine the Fӧrster Resonance Energy 
Transfer (FRET) interaction between p-cyanophenylalanine (pCNF) and a thioamide; 
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however, in these experiments Trp23 was mutated to Phe to allow for selective excitation 
of the pCNF fluorophore. As Acd can be directly excited in the presence of Trp, this 
mutation was not used and HP35 was synthesized with a C-terminal Acd residue and an 
N-terminal leucine (Leu) harboring a backbone thioamide. Additionally, an oxo-peptide 
control was also synthesized from the same batch of resin but with the final coupling 
being done with standard Fmoc-Leu-OH. After confirming that these substitutions did not 
alter the α-helical fold of the peptide with circular dichroism (CD) spectroscopy, both 
steady-state and dynamic fluorescence spectroscopy analyses were performed. In the 
steady-state 16 % quenching of Acd by the thioamide relative to an oxoamide control was 
observed at 1 °C. This effect increased with increasing temperature with a plateau of 22 
% at 66 °C and a sharp decrease to 15 % at 95 °C (Figure 2.4). We justified this by 
examining the CD spectrum of the construct undergoing a thermal melt. Transforming 
the data into fraction folded, we observed that as the temperature increased in the 1 – 66 
°C range, the folded polypeptide became mildly disordered, thus increasing the 
probability of Acd contacting the thioamide and its fluorescence being quenched. This 
quenching effect increased until the polypeptide began to globably unfold and the 
distance between the probes increased.  
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Figure 2.4: HP35 Model System for Thioamide Quenching of Acd. Left: Fluorescence intensities of HP35 
labeled exclusively with Acd (blue trace) and HP35 labeled with Acd and thioleucine (Leu’) at opposite 
termini (red trace). Right: Ribbon diagram of folded HP35 with Acd and thioleucine represented as line 
diagrams. Reprinted with permission from Goldberg, J. M.; Speight, L. C.; Fegley, M. W.; Petersson, E. J., 
Minimalist Probes for Studying Protein Dynamics: Thioamide Quenching of Selectively Excitable 
Fluorescent Amino Acids. Journal of the American Chemical Society 2012, 134 (14), 6088-6091. 
Copyright (2012) American Chemical Society. 
Interpretation of the dynamic quenching observed in the Acd/thioamide labeled HP35 
required more thoughtful deconvolution. Unlike the studies with free Acd, the lifetime 
data of the Acd/thioamide HP35 could not be fit to a single exponential function. Instead, 
the dynamic quenching observed could be best fit by a biexponential fit. To understand 
why this deviated from the data we retrieved by the Stern-Volmer titrations, we 
subsequently examined the dynamic thioamide quenching of Acd in the context of short 
proline (Pro) and glycine (Gly) peptides. While oxoamide control peptides could be fit to 
single exponential functions, none of the dual labeled constructs could. Instead, a 
biexponential function was also necessary in these cases. The requirement of the 
biexponential fit in both the HP35 and short peptide examples gives evidence that there is 
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some quenching that is independent of the Acd/thioamide interaction. This is not an 
uncommon phenomenon; redox-active amino acids such as tryptophan (Trp), tyrosine 
(Tyr), histidine (His), methionine (Met), and cysteine (Cys), as well as terminal amines 
(such as the N-terminus of any polypeptide) have been shown to quench the fluorescence 
of fluorophores in the context of a protein10, 91, 94. The biexponential fit also indicates that 
there may be two populations of peptide configurations, with greater and lesser degrees 
of quenching. 
As we began to contemplate the incorporation of Acd into large polypeptides and 
proteins, we sought to thoroughly examine the effect that proteinaceous functional groups 
could have on the fluorophore. Such environmental effects could be useful in creating 
dual-labeled proteins and studying changes in folding properties. Further, we deemed it 
necessary for us to fully understand Acd’s dynamics not only for the aforementioned 
types of experiments, but also to create a background measurement for using Acd as a 
FRET or PET probe with other exogenous fluorescence probes. After performing Stern-
Volmer titrations of Acd with the endogenous amino acids Tyr, Trp, Met, Cys, Met, His, 
and Gly, it was shown that Acd is quenched significantly by Trp and Tyr (Figure 2.5).  
The lack of spectral overlap between Acd’s emissions and Trp and Tyr’s absorption 
spectra combined with the data from both steady-state and dynamic fluorescence 
measurements indicated that Acd is quenched by these moieties through a PET 
mechanism. This mechanism has both static (where a nonemissive ground state complex 
is formed) and dynamic (where an electron is transferred in the excited state) 
components. These environmental effects reveal that these residues can be used as part of 
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fluorophore/quencher pairs with Acd and that other uses of Acd, such as FRET, require 
careful ‘Acd only’ controls to ensure proper measurements. 
 
Figure 2.5: Acd Stern-Volmer Interactions with Endogenous Amino Acids. Quenching by endogenous 
amino acids assessed though steady-state fluorescence Stern-Volmer titrations with five amino acids: Trp 
(filled red circles), Met (orange circles), Cys (green  upright triangles), His (pale blue downward triangles), 
Tyr (filled dark blue diamonds). Tyr methyl ester used for solubility, all other amino acids used as free 
acids. Inset: Fluorescence lifetime Stern-Volmer titrations with Trp (open red circles) and Tyr (open dark 
blue diamonds). Steady-state data shown for comparison. Reprinted with permission from Speight, L. C.; 
Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. 
A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent 
Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy 
Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright 
(2013) American Chemical Society. 
Due to significant overlap of Trp’s emission spectra within the excitation spectra of Acd, 
Trp and Acd make a reasonable FRET pair with a Fӧrster radius (R0) of 23 Å. This 
distance allows robust distance measurements in the 13 – 37 Å range. Trp/Acd FRET 
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pairs would be very useful because they could be entirely genetically-encoded, 
eliminating the need for post-translational labeling and purification. However this probe 
pair is far from ideal as it is difficult to separate the PET quenching effects from a FRET 
interaction. Additionally, as Acd has a strong absorbance band at 260 nm, one must 
excite Trp at no less than 290 nm to minimize direct excitation of the acceptor in Trp/Acd 
FRET experiments. We then examined the utility of other probes for use as a FRET probe 
with Acd in order to find a pair in which FRET was the only interaction and selective 
excitation of the donor is possible. With Acd still filling the role of the acceptor in FRET 
experiments, Mcm is a potent possible donor. The ample spectral overlap of these two 
fluorescent unnatural amino acids provides a R0 of 25 Å, making them ideal for distance 
measurements between 15 – 45 Å. Additionally, Acd can act as the acceptor with several 
common organic fluorophores such as carboxyfluorescein (R0 = 51 Å), BODIPY-Fl (R0 = 
49 Å), rhodamine 6G (R0 = 49 Å), and nitrobenzodioxazole (NBD; R0 = 37 Å). Only the 
carboxyfluorescein probe pair was tested in a model peptide system and unfortunately 
was shown to be non-ideal; the excitation band of carboxyfluorescein extends 
significantly into the excitation range of Acd. This complication precludes the use of this 
FRET pair as excitation of Acd at 386 nm leads to substantial direct excitation of 
carboxyfluorescein, Finally, there is literature precedent for Acd having substantial 
sensitivity to the polarity of its local environment where Φ can change from 0.95 in water 
to 0.29 in tetrahydrofuran (THF). This sensitivity to local polarity, as well as the other 
environmental and energy transfer properties of Acd, highlights the probe’s versatility as 
a biophysical tool.  
54 
Previously the Sisido group and collaborators have shown that Acd is ribosomally 
permissible using semi-synthetic tRNA strategies57. However, the limitations of this 
method (aa-tRNA is prone to hydrolysis and semi-synthetic versions are labor intensive 
to fabricate) inspired us to work with the Mehl group to identify an o-aaRS/tRNA pair 
capable of selectively using Acd as a substrate. Such a finding would allow us to produce 
site-specifically Acd labeled proteins on a scale conducive to yielding the milligram 
quantities of fluorescent protein needed for routine fluorescence experimentation. It is 
important to note that the generation of an o-aaRS/tRNA pair for Acd does not preclude 
its use exclusively to in vivo applications; however these methods are the most straight-
forward. Several groups have created in vitro translation systems capable of yielding 
milligram quantities of site-specifically labeled proteins harboring UAAs yet these 
technologies are generally fairly labor intensive to setup and/or are exclusive to the 
laboratory in which they were developed95, 96. In vivo methods on the other hand are 
much more enabling; if another group desires to take advantage of our methods they 
would need only a plasmid containing the o-aaRS/tRNA pair and a stock of the UAA to 
begin their own experiments within days.  
 
SYNTHESIS OF ACD 
The first step in the identification of an o-aaRS/tRNA pair and the development of in vivo 
incorporation methods for Acd was to devise an efficient, scalable synthesis of the UAA 
that could be used to prepare the gram quantities necessary for routine protein expression. 
These considerations were taken to make the use of Acd as a minimalistic site-specific 
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fluorescent protein label as general as possible. Previous routes to Acd utilized the UAA 
p-nitrophenylalanine (pNO2-F) as the principle starting material90. After installation of 
methyl ester (OMe) and t-butyl carbamate (Boc) protecting groups, the resulting 
compound (3) was hydrogenated with palladium on carbon (Pd/C) under a hydrogen 
atmosphere.  While the literature account of this transformation claimed it was high 
yielding (94 %), our group could not reproduce this efficiency under the described 
conditions (10% Pd/C in methanol (MeOH) under H2 for 2 hours). Instead, our group saw 
the formation of a side-product which could total as much as 15% of the total organic 
species after filtration of the catalyst. Initially it was assumed that this was an aryl-diazo 
compound formed by interaction of two product molecules with the Pd catalyst, however 
careful analysis of the H1 NMR of this product and the starting material revealed that it 
was a N,N’-diBoc protected species. The formation of this side-product was the result of 
some of the starting material harboring two Boc-groups on the α-amine due to the use of 
an excess of Boc-anhydride in the previous reaction followed by subsequent Pd-mediated 
transfer of one Boc group to the newly formed amine. Since the N,N’-diBoc material 
exhibited the same mobility on silica gel as the singly N-protected material, these were 
difficult to separate.  Thus, less Boc-anhydride was used in the N-terminal protection, and 
exclusively singly Boc-protected compound 4 was obtained. Furthermore, as proton 
transfer would be necessary for this Boc migration to occur, the solvent for the 
hydrogenation was changed from polar protic MeOH to polar aprotic ethyl acetate 
(EtOAc). The combined effects of these two changes led to quantitative conversion of the 
protected aryl nitro amino acid into the protected aryl amine amino acid, a 6 % 
improvement over the literature precedent (Scheme 2.1). 
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Scheme 2.1: Synthesis of Acd (1) Starting from p-NO2-F With Modifications Described in This Work. 
Following the hydrogenation of the protected aryl nitro amino acid, the next literature 
step was to couple the resulting amine (4) to iodobenzoic acid under copper (Cu) metal 
catalysis in a transformation known as the Ullman/Goldberg biaryl amine synthesis. 
Despite the ubiquitous nature of this transformation for the formation of biaryl amines, 
the mechanism is still poorly understood, especially when Cu powder is employed as the 
catalyst. Either Cu(I) or Cu(II) mechanisms can be responsible for the observed 
transformation, and it is possible that using Cu powder allows both mechanisms to be 
operative in the same pot (Figure 2.6). As the relative contributions of the Cu(I) and 
Cu(II) mechanisms may vary with subtle changes in conditions, it is not surprising that 
experimentally this transformation was not consistent with respect to the overall yield of 
the desired biaryl amine (5) and/or the levels of side-products formed. Despite these 
difficulties it was possible to produce gram scale quantities of pure biaryl amine (5) for 
subsequent transformations into the Acd fluorophore. 
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Figure 2.6: Cu(I) and Cu(II) proposed mechanisms for Ullman/Goldberg Biaryl Amine Synthesis. X = I, 
Br, Cl, SCN and L = ligand (typically diamines) 
With the protected biaryl amine functionalized amino acid (4) in hand, the next step in 
the literature protocol was to use the strong Lewis acid and mild Brønsted acid 
polyphosphoric acid (PPA) and heat to catalyze an intramolecular Friedel-Crafts’ 
acylation between the carboxylic acid of the newly coupled aryl ring to the ortho-position 
of the aryl ring closest to the amino acid backbone. This transformation completes the 
formation of the linear tricyclic heteroaromatic acridone nucleus while liberating the 
backbone amine from its Boc protecting group due to the acid conditions. As PPA is a 
strong Lewis acid, but mild Brønsted acid, and no water was deliberately added to the 
reaction, compound 6 was obtained with the methyl ester intact. As our interest in Acd 
was to use it as substrate for Fmoc based solid-phase peptide synthesis (SPPS) or in vivo 
incorporations, we desired to follow the PPA mediated Friedel-Crafts acylation and Boc 
deprotection with an immediate treatment with strong nucleophilic hydroxide base to 
liberate the OMe. These efforts were met with success; we were able to complete our 
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modified synthesis of the completely deprotected Acd (1) in 54 % overall yield. This was 
a dramatic improvement over the literature protocols for this route which yielded Acd 
still protected as the OMe in 23.6 % yield (Scheme 2.1).  
While our laboratory was successful not only in reproducing the literature pNO2-F route 
to Acd but also in improving its yield by over a factor of two, the synthesis was still not 
ideal. As the principle source of poor yields in the pNO2-F route was the Cu powder 
mediated coupling of 4 to iodobenzoic acid, we focused on this transformation in 
evaluating new routes to Acd. It was determined that Buchwald-Hartwig Pd-mediated 
amine cross-couplings could be a viable replacement for the inconsistent 
Ullman/Goldberg biaryl amine synthesis. The Buchwald-Hartwig amine cross-coupling, 
in contrast to the Ullman/Goldberg, requires only catalytic amounts of transition metal, 
more easily manageable solvents than DMF, and has been shown repeatedly in the 
literature to reliably produce coupled products in high yields97. While it would have been 
possible for us to simply replace the Ullman/Goldberg reaction with the Buchwald-
Hartwig and still use the same coupling partners, we envisioned that starting from another 
more common amino acid would make our new synthetic route more straight-forward, 
reproducible, and amenable to derivatization.  
Examination of the literature for amino acid derivatization revealed that synthesis of p-
iodophenylalanine was possible in moderate yields. As the iodo functionality is robust in 
coupling chemistry, it was initially envisioned as an ideal starting place for this new Acd 
synthesis. However the synthesis of this halogenated Phe derivative requires harsh 
reagents and conditions, limiting the potential scope of application of our method to 
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groups equipped to handle such an endeavor and the idea was subsequently abandoned98. 
While iodo functionalization is known to lead to robust couplings, Buchwald-Hartwig 
amine couplings are also capable of utilizing triflate (OTf) functionalized coupling 
partners as electrophiles. Fortunately, there was ample literature precedent for the 
synthesis of N-Boc-Tyr(OTf)-OMe (9) and we were able to produce this compound 
reliably in three steps from Tyr in 96 % overall yield99. Furthermore, an acceptable 
coupling partner was found in the commodity chemical methyl-2-aminobenozate 
(commonly known as methyl anthranilate and used as grape flavoring and as a bird 
repellent). 
After identifying these coupling partners, we then took advantage of the collaboration 
between the University of Pennsylvania’s Department of Chemistry and Merck to use the 
staff and equipment of the High-Throughput Experimentation Laboratory to screen 
optimal conditions for the Buchwald-Hartwig Pd-mediated amine coupling. The 
parameters of most interest to us were: solvent, reaction temperature, base, and Pd to 
ligand ratios. Initial investigations conducted prior to screening revealed that the 
economical ligand racemic 2,2’-bis(diphenylphosphino)-1,1’-binaphthyl (BINAP) was 
capable of facilitating the desired transformation and as such was kept constant in these 
initial screens. The other components of the screen kept constant were: 1.2 equivalents of 
amine and 3.0 equivalents of base relative to 9, Pd source (palladium(II) diacetate: 
Pd(OAc)2), a reaction time of 4 hours, and heating to 120°C.  Results of the screen 
revealed that the uncommon solvent cyclopentyl methyl ether (CPMe) was marginally 
better than toluene in serving as the medium for the transformation (Figure 2.7). For 
large scale syntheses, the prohibitive cost of CPMe led us to use toluene instead. 
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Additionally, the screen indicated that potassium carbonate (K2CO3) was a better base 
than any of the analogous cesium (Cs2CO3), lithium (Li2CO3), and sodium salts 
(Na2CO3). We chose to screen carbonate bases alone as they are known bases for the 
Buchwald-Hartwig reaction and are economical for large scale syntheses. Furthermore, 
the screen revealed dramatic decreases in product yield when lowering the Pd loading 
from 5.2 %. This was surprising to us as there are several reports of Buchwald-Hartwig 
couplings using much lower catalyst loadings100. The results of this screen guided our 
scale- up optimzations.  
 
Figure 2.7: Screening Results. Coupling of compounds X and Y carried in 96 well plates with varying 
solvent, base, and Pd(II) acetate compositions. Conversion determined as the ratio of the absorbances at 
215 nm of the product peak and a standard peak in HPLC chromatograms. Reprinted with permission from 
Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, 
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B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a 
Fluorescent Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance 
Energy Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-18814. 
Copyright (2013) American Chemical Society. 
Using the best results from the screen (5.2 % Pd(OAc)2, 3.75 % rac-BINAP, 3.01 
equivalents of K2CO3, 1.15 equivalents of amine, and 120°C for 4 hours) we were unable 
to completely drive the reaction to completion at larger scales. Making matters worse, 9 
proved to have the same mobility on silica gel as the biaryl amine coupled product (10) in 
all tested solvent mixtures (Scheme 2.2). Desiring to move forward with the synthesis to 
test the full scope of the route, we investigated methods for the selective hydrolysis of the 
triflate group while keeping the two OMe groups of 10 intact. A method using 
trialkylammonium hydroxide salts proved to be ineffective or unselective (several days 
for selective triflate hydrolysis and global hydrolysis of triflate and OMe groups at higher 
salt loadings)101. Interestingly, the same report included a procedure calling for treatment 
with tetrabutylammonium fluoride (TBAF), which we applied to the mixture of 9 and 10, 
resulting in selective triflate hydrolysis while allowing us to recover pure 10 in good 
yields101.  
While TBAF treatment of mixtures of 9 and 10 was sufficient to allow us to continue our 
synthetic route, it was not a permanent fix. Modest increases in the conversion of 9 to 10 
were obtained by increasing the reaction temperature to 135°C and prolonging the 
reaction to 16 hours. These conditions were unsuitable for the use of K2CO3 as this salt 
decomposed in the presence of the Pd catalyst at high temperature and longer reaction 
times. Further optimization of the parameters of the reaction to account for this by 
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changing to Cs2CO3 as the base, increasing the amine equivalents to 1.32, decreasing the 
concentration of 9 in toluene, and prolonging the reaction time to 23 hours allowed us to 
reproducibly convert all of 9 into 10 and recover it after chromatographic purification in 
greater than 90 % yield at the 250 mg and multi-gram scale.  
Continuing our efforts to simplify the synthesis and make it amenable to practice on large 
scales, we envisioned the use of sulfuric acid (H2SO4) as a replacement for PPA as it is a 
more common and economical reagent. H2SO4 has also been shown to catalyze Friedel-
Crafts reactions due to its strong Lewis acid character and its strong Brønsted acid 
character would easily cleave the Boc amine protecting group and both OMe groups (in 
the presence of water). Gratifyingly, 13.5M H2SO4 in water at 115°C for 16 hours 
followed by purification using cation exchange resin produced Acd (1) in 98 % yield. 
HPLC analysis of the product indicated that the compound was greater than 98 % pure, 
making this final transformation both high yielding and straight-forward to purify. With 
the high yielding production of the 9, fully optimized Buchwald-Hartwig amine cross-
coupling conditions, and the global deprotection/Friedel-Crafts acylation mediated by 
H2SO4, we established a novel five step synthesis of Acd (1) in 87 % yield (Scheme 2.2).  
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Scheme 2.2: Synthesis of Acd Starting from Tyr Using H2SO4 as the Final Reagent. 
 
O-aaRS/tRNA PAIR IDENTIFICATION  
In order to identify a mutant o-aaRS/tRNA pair capable of selectively utilizing Acd, we 
began a collaboration with the Mehl laboratory as it was envisioned that their strategy of 
screening previously evolved mutant o-aaRS/tRNA pairs would provide useful results 
faster than evolving an orthogonal pair de novo. Furthermore, as Acd is significantly 
larger than Tyr, using random or rational mutagenesis to carve out a large pocket in the 
aaRS active site was hypothesized to be a significant endeavor and could result in many 
inactive mutants due to radical changes to the aaRS overall folding architecture. Thus, the 
Mehl group first screened their library of mutant o-aaRS/tRNA pairs (all derived from M. 
jannaschii tyrosyl aaRS/tRNA pairs) capable of using three structurally similar amino 
acids: Nap, p-benzoylphenylalanine (Bzf), and 4-(2’-bromoisobutyrlamido)phenylalanine 
(Brb) (Figure 2.8). As the Mehl laboratory mutant o-aaRS/tRNA pairs were created by  
negative selection against only endogenous amino acids and were not challenged with 
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other UAAs, it was possible that one of the mutant o-aaRS/tRNA pairs could accept Acd 
in preference to the UAA for which it was evolved.  
 
Figure 2.8: Structures of Acd (1), Bzf, and Brb. 
Screening of the mutant o-aaRS/tRNA library was carried out by testing the incorporation 
of Acd into position 150 of GFP and assessing the GFP fluorescence of suspended cells. 
As GFP’s fluorophore only matures and fluoresces when it is fully translated and folded 
properly, any GFP fluorescence observed was taken to be the result of the tested mutant 
o-aaRS/tRNA pair successfully utilizing Acd as a substrate. It is important to note that 
these mutant o-aaRS/tRNA pairs were already selected against their native amino acid 
(Tyr in this case), so it was assumed that all observed GFP fluorescence is the result of 
the mutant o-aaRS/tRNA pair selectively aminoacylating Acd and delivering it to the 
ribosome in response to the UAG codon. Surprisingly, none of the mutant o-aaRS/tRNA 
pairs capable of using the structurally similar Nap or Bzf showed any activity towards 
Acd, even though some mutant Nap o-aaRS/tRNA pairs could use Bzf in addition to Nap. 
We were able to find two mutant o-aaRS/tRNA pairs capable of using Acd from the Brb 
library: BrbRS1 and BrbRS3 (Figure 2.9). Comparison of these two mutant aaRSs to the 
Nap aaRS revealed that residue 65 in both aaRSs capable of using Acd was glutamic acid 
(Glu). By analyzing existing crystal structures of M. jannaschii TyrRS mutants, we 
postulate that this residue makes a stabilizing hydrogen bond with the endocylic N-H in 
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the middle ring of the Acd fluorophore. As BrbRS1 showed the best activity, we decided 
to use it in all subsequent studies and now refer to it as AcdRS102.  
 
Figure 2.9: aaRS Selection and Confirmation of Acd Incorporation. Protein expression levels determined 
from fluorescence of GFP reporter construct containing a UAG stop codon at position 150. Fluorescence 
from full-length GFP indicates successful incorporation of a UAA (Acd or Bzf) from a charged tRNACUA. 
Comparison to expressions containing only proteinogenic amino acids indicates the fidelity of the o-
aaRS/tRNA pair (Neg). Fluorescence from WT GFP (black) is shown as a positive control. Reprinted with 
permission from Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, 
T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of 
Acridon-2-ylalanine, a Fluorescent Amino Acid for Lifetime and Forster Resonance Energy 
Transfer/Luminescence Resonance Energy Transfer Studies. Journal of the American Chemical Society 
2013, 135 (50), 18806-18814. Copyright (2013) American Chemical Society. 
Prior to embarking on rigorous in vivo incorporation studies, we explored the mechanism 
by which the AcdRS is capable of using Acd, but not Tyr. In the wild-type M. jannaschii 
sequence, residue 65 is Leu. Mutagenesis of this residue to Glu not only is necessary for 
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Acd utilization, but sufficient to remove the ability to use Tyr effectively. Such 
observations have been independently corroborated with other mutant o-aaRS/tRNA 
pairs by Tippmann and others103. There are an additional three mutations in the AcdRS 
relative to wild-type; Tyr32 is mutated to a Gly, Asp158 to Gly, and Ile159 to Cys. In all 
cases an amino acid is mutated to another of smaller size, consistent with the 
observations of others in terms of opening up the aaRS active site. Despite this precedent 
for the exclusion of the use of Tyr, we have observed Tyr incorporation even in the 
presence of Acd. However, this is not a uniform effect as it appears that the position of 
the UAG codon has a significant effect on Acd over Tyr selectivity as well as the overall 
yield of Acd containing protein. Many of the Acd proteins expressed in our laboratory 
contain exclusively Acd at the UAG site while others contain a mixture of both Acd and 
Tyr. Interestingly, this is seen much more in expressions of α-synuclein Acd mutants than 
CaM or triose phosphate isomerase (TIM) Acd mutants. We have only observed 
significant Tyr incorporation at one site in CaM, none in TIM, and several in α –
synuclein. Others have seen a positional effect with regards to amber suppression in 
which yields of a mutant protein containing a UAA vary greatly from position to 
position, even under otherwise identical conditions96. While the mechanisms responsible 
for these positional effects are unclear, current work in both the Mehl and Petersson 
laboratories is ongoing to make Acd mutant protein expressions more consistent position 
to position, in addition to creating methods to exclude Tyr entirely.  
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IN VIVO INCORPORATION & ALTERNATIVE ACD SYNTHESES 
While the use of permissive mutant o-aaRS/tRNA pairs is an extremely enabling method 
of finding a system capable of using a novel UAA, the fact that these macromolecular 
systems are never challenged against other UAAs became a problem with the use of Acd. 
The H2SO4 catalyzed Friedel-Crafts intramolecular acylation/global deprotection was 
shown to produce Acd in high yields and with high purity (> 98 %), however the 
remaining 2 % of material partially consisted of an aryl decarboxylation side-product, N-
phenyl-p-aminophenylalanine (Npf). Surprisingly, we found Npf to be incorporated into 
proteins in response to the amber codon in addition to Acd, even when it was present at < 
1% of the amino acid stock (analysis by HPLC). As this side-product proved difficult to 
separate from Acd using silica chromatography and it was hypothesized that its 
production was likely a result of using the strong Brønsted acid H2SO4, we adopted a new 
two-step protocol to avoid its formation. This new procedure utilized lithium hydroxide 
(LiOH) to saponify both methyl esters followed by treatment with PPA to cyclize the 
fluorophore and cleave the Boc protecting group. We chose LiOH as previous reports 
claimed it could be used without racemizing the amino acid’s chiral center, but the use of 
Acd produced in this route in solid phase peptide synthesis (SPPS) showed our material 
did racemize in this route, but not in the H2SO4 route104. We chose PPA because we did 
not see Npf incorporation using material synthesized with our previous route. 
Fortunately, application of LiOH saponification and PPA-mediated ring-closing and Boc 
deprotection yielding Acd of sufficient purity to eliminate Npf incorporation (Figure 
2.10 and Scheme 2.3). 
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Figure 2.10: HPLC, LRMS, and MALDI-MS Analysis of Amino Acids and Protein Expression. Left: 
HPLC chromatograms of amino acid monomer batches. H2SO4: Acd batch produced by global deprotection 
and cyclization in sulfuric acid. Inset shows LRMS selected ion chromatograms for Acd, calculated 
(M+H)+ m/z 283.1 and Npf calculated (M+H)+ m/z 257.1. Weaker Npf ion chromatogram signal scale 
multiplied by 102. Npf: Authentic Npf sample produced by coupling of aniline to 9. Acd: Pure Acd batch 
produced by PPA route. No mass corresponding to Npf was observed in LRMS analysis of this batch. 
Right: MALDI-MS analysis of full-length CaM-Leu113Acd construct expressed using either a ‘Mixed’ 
Npf/Acd batch from H2SO4 route; authentic Npf, calculated m/z 16833, found 16835; or pure Acd, 
calculated m/z 16858, found 16859. Reprinted with permission from Speight, L. C.; Muthusamy, A. K.; 
Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. J., 
Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent Amino Acid for 
Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy Transfer Studies. 
Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright (2013) American 
Chemical Society. 
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Scheme 2.3: PPA-mediated route to Acd (1). 
 
Recently we compared direct Npf incorporation to Acd incorporation by examining the 
fluorescence of a GFP construct harboring an internal amber codon using either of the 
UAAs and our Acd o-aaRS/tRNA pair. The data indicates that NpF is accepted by the o-
aaRS/tRNA pair roughly 1.5 fold better than Acd (Figure XXX). While this data alone 
does not explain the MALDI-MS data that shows a significant amount of Npf 
incorporation when it only comprises 2 – 5 % of the amino acid stock, we can rationalize 
this data due to the higher solublity of Npf than Acd as well as the fact that the Acd 
nucleus is a known DNA intercalator105. This intercalating ability of the Acd nucleus 
could sequester the amino acid in DNA rich sections of the E. coli cells and make the 
effective concentration of Npf available for protein synthesis much higher than that of 
Acd. Both lower solublity of Acd than Npf and Acd’s potential to intercalate into DNA 
can explain our MALDI-MS data in light of the fact that Npf is only taken 1.5 fold better 
by our o-aaRS/tRNA pair.  
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Figure 2.11: Relative Npf to Acd Incorporation. Experiment was done using our o-aaRS/tRNA pair, a GFP 
construct harboring an internal amber codon, and either no UAA, Npf, or Acd. GFP fluorescence of 
suspended cells was recorded to make the above plot.   
Interestingly however, when we tried to use the same cation exchange chromatography 
we used for the H2SO4 route for this new PPA procedure we saw Npf incorporation 
without being able to detect it in the Acd stock. Investigation into the composition of the 
Acd stock revealed a trace amount of deprotected but uncyclized material (12). Test 
expressions with exclusively this compound revealed that its use leads to Npf 
incorporation in proteins in response to the amber codon. These observations led us to 
postulate that this material is decarboxylated in vivo. As there are not an abundance of 
enzymes in E. coli capable of this transformation, we have identified YigC which is 
natively responsible for the decarboxylation of hydroxybenzoate as a candidate enzyme 
(Scheme 2.4) 106. Moreover, YigC is part of the ubiquinone biosynthesis pathway that is 
known to be up-regulated in E. coli when the organism is raised in M9 minimal media, 
which we routinely use for our expressions of UAA mutant proteins107. Fortunately, the 
isoelectric point (pI) of this uncyclized material (12) is 3.3 while Acd’s pI is 5.5, enabling 
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us to separate the materials by selective pH precipitation. We are currently working with 
the Mehl group to carry out negative selections of our o-aaRS/tRNA pair against Npf 
acceptance so that we can use the H2SO4 route exclusively as it is higher yielding and 
produces enantiopure Acd.  
 
Scheme 2.4: Action of YigC on Hydroxybenzoate and Proposed YigC decomposition of 12 to Npf (11). 
 
BIOPHYSICAL STUDIES: FRET/LRET/PET 
After developing an o-aaRS/tRNA pair and an efficient synthesis, we began to test the 
utility of Acd incorporation into proteins by expressing Acd mutants of α-synuclein, 
TIM, and CaM in E. coli (Figure 2.12). As noted previously, the yields of these Acd 
mutant proteins relative to the wild type (WT) varied greatly. The range that we observed 
differed from 3 % in a TIM mutant to 69 % in a CaM mutant (Tables 2.1 – 2.3). Because 
these are proteins that generally express well, even the 3 % yield enabled us to 
demonstrate the utility of Acd as a site-specific fluorescent probe in both the CaM and 
TIM systems.  
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Figure 2.12: SDS PAGE Gel Analysis of Mutant Protein Expression. Top: CaM mutants, Middle: TIM 
mutants, Bottom: α-synuclein mutants. Coomassie stained gels are shown on the left and fluorescence 
images on the right. Molecular weight (MW) markers: 7, 10, 17, 25, 40, 50, 75, 100, and 150 kDa. The 25 
and 75 kDa markers are fluorescently stained. Reprinted with permission from Speight, L. C.; Muthusamy, 
A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, 
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E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent Amino Acid for 
Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy Transfer Studies. 
Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright (2013) American 
Chemical Society. 
 Table 2.1: CaM Protein Expression. 
protein 
yield 
(mg/L) 
% yield relative to 
WT 
WT 30.0 - 
13 16.8 56.0 
41 18.1 60.3 
100 6.1 20.3 
113 20.7 69.0 
 
 Table 2.2: TIM Protein Expression. 
protein 
yield 
(mg/L) 
% yield relative to 
WT 
WT 26.4 - 
74 4.0 15.2 
101 0.8 3.0 
 
Table 2.3: α-Synuclein Protein Expression. 
protein 
yield 
(mg/L) 
% yield relative to 
WT 
WT 30.0 - 
39 2.0 6.7 
94 5.0 16.7 
 
We chose CaM as our first model system as this protein has been structurally 
characterized with a variety of substrates bound, and it has been extensively studied in 
biophysical experiments. Additionally, we aimed at exploring the perturbations caused by 
incorporating Acd by placing it at four distinct sites within CaM’s sequence, including 
both surface exposed and buried residues, and replacing both endogenous aromatic and 
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aliphatic residues (Phe13, Gly41, Tyr100, and Leu113). Following expression in E. coli and 
purification by phenyl sepharose chromatography, we ensured that the incorporation of 
Acd did not significantly disrupt the folding of CaM at any of the four sites. All four Acd 
mutants, in the absence of Ca2+, had melting points within 5 °C of WT CaM as 
determined by circular dichroism (CD) spectroscopy (Figure 2.13). In the presence of 
Ca2+ neither WT CaM nor the Acd mutants, could be thermally denatured by heating to 
95 °C.  
 
Figure 2.13: Temperature-Dependent Circular Dichroism Spectroscopy of WT CaM and Acd Mutants. 
Left: Fraction folded as a function of temperature as determined by molar residue ellipticity (θ) at 222 nm 
measured for 20 µM solutions of each protein in the absence of Ca2+. Right: Molar residue ellipticity (θ) at 
222 nm measured for 20 µM solutions of each protein in the presence of Ca2+. Reprinted with permission 
from Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; 
Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-
ylalanine, a Fluorescent Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence 
Resonance Energy Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-
18814. Copyright (2013) American Chemical Society. 
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ACD AS AN ENVIRONMENTAL PROBE 
As a final test to ensure that Acd incorporation at these sites did not substantially disrupt 
the normal properties of CaM, we used native PAGE gel analysis to confirm that the Acd 
mutation did not perturb binding of our target peptide, pOCNC (H2N-
FRRIARLVGVLREFAFR-CONH2). This peptide is derived from an olfactory cyclic 
nucleotide gated ion channel and its structure in complex with CaM had previously been 
determined by NMR (Figure 2.14)108. Its binding affinity to WT CaM has previously 
been determined to be 3 nM; therefore, we expected that only significant alterations in 
CaM structure would disrupt binding at 1 – 10 µM109. Indeed, all four Acd mutants bound 
a labeled derivative of pOCNC (Figure 2.15).   
 
Figure 2.14: CaM Labeling Sites. An image showing Acd (blue) at positions 13, 41, 100, and 113 in CaM 
(red) and highlighting position 1 in the pOCNC peptide (green). Ca2+ ions are shown as purple spheres. 
Adapted from PDB 1SYD using PyMol (Schrӧdinger, LLC; New York, NY) and Spartan (Wavefunction, 
Inc. Irvine, CA)108. Reprinted with permission from Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; 
Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient 
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Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent Amino Acid for Lifetime and 
Forster Resonance Energy Transfer/Luminescence Resonance Energy Transfer Studies. Journal of the 
American Chemical Society 2013, 135 (50), 18806-18814. Copyright (2013) American Chemical Society. 
 
Figure 2.15: Native PAGE Gel Analysis of CaM Peptide Binding. PAGE analysis demonstrates upward 
shift of the CaM protein band upon addition of pOCNC-F’1, a derivative of pOCNC-F in which Phe has 
been replaced with a backbone thioamide version of Phe, F’. Reprinted with permission from Speight, L. 
C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, 
R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent 
Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy 
Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright 
(2013) American Chemical Society. 
Following these demonstrations of the minimally perturbing nature of Acd incorporation, 
we wished to use Acd to monitor conformational changes associated with the binding of 
helical peptides to CaM. We then analyzed the fluorescence emission spectra of 10 µM 
CaM with varying concentrations of pOCNC. The fluorescence emission of CaM-
Phe13Acd, CaM-Tyr100Acd, and CaM-Leu113Acd were identical in the presence and 
absence of pOCNC, implying that Acd does not change environment during the binding 
of this peptide (Figure 2.16). 
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Figure 2.16: Fluorescence Spectra of CaM Mutants with Bound Peptides. Top Left: CaM-Phe13Acd/pOCNC, 
Top Right: CaM-Tyr100Acd/pOCNC, Bottom: CaM-Leu113Acd. All spectra recorded for solutions of 0 (red), 
2.5 (orange), 5 (yellow), 7.5 (green), 10 (blue), and 15 µM (purple) pOCNC solutions. Reprinted with 
permission from Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. 
S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-
2-ylalanine, a Fluorescent Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence 
Resonance Energy Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-
18814. Copyright (2013) American Chemical Society. 
In contrast, in its unbound form, CaM-Gly41Acd displayed a blue-shift in fluorescence 
relative to free Acd, and this blue shift was relieved upon the addition of pOCNC to the 
solution (Figure 2.17). Previous photophysical characterization of Acd by Szymanska et 
al. has shown that Acd emission undergoes a blue shift in non-polar environments. Since 
polycyclic aromatic compounds have been shown to bind in the helical cleft of CaM, we 
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believe that the change in Acd emission occurs because the binding of pOCNC forces the 
Acd residue to move from a hydrophobic pocket into bulk aqueous solvent110. While 
solvatochromic effects at position 41 could be used to monitor peptide binding to CaM, 
they complicate the interpretation of FRET data, so we focused our attention on the other 
positions.  
 
Figure 2.17: Monitoring CaM Binding By Changes in Acd Environment. Fluorescence spectra of 10 µM 
CaM-Gly41Acd in the presence of 0, 0.1, 0.15, 0.2, 0.25, 0.3, 0.4, 0.5, 0.75, 1.0, or 1.5 equivalents of 
pOCNC, colored black, purple, magenta, blue, aqua, green, lime, chartreuse, yellow, orange, and red, 
respectively. Inset: Peptide binding monitored by changes in the ratio of emission at 420 nm and 450 nm. 
Reprinted with permission from Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; 
Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and In Vivo 
Incorporation of Acridon-2-ylalanine, a Fluorescent Amino Acid for Lifetime and Forster Resonance 
Energy Transfer/Luminescence Resonance Energy Transfer Studies. Journal of the American Chemical 
Society 2013, 135 (50), 18806-18814. Copyright (2013) American Chemical Society. 
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ACD AS A FRET PROBE 
To demonstrate the use of Acd as a FRET acceptor for Trp and Mcm, we synthesized 
variants of pOCNC labeled at the N-terminus with these fluorophores. The CaM Acd 
mutants were each titrated with Trp-pOCNC or Mcm-pOCNC, and fluorescence emission 
was recorded from 350 to 550 nm while exciting at 295 nm (Trp) or 325 nm (Mcm). In 
the case of the Mcm-pOCNC titrations, we observed a decrease in Mcm emission and an 
increase in Acd emission due to FRET (Figure 2.18). Of note, one particular mutant, 
Leu113Acd was calculated to have a near perfect quenching efficiency (EQ) of 0.97. 
Gratifyingly, we observed nearly the same value, 0.98. Moreover, the relationships 
between the observed and calculated EQ for all Acd positions with the McM titrations 
were similarly well matched (Table 2.4). Several features of these experiments are 
important to highlight. First, we see that the binding reaches saturation in the 1:1 
complex, as determined by examining the difference spectrum in which the emission 
from 0.5 equivalents of Mcm-pOCNC was subtracted from the spectra of the 1.5:1 Mcm-
pOCNC/CaM-Acd. Second, Mcm and Acd are a robust FRET pair, with minimal direct 
excitation at 325 nm and strong emission due to FRET (emission in the 1:1 complexes is 
about half of the emission resulting from direct excitation of the CaM-Acd mutants 
studied at 385 nm). These observations, particularly the excellent quantitative agreement 
of the expected and observed EQ, gave us great confidence in using the Mcm/Acd FRET 
pair to study protein folding.  
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Figure 2.18: Fluorescence Spectra of CaM Mutants with Bound Peptides. Fluorescence Spectra of 10 µM 
CaM-Phe13Acd (Top Left), CaM-Tyr100Acd (Top Right), or CaM-Tyr100Acd in the presence of 0, 0.25, 0.5, 
0.75, 1.0, or 1.5 equivalents Mcm-pOCNC, colored red, orange, green, aqua, blue, and purple respectively.  
The fluorescence spectra of 10 µM Mcm-pOCNC alone is shown in dashed grey. All of these spectra were 
recorded with excitation at 325 nm. The spectra with 1.5 equivalents Mcm-pOCNC are difference spectra 
in which the emission from 5 µM Mcm-pOCNC was subtracted from the spectra of the 15 µM Mcm-
pOCNC/CaM Acd mutant mixture. The fluorescence spectra of 10 µM CaM mutants alone with excitation 
at 385 nm is shown in black. Insets: Peptide binding monitored by changes in the emission at 450 nm due 
to excitation at 325 nm, normalized to the emission at 450 nm due to excitation at 385 nm. Reprinted with 
permission from Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, 
T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of 
Acridon-2-ylalanine, a Fluorescent Amino Acid for Lifetime and Forster Resonance Energy 
Transfer/Luminescence Resonance Energy Transfer Studies. Journal of the American Chemical Society 
2013, 135 (50), 18806-18814. Copyright (2013) American Chemical Society. 
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Table 2.4: FRET in CaM/Mcm-pOCNC Complexes. 
pOCNC/CaM 
Acd Mutants 
EQ 
observed R (Å) 
EQ 
calculated 
Mcm1/Phe13Acd 0.92 16 0.91 
Mcm1/Tyr100Acd 0.81 18 0.81 
Mcm1/Leu113Acd 0.98 13 0.97 
 
EQ determined from quenching in 1:1 CaM/Mcm-pOCNC complex. R is an average value calculated from 
the twenty lowest energy structures in PDB ID 1SYD using the positions of the corresponding amino 
acids108. ΦD of 0.098 determined for Mcm-pOCNC in 1:1 complex with CaM by measurement of the 
fluorescence of equimolar concentrations of free Mcm-pOCNC, and 1:1 CaM/Mcm-pOCNC. Mcm-
pOCNC ΦD assumed to be 0.18, the value for free Mcm111. R0 for Mcm/Acd calculated using ΦD of 0.098 is 
23 Å.  
Binding of Trp-pOCNC to any of the three CaM-Acd mutants was also shown to be able 
to be monitored by FRET. In these cases, no background subtractions were necessary for 
superstoichiometic complexes since Trp has no fluorescence emission above 400 nm 
(Figure 2.19). However, there is substantial direct excitation of Acd upon irradiation at 
295 nm (27 % of the emission due to excitation at 385 nm). Since there is also a 
possibility of Trp quenching of Acd emission through PET, we cannot interpret the EQ 
data in terms of distances with the same certainty that we were afforded with Mcm. In 
addition, if this probe pair was to be used in another system containing more than one 
Trp, FRET data would need to be fit to complex models with more than one donor 
fluorophore. Regardless, Trp FRET can still be easily used to quantify protein-protein 
binding energies by fitting concentration-dependent data. One of the protein partners 
could be WT, provided that it contained at least one Trp residue. As noted above, both 
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Trp and Mcm each have benefits and drawbacks as FRET donors. In summary, since Trp 
can both transfer energy to Acd via FRET as well as accept it via PET, we view Mcm as 
a more optimal FRET donor. However, as it is possible to genetically incorporate both 
Trp and Acd into the same protein, this may be appealing for some applications.  
 
Figure 2.19: Fluorescence Spectra of CaM Mutants with Bound Peptides. Fluorescence spectra of 10 µM 
CaM-Phe13Acd (Top Left), CaM-Tyr100Acd (Top Right), or CaM-Leu113Acd in the prescence of 0, 0.25, 
0.5, 0.75, 1.0, or 1.5 equivalents Trp-pOCNC, colored red, orange, green, aqua, blue, and purple, 
respectively. The fluorescence spectra of 10 µM CaM Acd mutant alone or in the 1:1 Trp-pOCNC mixture 
with excitation at 385 nm is shown in black and grey, respectively. Inset: Peptide binding monitored by 
changes in the emission at 450 nm due to excitation at 295 nm, normalized to the emission at 450 nm due 
to excitation at 385 nm. Reprinted with permission from Speight, L. C.; Muthusamy, A. K.; Goldberg, J. 
M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient 
Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent Amino Acid for Lifetime and 
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Forster Resonance Energy Transfer/Luminescence Resonance Energy Transfer Studies. Journal of the 
American Chemical Society 2013, 135 (50), 18806-18814. Copyright (2013) American Chemical Society. 
 
ACD AS A LANTHANIDE LUMINESCENCE SENSITIZER 
In addition to singlet energy transfer interactions with organic chromophores like Trp or 
Mcm, Acd can undergo intersystem crossing to donate energy to lanthanide ions such as 
Eu3+ 112. While this has previously been demonstrated in short synthetic peptides, the 
ability to genetically encode Acd allows us to implement the same Eu3+ luminescence 
resonance energy transfer (LRET) probes in proteins expressed in E. coli. To demonstrate 
Acd-sensitized Eu3+ emission, we relied on the precedent for CaM binding a variety of 
cations, including the lanthanides Tb3+ and Eu3+ 113. Since efficient LRET typically 
requires close contact between the donor chromophore and the lanthanide ion, we chose 
CaM-Tyr100Acd as a construct for LRET studies because Tyr100 is within site III and 
proximal to site IV, two of the four cation binding sites of CaM. Following removal of 
both Ca2+ and chelators from purified CaM-Tyr100Acd by dialysis and ion-exchange 
chromatography respectively, titration of Eu(NO3)3 revealed a dose-dependent increase in 
Eu3+ emission at 592 and 615 nm (Figure 2.20). 
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Figure 2.20: Monitoring Eu3+ Binding to CaM by LRET. Luminescence emission spectra of 10 µM CaM-
Tyr100Acd in the presence of 0, 1, 2, 5, 6, 8, 10, 12, 16, 20, 24, 32, 40, 48, 56 equivalents of Eu(NO3)3, 
colored dashed red, dashed green, dashed blue, red, orange, yellow, chartreuse, light green, dark green, 
aqua, light blue, dark blue, light purple, dark purple, and black, respectively. Spectra were recorded with 
excitation at 385 nm. Inset: Eu3+ binding monitored by changes in the emission at 615 nm. Data fit to two 
cooperative binding transitions. Reprinted with permission from Speight, L. C.; Muthusamy, A. K.; 
Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. J., 
Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent Amino Acid for 
Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy Transfer Studies. 
Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright (2013) American 
Chemical Society. 
 The 615 nm emission data could be fit to a two site binding model with Kd’s of 28 µM 
and 154 µM and Hill coefficients of 1.1 and 2.6, respectively. The 615 nm signal 
primarily derives from the lower-affinity binding event(s), which presumably 
correspond(s) to binding at the C-terminus, particularly at site III, defined by residues 
Asp94, Asp96, Asn98, Tyr100, Ser102, and Glu105. Previous experiments have found higher 
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affinity (Kd = 1 µM) binding of lanthanides to this site; the lower affinity observed here 
may be due to disruption by the Acd residue as studies have found that minor mutations 
at site III can dramatically decrease Ca2+ affinity114, 115. For higher specificity LRET 
labeling, one may use lanthanide-binding sequences of the type described by Imperiali 
and coworkers116. 
 
ACD AS A PET PROBE 
In many proteins, specific quenching interactions with nearby Trp or Tyr may occur, as 
indicated by our Stern-Volmer experiments. These could be engineered into either 
peptide or protein binding partners, and Acd quenching could be used to monitor 
bimolecular interactions. Indeed, we have shown that this is the case for Acd mutants of 
TIM. TIM forms a homodimer as seen in Figure 2.21. We selected Phe74 and Tyr101 as 
positions for Acd incorporation since they approach each other at the dimer interface and 
they are relatively far (≥ 13 Å) from the other Trp and Tyr residues in TIM.  
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Figure 2.21: TIM Annotated Crystal Structure. An image showing a TIM homodimer (protomers colored 
cyan and green) with Phe74 (orange) and Tyr101 (pink) highlighted in both protomers. Other Trp and Tyr 
residues in both protomers are shown in stick representation and are labeled in the green protomer. Image 
adapted from PDB 1TRE using PyMol (Schrӧdinger, LLC; New York, NY)117.  Reprinted with permission 
from Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; 
Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-
ylalanine, a Fluorescent Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence 
Resonance Energy Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-
18814. Copyright (2013) American Chemical Society. 
The single mutants TIM-Phe74Acd and TIM-Tyr101Acd were expressed in E. coli and 
purified using Ni-NTA affinity chromatography. We hypothesized that when Acd was 
incorporated at position 74, it would be proximal to Tyr101 and thus be quenched, while 
when Acd was incorporated at position 101, there would be no quenching because there 
would not be a proximal Tyr residue. Furthermore, as the orientation of these residues is 
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a result of TIM’s overall fold, we could disrupt the quenching interaction by chemically 
denaturing the protein with urea while monitoring the changes in fluorescence emission 
and lifetime. In the absence of urea, both mutants are quenched relative to the 
fluorescence of equimolar concentrations of Acd (urea had no effect on the fluorescence 
of Acd). In line with our predictions, TIM-Phe74Acd was quenched to a greater degree, 
presumably due to its proximity to Tyr101. On the other hand, TIM-Tyr101Acd places no 
Trp or Tyr in close proximity to the Acd residue. Thus, some non-specific quenching due 
to the local environment must occur. The two mutants recover comparable levels of 
fluorescence upon titration with urea, since quenching by Tyr101 is relieved as TIM 
unfolds and dimer dissociation occurs (Figure 2.22). 
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Figure 2.22: Fluorescence Spectra of TIM Denaturation in Urea. Top Left: TIM-Phe74Acd, Top Right: 
TIM-Tyr101Acd, Bottom: free Acd. All spectra recorded for solutions of TIM or Acd in 0 (red), 0.05 (pink), 
0.1 (orange), 0.25 (yellow), 0.5 (light green), 0.75 (dark green), 1.0 (light blue), 2.0 (dark blue), 3.0 
(purple), and 4.0 M (black) urea solutions. Reprinted with permission from Speight, L. C.; Muthusamy, A. 
K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. 
J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent Amino Acid for 
Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy Transfer Studies. 
Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright (2013) American 
Chemical Society. 
 In addition to monitoring unfolding by changes in steady-state fluorescence, we also 
found it useful to measure quenching by changes in the fluorescence lifetime of Acd. 
Lifetime-based measurements of quenching made by time-correlated single photon 
counting (TCSPC) are very valuable because they are not sensitive to concentration 
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matching like steady-state measurements. Consistent with our steady-state data, we 
observed a decrease in the Acd lifetimes in both TIM-Phe74Acd and TIM-Tyr101Acd 
relative to free Acd: τavg(free) = 15.8 ns, τavg(TIM-Phe74Acd) = 6.8 ns, and τavg(TIM-
Tyr101Acd) = 12.7 ns). Lifetime measurements in 0, 2, 3, and 4 M urea demonstrate that 
the more dramatic Tyr-specific quenching in TIM-Phe74Acd is relieved by 3 M urea, and 
that global unfolding gives comparable lifetimes for both mutants in 4 M urea (Figure 
2.23). These experiments show how changes in Acd lifetime, due either to general 
quenching phenomena and/or specific placement near a quenching residue, may be used 
to monitor unfolding.  
 
Figure 2.23: Monitoring TIM Unfolding By Changes in Average Fluorescence Lifetimes. Average 
lifetimes for 2 µM solutions of TIM-Phe74Acd (organge), TIM-Tyr101Acd (magenta), or free Acd (blue) in 
15 mM HEPES 140 mM potassium chloride (KCl) buffer with varying concentrations of urea. Acd lifetime 
derived from biexponential fits to the primary data. Reprinted with permission from Speight, L. C.; 
Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. 
A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent 
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Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy 
Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright 
(2013) American Chemical Society. 
 
CONCLUSIONS AND FUTURE WORK 
The flUAA Acd had previously been shown to be a useful probe of protein 
conformational change, but its use had been limited to synthetic peptides and in vitro 
translation. Our work has expanded upon this, and provided a more efficient and 
affordable synthesis of Acd, as well as the identification of an Acd-specific o-aaRS/tRNA 
pair. These developments allow one to easily produce milligram quantities of Acd-
labeled proteins for biophysical studies. Additionally, we have more thoroughly 
characterized the photophysical properties of Acd, including quenching interactions with 
select endogenous amino acids and FRET interactions with common fluorophores such as 
Trp and Mcm. We have also demonstrated the incorporation of Acd into several proteins, 
including CaM, and used changes in Acd fluorescence to monitor peptide binding 
through solvatochromic effects, FRET, LRET, and PET.  
One of the advantages of our new Acd synthesis relative to previously published reports 
is its versatility. Some aspects of Acd photochemistry are non-ideal, such as its low 
extinction coefficient and blue wavelength emission. In some experiments, its sensitivity 
to solvent may also be problematic. To solve these problems, we have tested the 
compatibility of our route towards analogs of 9 and anthranilate coupling partners to 
generate Acd analogs with altered photophysical properties. Both 3-fluoro OTf 
derivatives and napthyl anthranilate analogues have been shown to be compatible with 
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our methods in initial test reactions. Further expansion of this methodology will include 9 
and anthranilate analogues bearing both electron-withdrawing and electron-donating 
groups to generate Acd derivatives containing these moieties. This strategy for the 
generation of fluorophores with higher extinction coefficients and more red-shifted 
emissions has been used previously for other chromophores118.  
Finally, since the Acd o-aaRS/tRNA pair identified in these studies can also accept Brb 
as a substrate, we are working with the Mehl group to crystallize these complexes to 
determine the structural basis for substrate binding. Our preliminary analysis indicates 
that Glu65 is likely important for Acd recognition. As noted within, it is not surprising for 
an aaRS that is permissive of several large amino acids to have a few key residues 
responsible for substrate binding. We are additionally exploring the permissivity of the 
Acd o-aaRS/tRNA system towards other tricyclic scaffolds such as xanthones, acridines, 
and the aforementioned Acd derivatives. We expect that many such flUAAs may be 
incorporatable using our methods. 
 
 EXPERIMENTAL METHODS 
General Information 
L-Tyrosine, thionyl chloride, di-tert-butyl dicarbonate (Boc anhydride), methyl 2-
aminobenzoate, N,N-diisopropylethylamine (DIPEA), (S)-(+)-4-Nitrophenylalanine 
methyl ester hydrochloride, iodobenzoic acid, and phenyl-sepharose CL-4B resin were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Boc-L-thionophenylalanine-1-(6-
nitro)benzotriazolide and Fmoc-β-(7-methoxycoumarin-4-yl)-alanine (Mcm) were 
92 
purchased from Bachem (Torrance, CA, USA).  Rink amide resin, Fmoc-Ala-OH, Fmoc-
Glu(OtBu)-OH, Fmoc-Leu-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Gly-OH, Fmoc-Val-OH, 
Fmoc-Phe-OH, Fmoc-Ile-OH, and Fmoc-Trp(Boc)-OH purchased from Novabiochem 
(currently EMD Millipore; Billerica, MA, USA). Piperidine and 2-(1H-benzotriazol-1-
yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) were purchased from 
American Bioanalytical (Natick, MA, USA). N-Phenyl-bis(trifluoromethanesulfonimide) 
was purchased from Oakwood Chemical (West Columbia, SC, USA).   E. coli 
BL21(DE3) cells were purchased from Stratagene (La Jolla, CA, USA). E. coli 
ElectroMAX DH10B cells were purchased from Invitrogen (Grand Island, NY,USA). Ni-
NTA resin was purchased from Qiagen (Hilden, Germany); BD Talon™ resin was 
purchased from Clontech (Mountain View, CA, USA). Milli-Q filtered (18 MΩ) water 
was used for all solutions (Millipore; Billerica, MA, USA).  All other reagents and 
solvents were purchased from Fisher Scientific (Pittsburg, PA, USA). All peptide 
synthesis reaction vessels (RVs) were treated with Sigmacote prior to use. 
DNA sequencing was performed at the University of Pennsylvania DNA sequencing 
facility.  Matrix-assisted laser desorption ionization (MALDI) mass spectra were 
collected with a Bruker Ultraflex III MALDI-TOF-TOF mass spectrometer (Billerica, 
MA).  UV/Vis absorbance spectra were obtained with a Hewlett-Packard 8452A diode 
array spectrophotometer (currently Agilent Technologies; Santa Clara, CA).  NMR 
spectra, 1H and 13C, were collected with a Bruker DRX 500 MHz instrument.  CDCl3 was 
calibrated at δ 7.27 for 1H and δ 77.2 for 13C. CD3OD was calibrated at δ 3.31 for 1H and 
δ 49.15 for 13C.  DEPT-135 Carbon NMR notation as follows: no signal is designated by 
(np), a positive signal is designated by (+), and a negative signal is designated by (-).  
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High-resolution mass spectra (HRMS) were obtained on a Waters LC-TOF mass 
spectrometer (model LCT-XE Premier) using electrospray ionization in positive mode. .  
UV absorbance spectra were obtained with a Hewlett-Packard 8452A diode array 
spectrophotometer (currently Agilent Technologies; Santa Clara, CA, USA).  
Fluorescence spectra were collected with a Varian Cary Eclipse fluorescence 
spectrophotometer (currently Agilent Technologies) fitted with a Peltier multicell holder, 
a Photon Technologies International (PTI) QuantaMaster™ fluorometer (Birmingham, 
NJ, USA), a Tecan M1000 plate reader (Mannedorf, Switzerland), or a BioTek Synergy2 
plate reader (Winooski, VT, USA) with a UV transparent 96 well plate.  Steady-state 
Stern-Volmer experiments were conducted on a PerkinElmer Envision Xcite multilabel 
reader (PerkinElmer Health Sciences Inc.; Shelton, CT, USA) with a black bottomed 96 
well plate.  Circular dichroism experiments were conducted with an Aviv 410 CD 
spectrometer (Aviv Biomedical; Lakewood, NJ, USA).  Automated peptide synthesis was 
performed on a Liberty 1 system (CEM Corp.; Matthews, NC, USA) in the UPenn 
Biological Chemistry Resource Center.  Protein purification was conducted on an ÄKTA 
fast protein liquid chromatography (FPLC) system (GE Healthcare Life Sciences; 
Piscataway Township, NJ, USA).  Peptides were purified with a Varian ProStar High-
Performance Liquid Chromatography (HPLC) instrument outfitted with a diode array 
detector (currently Agilent Technologies) using aqueous (A) (H2O + 0.1% CF3CO2H) and 
(B) organic (CH3CN + 0.1% CF3CO2H) phases.  Small molecule analyses were 
performed on an Agilent 1100 HPLC instrument outfitted with a diode array detector 
using the same aqueous and organic phases. 
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Synthesis of Acd (1) via p-NO2F Route 
 
Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-nitrophenyl)propanoate (3) 
2.82 g (10.88 mmol) 2 was dissolved in 16 mL of 3:1 THF:H2O in a round bottom flask 
(RBF) and cooled to 0 °C in an ice water bath. 1.32 g (12.46 mmol) Na2CO3 was added 
and the mixture was allowed to stir for 15 min. 3.20 g (14.66 mmol) Boc2O was then 
added and the solution was allowed to stir and warm to room temperature (RT) overnight. 
The solution was then acidified with 3 M HCl to pH 2, 9 mL of H2O was added, and the 
organics were extracted with ethyl acetate (EtOAc), dried with MgSO4, and concentrated 
in vacuo. The crude yellow oil was purified with 1:1 EtOAc:Hexanes (Rf = 0.5) to yield 
3.42 g 3 (97.1 %). Characterization matched that which was previously described90.  
 
Methyl (S)-3-(4-aminophenyl)-2-((tert-butoxycarbonyl)amino)propanoate (4) 
84 mg Pd/C was added to a dry RBF with 5 mL EtOAc, sparged 3 times with alternating 
vacuum evacuation / argon fill, and then sparged 3 times with alternating vacuum 
evacuation / H2 fill. 1.05 g (3.24 mmol) 3 was added in 11 mL EtOAc and then the 
solution was again sparged 3 times with alternating vacuum evacuation / H2 fill. After 3 
hr 15 min, the reaction was complete by TLC (Rf = 0.3 in 1:1 EtOAc:Hexanes). The 
solution was then filtered through celite using EtOAc as the eluent and the organic filtrate 
was concentrated in vacuo. The crude yellow oil was then purified with 1:1 
EtOAc:Hexanes to yield 0.95 g (99.1 %). Characterization matched that which was 
previously described90.  
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(S)-2-((4-(2-((tert-butoxycarbonyl)amino)-3-methoxy-3-
oxopropyl)phenyl)amino)benzoic acid (5) 
Compound 5 was synthesized essentially as described. Characterization matched previous 
reports90.  
 
(S)-2-amino-3-(9-oxo-9,10-dihydroacridin-2-yl) propanoic acid (Acd, 1). 
PPA (3 mL) was added to a flask containing 5 (0.188 g, 0.454 mmol) and the mixture 
was heated to 135 °C and stirred magnetically for 2 hr. The reaction was removed from 
heat and allowed to cool to 50 °C. Water (50 mL) was added and the flask was allowed to 
stand at 4 °C overnight. The resulting yellow precipitate was filtered and washed with 
cold water. The compound was dried under reduced pressure, then added to 3 mL of 1:1 
1,4 dioxane:water and the pH adjusted to 9 by dropwise addition of 10 M NaOH. After 
stirring for 2 hr, the mixture was acidified with 6 M HCl to pH 2 and cooled on ice to 
precipitate product. The resulting solid was collected by vacuum filtration and dried to 
yield 1 as a yellow powder (0.081 g; 63 %). 1H NMR (500 MHz, CD3OD): δ 8.33 (dd J = 
1.8, 1.1 Hz, 1H), 8.25 (d, J = 1.8 Hz, 1H), 7.75 (m, 1H), 7.68 (dd, J = 8.6, 2.1 Hz, 1H), 
7.53 (dd, J – 8.5, 3.8 Hz, 2H), 7.3 (m, 1 H), 4.28 (dd, J = 7.7, 5.4 Hz, 1H), 3.54 (m, 2H); 
13C NMR (125 MHz, CD3OD): δ 180.1 (np), 171.5 (np), 142.7 (np), 142.2 (np), 136.1 
(+), 135.3 (+), 129.0 (np), 128.3 (+), 127.5 (+), 123.0 (+), 119.6 (+), 119.3 (np), 118.6 
(+), 117.0 (np), 55.3 (+), 37.2 (-); HRMS (ESI) m/z calculated for C16H15N2O3+ 
[M+H]+ 283.1083, found 283.1093. 
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Synthesis of Acd (1) via L-Tyrosine Route 
 
Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-
(((trifluoromethyl)sulfonyl)oxy)phenyl)propanoate (9) 
Compound 9 was synthesized essentially as described. Characterization matched previous 
reports99.  
 
(S)-methyl 2-((4-(2-((tert-butoxycarbonyl)amino)-3-methoxy-3-
oxopropyl)phenyl)amino)benzoate (10) 
 75 mL of toluene was degassed with argon for 15 min in a 250 mL flame dried round 
bottom flask.  Tyr derivative 9 (3.00 g, 7.02 mmol) was added to the flask followed by 
methyl 2-aminobenzoate (1.20 mL, 9.27 mmol).  This solution was degassed with argon 
for 5 min.  Then palladium(II) acetate (0.08 g, 0.37 mmol), and racemic 2,2'-
bis(diphenyl-phosphino)-1,1'-binaphthyl (0.05 g, 0.09 mmol) were added to the flask.  
Cesium carbonate (6.88 g, 21.1 mmol) was ground and added to the flask.  The flask was 
then fitted with a reflux condenser and heated to 135 °C for 23 h.  After allowing the 
solution to cool to ambient temperature, the contents were filtered through a short plug of 
silica gel using CH2Cl2 to transfer the material to the silica (250 mL) and then ethyl 
acetate (500 mL) was used to elute the product.  The clarified solution was then 
concentrated under reduced pressure.  Silica gel flash column chromatography (10% 
ethyl acetate in hexanes) afforded 2.759 g (6.44 mmol, 91.7%) of a pale yellow oil.  Rf  = 
0.2 in 15% ethyl acetate in hexanes; 1H NMR (500 MHz, CDCl3) δ 9.44 (s, 1H), 7.96 (d, 
J = 8.0 Hz, 1H), 7.31 (t, J = 7.9 Hz, 1H), 7.23 (d, J = 8.5 Hz 1H), 7.18 (d, J = 8.2 Hz, 
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2H), 7.10 (d, J = 8.1 Hz, 1 H), 6.73 (t, J = 7.5 Hz, 1 H), 5.05 (d, J = 7.9 Hz, 1 H), 4.61 – 
4.57 (m, 1 H), 3.90 (s, 3H), 3.74 (s, 3H), 3.07 (dd, J = 26.5, 5.7 Hz, 2 H), 1.43 (s, 9H); 
13C NMR (125 MHz, CDCl3): δ 172.5 (np), 169.0 (np), 155.3 (np), 148.0 (np), 139.8 
(np), 134.2 (+), 131.8 (+), 131.3 (np), 130.4 (+), 122.6 (+), 117.3 (+), 114.2 (+), 112.1 
(np), 80.0 (np), 54.6 (+), 52.4 (+), 51.9 (+), 38.0 (-), 28.5 (+); HRMS (ESI) m/z calcd for 
C23H28N2O6 [M+H]+ 429.2000, found 429.2026. 
 
Hydrolysis of 9 in the Presence of 10 
 
The crude product mixture (0.94 g mixture of 9 and 10) was dissolved in 1 mL of THF in 
a glass vial with a stir bar. 0.7 mL of 1 M TBAF in THF with trace water was added to 
the vial. The vial was kept in an argon atmosphere as the reaction proceeded at room 
temperature for 16 hours. 2 mL of methanol was added and the reaction was then stirred 
for an additional 5 min. The solution was then transferred to a separatory funnel and 2 
mL of saturated ammonium chloride (aq) was added. The products were extracted against 
four 5 mL portions of dichloromethane. The organic phase was dried over magnesium 
sulfate and concentrated under vacuum. The desired product was isolated using a 7:3 
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Hexanes:Ethyl acetate flash silica column. The desired product was isolated in 85.1% 
yield (0.80 g). 
 
(S)-2-amino-3-(9-oxo-9,10-dihydroacridin-2-yl) propanoic acid (Acd, 1)  
12 mL 13.5 M sulfuric acid was added to a flask containing 6 (1.02 g, 2.38 mmol).  The 
flask was then fitted with a reflux condenser and heated to 115 °C for 16 h in an oil bath.  
80 mL water was then added slowly to the flask and allowed to stir for 15 min.  The 
reaction was then removed from the hot oil bath and allowed to cool with stirring.  Upon 
reaching ambient temperature, the solution was then cooled to 4 °C, and let stand for 2 h.  
During the 2 h cooling period, 100 g of Dowex ion exchange resin was made into a slurry 
with 1.8 M aqueous sulfuric acid and applied to a flash chromatography column.  The 
resin was washed with 350 mL 1.8 M aqueous sulfuric acid, 2 L water, 1 L 1.5 M 
aqueous ammonium hydroxide, and 4 L water.  Following these washes, the resin was 
dried by passing air through the column.  The cooled Acd solution was then vacuum 
filtered on a Büchner funnel to remove precipitated material and the clarified solution 
was applied to the washed and dried ion exchange resin.  The resulting resin slurry was 
shaken in the chromatography column for 5 min before the solution was drained.  This 
solution is then reapplied to the dried resin and shaken for an additional 5 min.  The 
twice-passed solution was then set aside.  The loaded resin was washed by 4 L water 
before the compound of interest was eluted with 1.45 L 1.5 M ammonium hydroxide.  
The solution was concentrated to 50 mL by rotary evaporation and then lyophilized to 
dryness, yielding a crop of Acd as a yellow powder (0.64 g 2.26 mmol 94.9 %).  The ion 
exchange resin was recycled by washing with 4 L water and dried until further use.  To 
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maximize yield, the twice-passed solution was reapplied to washed and dried ion 
exchange resin and the process repeated to yield a second crop of Acd (0.02 g 0.08 mmol 
3.4 %).  Total yield for the two columns was 98.3 % and purity was > 98 % by analytical 
HPLC. Further characterization matched that which was previously described91.     
 
       Table 2.5. Acd HPLC Analysis Gradient. 
Time (min) % Solvent A 
0:00 99 
6:00 98 
12:00 95 
18:00 90 
30:00 50 
35:00 1 
40:00 1 
50:00 99 
 
Synthesis of Acd (1) via LiOH saponification and PPA deprotection/cyclization 
 
(S)-2-((4-(2-((tert-butoxycarbonyl)amino)-2-carboxyethyl)phenyl)amino)benzoic 
acid (13) 
 
Diester 10 (2.16 g, 5.04 mmol) was added to a 250 mL round bottom flask with a stir bar 
and 50 mL of tetrahydrofuran (THF).  This solution was then cooled to 4 °C.  Lithium 
hydroxide (3.31 g, 138.15 mmol) was dissolved in a separate flask with 150 mL water 
and vigorous stirring.  The LiOH solution was then slowly added to the solution 
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containing 10.  The flask was fitted with a rubber septum and a balloon filled with argon 
and stirred magnetically at 4 °C.  After 24 h, the solution was warmed to ambient 
temperature and the pH was adjusted to 3 with 42 mL of 3 M HCl.  Crude product was 
extracted with CH2Cl2 (3 x 100 mL, 1 x 50 mL), dried with magnesium sulfate, and 
concentrated under reduced pressure.  The resulting crude oil was re-dissolved in 20 mL 
DCM and cooled at 4 °C for 16 h.  A first crop of recrystallized product (a fine white 
powder) was collected by vacuum and washed with 100 mL of cold CH2Cl2 (1.63 g, 4.08 
mmol, 80.8 %).  The filtrate was then concentrated under reduced pressure, and a second 
crop was collected by repeating the recrystallization procedure with 10 mL CH2Cl2 (0.04 
g, 0.09 mmol, 1.8 %).  The total yield for the two crops of fine white powder was 82.6 %.  
1H NMR (500 MHz, CD3OD) δ 7.96 (dd, J = 8.0, 1.4, 1H), 7.32 – 7.27 (m, 1H), 7.24 – 
7.11 (m, 5H), 6.71 (t, J = 7.5 Hz, 1H), 4.36 (dd, J = 8.8, 5.0 Hz, 1H), 3.14 (dd, J = 8.9, 5 
Hz, 1 H), 2.90 (dd, J = 9.0, 4.7 Hz, 1 H), 1.4 (s, 9 H); 13C NMR (125 MHz, CD3OD): δ 
175.5 (np), 171.9 (np), 157.9 (np), 149.5 (np), 140.9 (np), 135.2 (+), 133.7 (np), 133.4 
(+), 131.5 (+), 123.3 (+), 118.1 (+), 114.9 (+), 113.4 (np), 80.7 (np), 56.4 (+), 38.3 (-), 
28.8 (+); HRMS (ESI) m/z calcd for C21H25N2O6 [M+Na]+ 423.1532, found 423.1525. 
 
(S)-2-amino-3-(9-oxo-9,10-dihydroacridin-2-yl) propanoic acid (Acd, 1).   
51.71 g polyphosphoric acid (PPA) was weighed into a 250 mL flask.  A stir bar was 
added and the material was heated to 135 °C for 15 min in an oil bath. 11 (1.00 g, 2.5 
mmol) was added directly to the flask of PPA and allowed to react for 2 h.  50 mL water 
was slowly added (2 mL portions over 10 min) and the reaction was allowed to cool to 60 
°C.  After stirring for 1 h at 60 °C, the flask was removed from the oil bath, the solution 
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decanted into a 500 mL beaker, and cooled to ambient temperature.  Insoluble impurities 
were removed by vacuum filtration and the clarified solution was returned to a 500 mL 
beaker with a stir bar.  The pH of the solution was adjusted to 5.5 by addition of 100 mL 
of 10 M NaOH (aq) and then the solution was cooled to 4 °C for 16 h.  Next, crude 
product was collected by vacuum.  After drying on the filter cake, the crude material was 
suspended in 50 mL water and brought into solution by drop-wise addition of 5 M NaOH 
(bringing the pH to 9.0).  Insoluble impurities were removed by vacuum filtration.  The 
pH of the clarified solution was then adjusted to 5.5 with 3 M HCl, cooled to 4 °C, and 
let stand for 4 hours.  Bright yellow precipitate was collected by vacuum filtration and 
dried overnight by vacuum yielding 0.53 g (1.86 mmol, 74.4 %).  The purity was > 99% 
by analytical HPLC. Further characterization matched that which was previously 
described91.  
 
Screening of Cross-Coupling Conditions 
 The experimental procedures in this work were similar to those previously reported119.  
The experimental design was accomplished using Accelrys Library Studio (San Diego, 
CA, USA).  Screening reactions were carried out in 1 mL flat bottom glass vials (30 mm 
x 8 mm) in a 96-well plate aluminum reactor block from Analytical Sales and Services 
(Pompton Plains, NJ, USA). 
Liquid chemicals were dosed using multi-channel or single-channel pipettors. Solid 
chemicals were dosed as solutions or slurries in appropriate solvents.  Undesired addition 
solvent was removed using a JKem blow-down system (St. Louis, MO, USA) located 
inside the glovebox.  The reactions were heated and stirred on a heating block with a 
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tumble-stirrer (V&P Scientific; San Diego, CA, USA) or IKA magnetic stirrer hot plate 
(Wilmington, NC, USA) using 1.32 mm diameter x 1.57 mm length parylene stir bars.  
The reactions were sealed in the 96-well plate during reaction.  Below each reactor vial in 
the aluminum 96-well plate was a 0.062 mm thick silicon-rubber gasket.  Directly above 
the glass vial reactor top was a Teflon perfluoroalkoxy copolymer resin sealing gasket 
and above that, two more 0.062 mm thick silicon-rubber gaskets.  The entire assembly 
was compressed between an aluminum top and the reactor base with nine screws.  The 
conditions for the coupling of 9 and methyl anthranilate included variations of the 
following: 
 
Bases Solvents Pd loading (mol %) 
Cesium carbonate n-Butanol 5.2 
Potassium Carbonate N-Methylpyrolidine 2.5 
Sodium Carbonate Cyclopentylmethylether 1 
Lithium Carbonate N,N-Dimethylacetamide 0.1 
 Toluene  
 1,4-Dioxane  
 
The following procedure is representative of the high-throughput experimentation 
reaction described in this publication.  Palladium diacetate (10, 25 and 50 μL of a 0.01 M 
solution in THF and 101 μL of a 0.001 M solution in THF) was used in all cases.  A 
racemic BINAP (10, 25 and 50 μL of a 0.014 M solution in THF and 101 μL of a 0.0014 
M solution in THF) was added to the reaction vials and this was evacuated to dryness on 
a JKem-blow-down block.  Base (30 μmol, stock solutions gave an approximate 25 
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mg/mL slurry in THF) was then added to the ligand/catalyst mixture, and this was 
evacuated to dryness on a JKem-blow-down block.  A parylene stir-bar was added to 
each reaction vial.  The aryl triflate 9 (10 μmol/reaction) and methyl-2-aminobenzoate  
(10 μmol/reaction) were then dosed together in the reaction solvents (100 μL of a 0.1 M 
solution).  The vials were then sealed and heated at 120 ºC for 4 h. After cooling to 
ambient temperature, the reaction mixtures were diluted with a solution of internal 
standard in CH3CN (2 μmol biphenyl, 500 μL of solution), and the contents were stirred.  
Into a separate 96-well plate LC block was added 700 μL of CH3CN and then 25 μL of 
the diluted reaction mixtures.  The 96-well plate LC block was then sealed with a 
polypropylene 1 mL cap mat.  The reactions were analyzed using an Agilent 
Technologies 1200 series HPLC with a 96-well plate auto-sampler.   
 
Peptide Synthesis and Purification.   
The CaM binding peptide pOCNC has the sequence FRRIARLVGVLREFAFR; two 
derivatives in which the N-terminal phenylalanine has been replaced with either Mcm or 
Trp are named Mcm-pOCNC and Trp-pOCNC respectively.  The general sequence of 
these peptides is derived from the bOCNCp peptide fragment described by Contessa et al. 
(sequence: GGFRRIARLVGVLREWAYR)108.  The pOCNC and pOCNC-F’1 peptides 
(where F’ indicates thiophenylalanine) were constructed using a combination of 
automated and manual synthesis.  Residues R17-R2 were added to 100 μmol of Rink 
amide resin (100 – 200 mesh; 0.6 mmol substitution/g; 100 μmol) using a Liberty 1 
peptide synthesizer as follows. 
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The peptide RRIARLVGVLREWAYR was synthesized (100 micromole scale) by solid 
phase peptide synthesis, using Fmoc chemistry, on a Liberty1 Automated Microwave 
Peptide Synthesizer.  Piperidine (20 %) in DMF was used as the deprotection agent, 0.5 
M HBTU in DMF was used as the activator, and 2 M DIPEA in NMP was used as the 
activator base.  Five molar equivalents of the amino acid were used for each coupling on 
Rink Amide MBHA resin (0.59 mmol/g substitution, Novabiochem).  Residues Arg1, 
Arg2, Arg5, Arg11, and Arg16 were coupled using Method 1.  Residues Ile3, Leu6, Val7, 
Gly8, Val9, and Phe15 were coupled using Method 2. Residues Ala4, Leu10, Glu12, Phe13, 
Ala14 were coupled using Method 3.  Method 1: Initial 30 s microwave deprotection (40 
W, 75 ºC), followed by 3 min microwave deprotection (40 W, 75 ºC).  Two consecutive 
coupling cycles were used.  The first coupling was at room temperature for 25 min 
followed by an additional 5 min under microwave power (25 W, 75 ºC).  The second 
coupling was performed under microwave power for 5 min (25 W, 75 ºC).  Method 2: 
Initial 30 s microwave deprotection (40 W, 75 ºC), followed by 3 min microwave 
deprotection (40 W, 75 ºC).  A single microwave coupling was performed for 5 min (25 
W, 75 ºC).  Method 3: Initial 30 s microwave deprotection (40 W, 75 ºC), followed by 3 
min microwave deprotection (40 W, 75 ºC).  Two consecutive microwave couplings were 
performed for 5 min (25 W, 75 ºC). 
Before removal of the Fmoc-group from R2, the resin beads were divided into two equal 
portions and transferred to clean RVs for manual coupling of either Fmoc-L-Phe-OH or 
Boc-L-thionophenylalanine-1-(6-nitro)benzotriazolide.  The coupling of Fmoc-L-Phe-OH 
to R2-R17 to form pOCNC was performed for 45 min with 5 equiv HBTU and 10 equiv 
DIPEA.   The addition of Boc-L-thionophenylalanine-1-(6-nitro)benzotriazolide to form 
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pOCNC-F’1 was performed for 45 min with 10 equiv DIPEA.  After removal of the N-
terminal Fmoc-group from pOCNC with 20% piperidine, the resin beads were washed 
with CH2Cl2, dried under vacuum, and incubated on a rotisserie for 120 min with 10 mL 
TFA/TIPSH (95:5 v/v).  The thioamide-containing pOCNC-F’1 was cleaved from the 
resin (without piperidine treatment) and deprotected by washing the resin with CH2Cl2, 
drying under vacuum, and incubating for 90 min with 10 mL TFA/TIPSH (95:5 v/v).  
After each incubation period, the cleavage cocktail for the peptide was expelled from the 
RV with nitrogen and dried by rotary evaporation.  Crude peptide was redissolved in 10 
mL CH3CN/H2O (3:2 v/v) and purified by reverse phase HPLC with gradients 1 and 2 
(Table 2.7).  Using this method, the peptide eluted at approximately 19.5 min.  Peptide 
identity was confirmed by MALDI-MS (Table 2.6). 
Similarly, the peptides Mcm-pOCNC and Trp-pOCNC were made on the 50 μmol scale 
by manual solid phase peptide synthesis.  Rink amide resin (100 – 200 mesh; 0.6 mmol 
substitution/g; 50 µmol) was added to a dry clean RV.  Two successive 90 min 
incubations of 10 mL dimethylformamide (DMF) and magnetic stirring were used to 
swell the resin.  Following swelling, DMF was removed by vacuum.  20% piperidine in 
DMF (5 mL) was used to deprotect the resin in two successive 15 min incubations with 
magnetic stirring.  Then the resin was washed extensively with DMF.  The first amino 
acid (5 equiv) and HBTU (5 equiv) were dissolved in DMF (5 mL) and added to the RV 
along with DIPEA (10 equiv; 44 µL).  The mixture was allowed to react for 45 min with 
magnetic stirring. Spent solution was removed with vacuum suction and the resin beads 
were washed thoroughly with DMF.  The coupling was repeated with an additional 5 
equiv of amino acid and HBTU and 10 equiv of DIPEA (in 5 mL DMF).  The second 
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spent solution was removed with vacuum suction and the resin beads were again washed 
thoroughly with DMF.  The N-terminal Fmoc protecting group was removed by two 
successive 15 min treatments of 20% piperidine in DMF (5 mL).  Subsequent amino acid 
couplings and deprotections were conducted as described above until R2. Prior to the the 
N-terminal Fmoc deprotection of R2, the beads were split into two 25 µM portions in 
separate vessels. In one vessel, the beads were treated twice with 5 equiv of Fmoc-Mcm-
OH, 5 equiv HBTU, and 10 equiv DIPEA for 45 min while the beads in the other vessel 
were given the same treatment with the replacement of 5 equiv Fmoc-Trp(Boc)-OH for 
Fmoc-Mcm-OH.   The peptides were then cleaved from the resin separately by incubating 
the beads with 10 mL TFA/TIPSH (95:5 v/v) for 120 min on a rotisserie.  After this 
treatment, the resulting solutions were expelled from the RV with nitrogen and 
concentrated by rotary evaporation.  The resulting residues were resuspended in 2 mL 
acetonitrile and split into two 1 mL portions.  Then 14 mL diethyl ether was added to 
each portion to precipitate the peptide after 10 min of incubation at - 20 ºC.  The 
precipitates were collected by centrifuging for 5 min at 3000 rpm and decanting the 
supernatant.  This precipitate was air dried and resuspended in 10 mL H2O/CH3CN/TFA 
(10:10:1) for HPLC purification.  The crude peptide was purified by reverse phase HPLC 
with gradient 3 (Table 2.7).  Using this method, the peptides eluted at approximately 17 
min.  Peptide identities were confirmed by MALDI MS (Table 2.6). 
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 Table 2.6: Calculated and Observed Peptide and Protein Masses. 
Peptide 
Calculated m/z 
[M+H]+ 
Observed m/z 
[M+H]+ 
Calculated m/z 
[M+Na]+ 
Observed m/z 
[M+Na]+ 
pOCNC 2106.3 2106.3 2128.6 2128.8 
pOCNC-F'1 2122.3 2122.6 2144.2 2144.7 
Mcm-pOCNC 2204.6 2204.3 2226.6 2226.2 
Trp-pOCNC 2145.6 2145.2 2167.6 2167.2 
GFP-WT 27828 27828   
GFP-N150δ 27978 27978   
αS-WT 14461 14461   
αS-Y39 δ 14562 14563   
αS-F94 δ 14578 14578   
CaM-WT 16707 16707   
CaM-F13δ 16824 16825   
CaM-G41δ 16915 16914   
CaM-Y100δ 16808 16808   
CaM-L113δ 16858 16859   
TIM-WT 31112 31113   
TIM-F74δ 31229 31230   
TIM-Y101δ 31213 31214   
TIM-F74Y101δ 31330 31331   
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Table 2.7: Solvent Gradients Used for Peptide Purification and Analysis. 
Gradient 
Time  
(min) 
Buffer A  
(%) 
Gradient 
Time 
 (min) 
Buffer A  
(%) 
1 0:00 98 2 0:00 98 
 5:00 98  5:00 98 
  8:00 71  8:00 71 
  29:00 59  19:00 64 
  33:00 0  23:00 0 
  38:00 0  28:00 0 
 43:00 98  33:00 98 
3 0:00 98    
 5:00 98    
  12:00 50    
  22:00 38    
  25:00 0    
  30:00 0    
  34:00 98    
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Figure 2.24: Representative Structures of p-OCNC Peptides Used in This Work. Reprinted with permission 
from Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; 
Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-
ylalanine, a Fluorescent Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence 
Resonance Energy Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-
18814. Copyright (2013) American Chemical Society. 
 
Absorption and Fluorescence Spectroscopy of Fluorophore Pairs 
UV/Vis absorbance and fluorescence spectra were acquired for Trp, 7-methoxycoumarin-
4-yl alanine (Mcm), and Acd peptides, and BODIPY Fl, 5-carboxyfluorescein (Fam), 
rhodamine 6G (R6G), and 2-((7-nitrobenzo[1,2,5]oxadiazol-4-yl)amino)ethanol (NBD).  
Absorption spectra were collected using quartz cells with 1 cm path lengths.  
Fluorescence spectra were collected as the average of three scans at 25 °C of three 
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samples of each solution using quartz cells with 1 cm path lengths.  Excitation and 
emission slit widths were 5 nm, scan rate 120 nm/min, averaging time 0.5 s, and data 
interval 1.0 nm. 
 
Figure 2.25: Absorption and Fluorescence Spectra of Trp.  Absorbance (A) and fluorescence (B) spectra of 
7.5 µM LeuProProTrp in pH 7.0 phosphate buffered saline (PBS; 10 mM  Na2HPO4, 150 mM NaCl, pH 
adjusted with HCl).  Concentration determined using published extinction coefficient of Trp (λ278 = 5, 700 
M-1•cm-1)120.  Peptide synthesized as described92. Reprinted with permission from Speight, L. C.; 
Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. 
A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent 
Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy 
Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright 
(2013) American Chemical Society. 
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Figure 2.26: Absorption and Fluorescence Spectra of Mcm, Acd, and Fam.  Absorbance (A) and 
fluorescence (B) spectra of 8.8 µM LeuProProMcm in pH 7.0 PBS .  Peptide synthesized as described92.  
Absorbance (C) and fluorescence (D) spectra of 0.26 mM Acd and 2 µM Acd, respectively, in PBS, pH 7.0.  
Absorbance (E) and fluorescence (F) spectra of 9.5 µM Fam and 1.5 µM Fam, respectively, in 100 mM 
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phosphate buffer, pH 7.0.  Concentrations determined using published extinction coefficients of Mcm (λ325 
= 12, 000 M-1•cm-1), Acd (λ386 = 5, 700 M-1•cm-1), and Fam (λ492 = 68, 000 M-1•cm-1).111, 121 Reprinted with 
permission from Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, 
T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of 
Acridon-2-ylalanine, a Fluorescent Amino Acid for Lifetime and Forster Resonance Energy 
Transfer/Luminescence Resonance Energy Transfer Studies. Journal of the American Chemical Society 
2013, 135 (50), 18806-18814. Copyright (2013) American Chemical Society. 
113 
 
Figure 2.27: Absorption and Fluorescence Spectra of BODIPY Fl, R6G, and NBD in 100 mM phosphate 
buffer, pH 7.0. Absorbance (A) and fluorescence (B) spectra of 4.3 and 1.2 µM BODIPY Fl, respectively.  
Absorbance (C) and fluorescence (D) spectra of 4.5 and 0.25 µM R6G, respectively.  Absorbance (E) and 
fluorescence (F) spectra of 86 and 15 µM NBD, respectively.  Concentrations determined using published 
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extinction coefficients of BODIPY Fl (λ502 = 82, 000 M-1•cm-1), R6G (λ530 = 116 000 M-1•cm-1), and NBD 
(λ484 = 6835 M-1•cm-1).122, 123 Reprinted with permission from Speight, L. C.; Muthusamy, A. K.; Goldberg, 
J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient 
Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent Amino Acid for Lifetime and 
Forster Resonance Energy Transfer/Luminescence Resonance Energy Transfer Studies. Journal of the 
American Chemical Society 2013, 135 (50), 18806-18814. Copyright (2013) American Chemical Society. 
 
Acd Steady-State Stern-Volmer Experiments 
Stocks of 50 μM Acd and 100 mM tyrosine methyl ester (Tyr-OMe), cysteine, histidine, 
glycine, and tryptophan (83.6 mM stock solution) in 100 mM sodium phosphate buffer, 
pH 7.00, were used to prepare samples that were uniform in Acd concentration (5 μM) 
and variable in amino acid concentration (0, 2.5, 5, 15, 25, 35, 50, and 65 mM).  The 
fluorescence of each sample was measured by exciting the solution at 385 nm and 
recording the emission at 450 nm.  Measurements were made in Corning 3650 black flat-
bottom microplates on a Perkin Elmer Envision Xcite instrument at 25 and 40 °C.  
Excitation and emission bandwidths were 8 nm and the gain was calculated automatically 
from a plate containing 5 uM Acd in four wells.  The samples were allowed to equilibrate 
for several min at each temperature before scans were taken.  The fluorescence intensity 
at 450 nm was averaged from three separate trials to obtain values for Stern-Volmer 
calculations.  The data for a given temperature were fit to Equation 1a or 1b with 
KaleidaGraph (Synergy Software; Reading, PA, USA). 
F0
F
= 1+ KSt Q[ ] (1a) 
 
115 
( [ ] ) )( ][11 DySt0 QKQK
F
F
++=  (1b) 
F0 is the average fluorescence intensity at 450 nm in the absence of quencher; F is the 
fluorescence intensity at 450 nm at each amino acid concentration step; KSt is the static 
Stern-Volmer constant in M-1; KDy the dynamic Stern-Volmer constant in M-1, and [Q] is 
the quencher concentration in M.  Only Trp and Tyr data were fit to equation S1b since 
all other quenching was negligible.  KSt for Trp is 21.25 ± 0.28 M-1 at 25 °C.  KSt for Tyr-
OMe is 8.81 ± 0.24 M-1 at 25 °C.  KDy was fixed at the value obtained from lifetime 
experiments (see below) for both Trp and Tyr-OMe. 
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Figure 2.28: Steady-State Stern-Volmer Titrations of Acd with Amino Acids.  Acd fluorescence (λex = 385 
nm, λem = 450 nm) recorded with varying concentrations of Cys, Gly, His, Met, Trp, or Tyr-OMe in 100 
mM sodium phosphate buffer, pH 7.00 at 25 °C (red) or 40 °C (green).  Average of three trials, error bars 
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are calculated from standard error.  Fits to equation S1a shown for Cys, Gly, His, and Met.  Fits to equation 
S1b shown for Trp (R2 = 0.99961 at 25 °C) and Tyr-OMe (R2 = 0.99814 at 25 °C). Reprinted with 
permission from Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, 
T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of 
Acridon-2-ylalanine, a Fluorescent Amino Acid for Lifetime and Forster Resonance Energy 
Transfer/Luminescence Resonance Energy Transfer Studies. Journal of the American Chemical Society 
2013, 135 (50), 18806-18814. Copyright (2013) American Chemical Society. 
 
Acd Fluorescence Lifetime Stern-Volmer Experiments  
Fresh solutions of each sample were prepared at identical concentrations for Stern-
Volmer lifetime experiments.  Time-resolved fluorescence measurements were 
performed using the Time-Correlated Single Photon Counting (TCSPC) method.  The 
TCSPC system consisted of a blue diode laser (PicoQuant GmbH; Berlin, Germany) 
generating 10 MHz output pulses at 405 nm, a subtractive double monochromator with an 
MCP-PMT (Hamamatsu Photonics R2809U; Bridgewater, NJ, USA), and a TCSPC 
computer board (Becker and Hickl SPC-630; Berlin, Germany).  Emission at 450 nm was 
monitored.  All samples were thermostatted at 25 °C.  Data analysis was performed with 
FluoFit software (PicoQuant) using a single-exponential decay model (Equation 2). 
I( t) = Aie
−
t
τ i
i=1
n
∑  (2) 
Here, n = 1, for a single-exponential fit, and the parameters Ai and τi are the amplitude 
and lifetime of the ith component, respectively.  Reduced χ2 values were calculated for 
each fit according to Equation 3. 
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χ
2
=
1
N − p
W ( j) 2 decay ( j) − fit( j)[ ]
2
j =1
N
∑            W ( j) = 1
decay( j )
 (3) 
In this equation, N is the number of fitted data points j (i.e. measured photon counts at a 
given delay time, a bin); p is the number of adjustable, fitted parameters; W(j) is a 
Poisson weighting factor; decay(j) is the experimentally determined decay curve; and 
fit(j) is the fitted model.  The residuals were calculated according to Equation 4 using 
these values. 
R = W ( j) decay ( j ) − fit ( j)[ ] (4) 
Fluorescence lifetime data were used to construct a Stern-Volmer plot according to 
Equation 5. 
τ0
τ
= 1 + KDy Q[ ] (5) 
where τ0 is the fluorescence lifetime in the absence of quencher (15.73 ± 0.05 ns); τ is the 
lifetime at each quencher concentration; KDy is the Stern-Volmer constant in units of M-1; 
and [Q] is the concentration of the quencher (Tyr-OMe or Trp) in M (Fig. S6).  Using this 
equation, we found KDy = 38.20 ± 0.28 M-1 for Tyr-OMe and KDy = 48.98 ± 0.22 M-1 for 
Trp. 
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Figure 2.29: Lifetime Stern-Volmer experiments.  Left:  Fits to normalized Acd fluorescence lifetime data 
with varying concentrations of tyrosine methyl ester (Tyr-OMe) or tryptophan in 100 mM sodium 
phosphate buffer, pH 7.00 (λex = 405 nm; λem = 450 nm).  Right: Stern-Volmer plots of lifetime data at 25 
°C.  Error bars are calculated from fits of the raw data; R2 = 0.99997 for Tyr-OMe, R2 = 0.99997 for Trp. 
Reprinted with permission from Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; 
Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and In Vivo 
Incorporation of Acridon-2-ylalanine, a Fluorescent Amino Acid for Lifetime and Forster Resonance 
Energy Transfer/Luminescence Resonance Energy Transfer Studies. Journal of the American Chemical 
Society 2013, 135 (50), 18806-18814. Copyright (2013) American Chemical Society. 
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Förster Distance Calculations 
The Förster distance, R0, is given in Å by equation (6) 
R0
6 =
9000(ln10)κ 2ΦDJ
128π 5n4N
A
 (6) 
where κ2 is a geometrical factor that relates the orientation of the donor and acceptor 
transition moments, ΦD is the quantum yield of the donor, n is the index of refraction of 
the solvent, NA is Avogadro’s number, and J is the spectral overlap integral defined in 
units of M-1•cm-1•nm4. Combining constants and rearranging gives R0 as  
R0 = 0.211{ΦDκ
2
n
−4
J}1/6  (7) 
J is formally defined as  
J = fD (λ)εA (λ)λ
4 dλ
0
∞
∫  (8) 
where εA(λ) is the molar extinction coefficient of the acceptor at each wavelength λ and 
fD(λ) is the normalized donor emission spectrum given by 
fD (λ) =
FDλ (λ)
FDλ (λ)dλ
0
∞
∫
 
(9) 
where FDλ(λ) is the fluorescence of the donor at each wavelength λ.  Fluorescence spectra 
of Trp (LeuProProTrp), Mcm (LeuProProMcm), and Acd (LeuProProAcd) were 
integrated with KaleidaGraph from 305 to 500 nm for Trp, 336 to 600 nm for Mcm, and 
400 to 600 nm for Acd to calculate fD(λ).  UV/Vis spectra of Acd, BODIPY Fl, Fam, 
R6G, and NBD in water were used to determine εA(λ).  J values were obtained using 
Equation (S8) for various donor/acceptor pairs are given in Table 2.8.   Substituting these 
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results into Equation (S7), as well as the donor quantum yields in Table 2.8, 1.33 for the 
index of refraction of water, and 2/3 for κ2 gives the Förster distances listed in Table S3.  
These R0 values were used to generate plots of FRET efficiency as a function of distance 
using Equation 10. 
EFRET =
1
1+
R
R0






6  
(10) 
Here, EFRET is the FRET efficiency and R is the separation between the chromophores.  
Plots of FRET efficiency for each chromophores are shown in Figure 2.30. 
 
Table 2.8: Photophysical Characteristics of Acd FRET Pairs. 
FRET Pair 
(Donor, Acceptor) 
ΦD 
 
J 
(M-1•cm-1•nm4) 
R0 
(Å) 
εA (M-1•cm-1) 
@ λmax (nm) 
Trp, Acd 0.13124 5.47 x 1013 22.6 5, 700 @ 386 
Mcm, Acd 0.18111 7.96 x 1013 25.4 5, 700 @ 386 
Acd, Fam 0.95 9.64 x 1014 50.8 68, 000 @ 492 
Acd, BODIPY 0.95 8.18 x 1014 49.4 82, 000 @ 504 
Acd, R6G 0.95 7.86 x 1014 49.1 116, 000 @ 530 
Acd, NBD 0.95 5.47 x 1014 37.0 6, 835 @ 484 
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Figure 2.30: Distance Dependence of Acd FRET Interactions.  FRET efficiencies of donor/acceptor pairs 
Trp/Acd (A), Mcm/Acd (B), Acd/Fam (C), Acd/BODIPY (D), Acd/R6G (E) and Acd/NBD (F) calculated 
according to Equations (S7), (S8), and (S10) using the values in Table 2.8. Reprinted with permission from 
Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, 
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B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a 
Fluorescent Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance 
Energy Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-18814. 
Copyright (2013) American Chemical Society. 
 
Synthetase Sequences 
M. jannaschii TyrRS 
 
          1                                                          60 
          MDEFEMIKRNTSEIISEEELREVLKKDEKSAYIGFEPSGKIHLGHYLQIKKMIDLQNAGF 
 
         61                                                          120 
          DIIILLADLHAYLNQKGELDEIRKIGDYNKKVFEAMGLKAKYVYGSEFQLDKDYTLNVYR 
 
        121                                                          180 
          LALKTTLKRARRSMELIAREDENPKVAEVIYPIMQVNDIHYLGVDVAVGGMEQRKIHMLA 
 
        181                                                          240 
          RELLPKKVVCIHNPVLTGLDGEGKMSSSKGNFIAVDDSPEEIRAKIKKAYCPAGVVEGNP 
 
        241                                                          300 
          IMEIAKYFLEYPLTIKRPEKFGGDLTVNSYEELESLFKNKELHPMDLKNAVAEELIKILE 
 
        301 
          PIRKRL 
 
 
 
 
 
 
 
 
 
 
Synthetase Mutants 
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 31 32 65 107 108 109 158 159 161 162 164 167 
TyrRS Ala Tyr Leu Glu Phe Gln Asp Ile Tyr Leu Val Ala 
BrbRS1  Gly Glu    Gly Cys     
BrbRS2  Gly Val  Trp Met Gly Pro     
BrbRS3  Gly Glu  Trp Met Ser      
BzfRS1  Gly  Pro   Thr Ser Arg    
BzfRS2  Gly  Pro   Thr Ser Arg Ala   
BzfRS3  Gly  Pro   Ser Ser Arg    
BzfRS4 Val Gly  Pro   Ser Ser Arg    
BzfRS4  Gly  Pro   Ser Ser Arg  Ala  
NapRS1  Ala  Pro   Pro Ala    Val 
 
Figure 2.31: Sequences of Candidate Synthetases.  Top: Amino acid sequence of parent M. jannaschii 
TyrRS. Residues where mutations were examined are highlighted in red.   Bottom: Sequences of mutant 
synthetases screened for selective Acd incorporation using GFP assay.  Amino acids listed by position 
number.  Blank cells indicate no mutation.  BrbRS1 = AcdRS. Reprinted with permission from Speight, L. 
C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, 
R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent 
Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy 
Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright 
(2013) American Chemical Society. 
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Cloning of Calmodulin Expression Constructs  
 pCaM, A plasmid containing the wild-type chicken calmodulin (CaM) gene was 
provided by Joshua Wand from the Perelman School of Medicine at the University of 
Pennsylvania.  An insert containing the CaM gene (458 base pairs from start to stop 
codon) was cloned into a pET15b vector (Novagen; Gibbstown, NJ, USA) between the 
NcoI and XhoI cut sites.  Quikchange® site-directed mutagenesis was used to generate 
CaM mutants by inserting a TAG codon at the site of interest: F13δ, G41δ, Y100δ, and 
L113δ.  The mutant plasmids were verified by DNA sequencing analysis with a T7 
promoter primer. 
A. CaM Gene 
5'-atggctgatcaactgacagaagagcagattgcagaattcaaagaagctttttcactattt 
gacaaggatggtgatggtactataactacaaaggagttggggactgtgatgagatcacttggt 
cagaaccccacagaagcagaattacaggacatgatcaatgaagtagacgctgatggcaatggc 
acaattgacttcccagagtttctgacaatgatggcaagaaaaatgaaagatacagatagcgaa 
gaagaaattagagaagcgttccgtgtgtttgacaaggatggtaatggttacattagtgctgca 
gaacttcgtcatgtgatgacaaatcttggggagaagctaacagatgaagaagttgatgaaatg 
attagggaagcagacattgatggtgatggtcaagtaaactatgaagagtttgtacagatgatg 
acagcgaagtga-3' 
B. Chicken CaM Amino Acid Sequence 
MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINE
VDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHV
MTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK 
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C. DNA Oligomers used for Quikchange® Mutagenesis 
F13δ_For 5'-ACTGACAGAAGAGCAGATTGCAGAATAGAAAGAAGCTTTTTCACTATTTGAC-3' 
F13δ_Rev 5'-GTCAAATAGTGAAAAAGCTTCTTTCTATTCTGCAATCTGCTCTTCTGTCAGT-3' 
G41δ_For 5'-TTCTGTGGGGTTCTGCTAAAGTGATCTCATCACAGTCCCCAACTCC-3' 
G41δ_Rev 5'-GGAGTTGGGGACTGTGATGAGATCACTTTAGCAGAACCCCACAGAA-3' 
Y100δ_For 5'-GACAAGGATGGTAATGGTTAGATTAGTGCTGCAGAACTTCG-3' 
Y100δ_Rev 5'-CGAAGTTCTGCAGCACTAATCTAACCATTACCATCCTTGTC-3' 
L113δ_For 5'-CTGCAGAACTTCGTCATGTGATGACAAATTAGGGGGAGAAGCTAACA-3' 
L113δ_Rev 5'-TGTTAGCTTCTCCCCCTAATTTGTCATCACATGACGAAGTTCTGCAG-3' 
Figure 2.32: CaM Mutagenesis. A) DNA sequence of chicken CaM gene from start to stop codon.  B) 
Amino acid sequence of chicken CaM. F13, G41, Y100, L113 highlighted in bold red.  C) Forward and reverse 
DNA oligomers used for site-directed mutagenesis. Reprinted with permission from Speight, L. C.; 
Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. 
A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent 
Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy 
Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright 
(2013) American Chemical Society. 
 
Wild-Type Calmodulin Protein Expression  
The plasmid containing the chicken CaM gene, pCaM, was used to transform E. coli 
BL21(DE3) cells.  Transformed cells were selected on the basis of ampicillin resistance.  
Single colonies were used to inoculate 5 mL of LB media supplemented with ampicillin 
(100 µg/mL).  To an autoclaved solution containing 42 mM Na2HPO4, 22 mM KH2PO4, 
19 mM NH4Cl, and 86 mM NaCl (M9 salts), the following autoclaved solutions were 
added per liter of M9 salts: 1 mL of 2 M MgSO4, 1 mL of 15 mg/mL FeCl2 (in 1.0 M 
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HCl), 1 mL of 15 mg/mL ZnCl2 (in acidified H2O), 6.25 mL of 40% glucose, 100 µL of 
1M CaCl2 and 2 mL of 10% BactoTM Yeast Extract.  The primary 5 mL culture was 
incubated at 37 °C with shaking at 250 rpm for 4 h.  Upon the primary culture reaching 
saturation, it was added to 1 L of M9 minimal media supplemented with ampicillin (see 
concentrations).  The 1 L culture was incubated at 37 °C with shaking at 250 rpm until 
the OD600 reached 0.7 AU.  Protein expression was induced with isopropyl D-galactoside 
(IPTG), and the culture was incubated at 37 °C with shaking at 250 rpm for an additional 
16 h.  The cells were again harvested by centrifuging at 5000 x g for 15 min and the 
resulting pellet was suspended in 15 mL of MOPS resuspension buffer (50 mM 3-(N-
morpholino) propanesulfonic acid (MOPS), 100 mM KCl, 1 mM ethylenediamine 
tetraacetic acid (EDTA), pH 7.5).  Following sonication, the cell lysate was allowed to 
cool on ice for 5 min.  CaCl2 was added to the sonicated lysate to a final concentration of 
5 mM prior to centrifugation for 20 min at 30,000 x g, 4 °C. 
 
Acd Mutant Calmodulin Protein Expression 
 The pCaM-F13δ, -G41δ, -Y100δ, or -L113δ   plasmid (with Amp resistance) was used to 
transform E. coli BL21(DE3) cells.  These cells were previously transformed with the 
pDule2-Acd plasmid and made competent following the Hanahan method.122  The 
pDule2-Acd plasmid encodes the AcdRS and cognate tRNA (streptomycin resistant).  
Transformed cells were selected on the basis of Amp and Strep resistance.  Single 
colonies were used to inoculate 5 mL of LB media supplemented with Amp and Strep 
(100 µg/mL each).  To an autoclaved solution containing 42 mM Na2HPO4, 22 mM 
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KH2PO4, 19 mM NH4Cl, and 86 mM NaCl (M9 salts), the following autoclaved solutions 
were added per liter of M9 salts: 1 mL of 2 M MgSO4, 1 mL of 15 mg/mL FeCl2 (in 1.0 
M HCl), 1 mL of 15 mg/mL ZnCl2 (in acidified H2O), 6.25 mL of 40% glucose, 100 µL 
of 1M CaCl2 and 2 mL of 10% BactoTM Yeast Extract.  The primary 5 mL culture was 
incubated at 37 °C with shaking at 250 rpm for 4 h.  Upon reaching saturation, the 
primary culture was added to 1 L of M9 minimal media supplemented with Amp and 
Strep.  The 1 L culture was incubated at 37 °C with shaking at 250 rpm until the OD600 
reached 0.7 AU.  At this point, a solution of 282 mg Acd in 4 mL sterile water (with 4 
drops 10 M NaOH to solubilize Acd) was added and protein expression was induced with 
IPTG.  The culture was incubated at 37 °C for an additional 16 h.  The cells were 
harvested at 5000 x g for 15 minutes and the resulting pellet was suspended in 15 mL of 
MOPS resuspension buffer (50 mM MOPS, 100 mM KCl, 1 mM EDTA, pH 7.5).  
Following sonication, the cell lysate was allowed to cool on ice for 5 min.  CaCl2 was 
added to the sonicated lysate to a final concentration of 5 mM prior to centrifugation for 
20 minutes at 30,000 x g, 4 °C. 
CaM was purified from the cleared cell lysate using a phenyl-sepharose (PhS) CL-4B 
column with EDTA as eluent.  Using a total resin bed volume of 10 mL, the column was 
first equilibrated with 4 column volumes of PhS Buffer A (50 mM Tris base, 1 mM 
CaCl2, pH 7.5).  After the cleared cell lysate was loaded and allowed to pass through the 
resin, the column was washed with 4 column volumes of PhS Buffer A, 4 column 
volumes of high-salt PhS Buffer B (50 mM Tris base, 0.5 M NaCl, 0.1 mM CaCl2, pH 
7.5), and an additional 2 column volume washes of PhS Buffer A to restore low-salt 
conditions.  CaM was eluted with PhS Buffer C (10 mM Tris base, 10 mM EDTA, pH 
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7.5) and collected in 1 mL fractions and the presence of protein was detected by SDS-
PAGE.  Fractions containing protein were combined and dialyzed against water for 16 h 
at 4 ºC and dialyzed into 15 mM HEPES, 140 mM KCl, 6 mM CaCl2, pH 6.7. 
For CaM-Y100δ, additional purification was performed.  Following PhS purification, 
fractions containing protein were directly loaded onto a HiTrap Q-Column (GE 
Healthcare) on an ÄKTA FPLC system.  The running buffer was 50 mM Tris pH 7.5 and 
the eluent was 50 mM Tris, 500 mM NaCl, pH 7.5.  Fractions containing CaM-Y100δ 
eluted between 44 and 47 minutes (corresponding to 31 to 34 % elution buffer).  These 
fractions were combined and dialyzed against water and then against 15 mM HEPES, 140 
mM KCl, pH 6.70. 
 
Cloning of TIM Expression Constructs   
The tpiA gene from E. coli genome was cloned into pBad vector (Invitrogen) between the 
NcoI and KpnI cut sites.  Quikchange® site-directed mutagenesis was used to generate 
the TAG mutants F74δ and Y101δ.  The mutant plasmids were verified by DNA 
sequencing analysis with a pBad primer below. 
A. TIM Gene 
5'atggggggttctcatcatcatcatcatcatggtatggctagcatgactggtggacagcaaatgggtcgg
gatctgtacgacgatgacgataaggatcgatggggatccgagctcgagcgacatcctttagtgatgggta
actggaaactgaacggcagccgccacatggttcacgagctggtttctaacctgcgtaaagagctggcag
gtgttgctggctgtgcggttgcaatcgcaccaccggaaatgtatatcgatatggcgaagcgcgaagctga
aggcagccacatcatgctgggtgcgcaaaacgtggacctgaacctgtccggcgcattcaccggtgaaac
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ctctgctgctatgctgaaagacatcggcgcacagtacatcatcatcggtcactctgaacgtcgtacttacca
caaagaatctgacgaactgatcgcgaaaaaattcgcggtgctgaaagagcagggcctgactccggttct
gtgcatcggtgaaaccgaagctgaaaatgaagcgggcaaaactgaagaagtttgcgcacgtcagatcga
cgcggtactgaaaactcagggtgctgcggcattcgaaggtgcggttatcgcttacgaacctgtatgggca
atcggtactggcaaatctgcaactccggctcaggcacaggctgttcacaaattcatccgtgaccacatcgc
taaagttgacgctaacatcgctgaacaagtgatcattcagtacggcggctctgtaaacgcgtctaacgctg
cagaactgtttgctcagccggatatcgacggcgcgctggttggtggtgcttctctgaaagctgacgccttc
gcagtaatcgttaaagctgcagaagcggctaaacaggcttaa-3' 
B. E. coli TIM Amino Acid Sequence 
MGGSHHHHHHGMASMTGGQQMGRDLYDDDDKDRWGSELERHPLVMGNWKL
NGSRHMVHELVSNLRKELAGVAGCAVAIAPPEMYIDMAKREAEGSHIMLGAQN
VDLNLSGAFTGETSAAMLKDIGAQYIIIGHSERRTYHKESDELIAKKFAVLKEQG
LTPVLCIGETEAENEAGKTEEVCARQIDAVLKTQGAAAFEGAVIAYEPVWAIGTG
KSATPAQAQAVHKFIRDHIAKVDANIAEQVIIQYGGSVNASNAAELFAQPDIDGA
LVGGASLKADAFAVIVKAAEAAKQA 
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C. DNA Oligomers used for Quikchange® Mutagenesis 
F74δ_For 5’–CTGAACCTGTCCGGCGCATAGACCGGTGAAACCTCTGCTG-3’ 
F74δ_Rev 5’–CAGCAGAGGTTTCACCGGTCTATGCGCCGGACAGGTTCAG-3’ 
Y101δ_For 5’–CTGAACGTCGTACTTAGCACAAAGAATCTGAC-3’ 
Y101δ_Rev 5’–GTCAGATTCTTTGTGCTAAGTACGACGTTCAG-3’ 
pBad_Seq 5’–ATGCCATAGCATTTTTATCC–3’ 
Figure 2.33: TIM Mutagenesis. A) DNA sequence of E. coli tpiA gene from start to stop codon.  B) Amino 
acid sequence of E. coli TIM. F74,Y101 highlighted in bold red.  C) Forward and reverse DNA oligomers 
used for site-directed mutagenesis and sequencing. Reprinted with permission from Speight, L. C.; 
Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. 
A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent 
Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy 
Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright 
(2013) American Chemical Society. 
 
Wild-Type TIM Expression  
The wt-TIM plasmid containing the E. coli TIM gene with (with Amp resistance) was 
used to transform E. coli DH10B cells via electroporation. Single colonies were then 
picked and grown overnight at 37°C with 250 rpm shaking in 5 mL of LB media (with 
Amp antibiotic). These starter cultures were then used to inoculate 500 mL of 
autoinduction media (created as previously described).66  The cultures were grown for 24 
h under these conditions. The cells were harvested at 5000 x g for 15 min and the 
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resulting pellet was suspended in 15 mL 20 mM Tris Base, 300 mM KCl, and 15 mM 
imidazole. Following sonication, the cell lysate was allowed to cool on ice for 5 min. The 
cell lysate was cleared of debris by centrifugation for 20 min at 30,000 x g, 4 °C. The 
cleared lysate was then added to 3 mL of Ni-NTA slurry and incubated at 4 °C for 1 hour 
with moderate shaking to ensure thorough mixing. Following this incubation, the column 
flow-through was collected and the slurry was washed with the following buffers: 20 mL 
of 20 mM Tris Base, 300 mM KCl, and 50 mM imidazole, 20 mL of 20 mM Tris Base, 
300 mM KCl, and 75 mM imidazole, and 10 mL of 20 mM Tris Base, 300 mM KCl, and 
100 mM imidazole. Acd-TIM mutants were eluted from the Ni-NTA column by 4 x 1.5 
mL and 1 x 5 mL portions of 20 mM Tris Base, 300 mM KCl, and 250 mM imidazole. 
Elution fractions containing the protein of interest were identified by SDS-PAGE 
analysis. 
 
Acd Mutant TIM Expression  
The TIM-F74δ or -Y101δ plasmid (with Amp resistance) along with a pDule1 plasmid 
containing the AcdRS and cognate tRNA (with Tet resistance) was used to transform E. 
coli DH10B cells via electroporation.  Single colonies were then picked and grown 
overnight at 37 °C with 250 rpm shaking in 5 mL of LB media (with Amp and Tet 
antibiotics).  These starter cultures were then used to inoculate 500 mL of autoinduction 
media (created as previously described).66  After 30 minutes of growth at 37 °C with 250 
rpm shaking, a solution of 282 mg Acd in 4 mL sterile water (with 4 drops 10 M NaOH 
to solubilize Acd) was added.  The cultures were grown for 24 h under these conditions.  
The cells were harvested at 5000 x g for 15 minutes and the resulting pellet was 
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suspended in 15 mL 20 mM Tris Base, 300 mM KCl, and 15 mM imidazole.  Following 
sonication, the cell lysate was allowed to cool on ice for 5 min.  The cell lysate was 
cleared of debris by centrifugation for 20 minutes at 30,000 x g, 4 °C.  The cleared lysate 
was then added to 3 mL of Ni-NTA slurry and incubated at 4 °C for 1 h with moderate 
shaking to ensure thorough mixing.  Following this incubation, the column flow-through 
was collected and the slurry was washed with the following buffers: 20 mL of 20 mM 
Tris Base, 300 mM KCl, and 50 mM imidazole, 20 mL of 20 mM Tris Base, 300 mM 
KCl, and 75 mM imidazole, and 10 mL of 20 mM Tris Base, 300 mM KCl, and 100 mM 
imidazole. Acd-TIM mutants were eluted from the Ni-NTA column by 4 x 1.5 mL and 1 
x 5 mL portions of 20 mM Tris Base, 300 mM KCl, and 250 mM imidazole.  Elution 
fractions containing the protein of interest were identified by SDS-PAGE analysis. 
 
Cloning of α-Synuclein Expression Constructs  
A plasmid containing the human wild-type αS gene cloned between NdeI and HindIII in 
the expression vector pRK172 was provided by Dr. Virginia Lee (Perelman School of 
Medicine, University of Pennsylvania).  Quikchange® site-directed mutagenesis was 
used to generate the TAG mutants Y39δ and F94δ.  Sequencing was confirmed using a T7 
promoter. 
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A. αS Gene 
5'atggatgtattcatgaaaggactttcaaaggccaaggagggagttgtggctgctgctgagaaaaccaaa
cagggtgtggcagaagcagcaggaaagacaaaagagggtgttctctatgtaggctccaaaaccaagga
gggagtggtgcatggtgtggcaacagtggctgagaagaccaaagagcaagtgacaaatgttggaggag
cagtggtgacgggtgtgacagcagtagcccagaagacagtggagggagcagggagcattgcagcagc
cactggctttgtcaaaaaggaccagttgggcaagaatgaagaaggagccccacaggaaggaattctgga
agatatgcctgtggatcctgacaatgaggcttatgaaatgccttctgaggaagggtatcaagactacgaac
ctgaagcctaa-3' 
B. Human αS Amino Acid Sequence 
MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHG
VATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKN
EEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA 
C. DNA Oligomers used for Quikchange® Mutagenesis 
Y39δ_For 5'-AAAAGAGGGTGTTCTCTAGGTAGGCTCCAAAACCAAG-3' 
Y39δ_Rev 5'-CTTGGTTTTGGAGCCTACCTAGAGAACACCCTCTTTT-3' 
F94δ_For 5'-GCATTGCAGCAGCCACTGGCTAGGTCAAAAAGGACCAGTTGGG-3' 
F94δ_Rev 5'-CCCAACTGGTCCTTTTTGACCTAGCCAGTGGCTGCTGCAATGC-3' 
Figure 2.34: α-Synuclein Mutagenesis. A) DNA sequence of human αS gene from start to stop codon.  B) 
Amino acid sequence of human αS. Y39 and F94 are highlighted in bold red.  C) Forward and reverse DNA 
oligomers used for site-directed mutagenesis. Reprinted with permission from Speight, L. C.; Muthusamy, 
A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, 
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E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent Amino Acid for 
Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy Transfer Studies. 
Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright (2013) American 
Chemical Society. 
 
Wild-Type α-Synuclein Expression  
The plasmid containing the αS gene was transformed into E. coli BL21(DE3) cells.  
Single colonies were used to inoculate 4 mL of LB media supplemented with ampicillin 
(100 μg/mL).  The primary culture was grown at 37 °C with shaking at 250 rpm for 4 h. 
A 500 mL secondary culture was inoculated using 1 mL of the primary culture and grown 
at 37 °C with shaking at 250 rpm for 20 h.  The cells were harvested at 5000 x g for 15 
min and the resulting pellet was resuspended in 20 mM Tris, pH 8.0 with 1 mM PMSF 
and sonicated.  Following sonication, the cell lysate was boiled for 30 min prior to 
centrifugation for 20 min at 30,000 x g, 4 °C.  The cleared lysate was dialyzed overnight 
against 20 mM Tris pH 8.0 at 4 °C prior to loading on a Superdex 200 column (25 cm) 
connected to a BioCad Sprint (FPLC) system.  FPLC fractions were dialyzed against 20 
mM Tris pH 8.0 at 4 °C and further purified using a HiTrap Q HP column (GE 
Healthcare) on the BioCad FPLC. Fractions were dialyzed against Milli-Q water at stored 
at 4 °C.  Protein was concentrated using 3KDa Amicon Ultra-0.5 mL centrifugal filters 
(EMD Millipore) and adjusted to 500 μM by BCA assay and stored at -80 °C until further 
use.  SDS-PAGE analysis was performed to analyze the purity of αS. 
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Acd Mutant α-Synuclein Expression  
E. coli BL21-Gold (DE3) cells were transformed with the  αS-Y39δ or -F94δ plasmid and 
a pDule2 plasmid containing the AcdRS and tRNACUA pair.  Cells were selected for 
resistance to both ampicillin (100 μg/mL) and streptomycin (100 μg/mL).  Single 
colonies were used to inoculate 4 mL of LB media.  The primary culture was grown at 37 
°C with shaking at 250 rpm for 4 h.  A 500 mL secondary culture was inoculated using 1 
mL of the primary culture and grown at 37 °C with shaking at 250 rpm until OD600 = 0.8.  
Protein expression was induced with 1 mM Acd (282 mg in 4 mL sterile water 
solubilized with 4 drops 10 M NaOH) and 1 mM IPTG, then cells were grown at 37 °C 
for 18 h.  The cells were harvested at 5000 x g for 15 min and the resulting pellet was 
resuspended in 20 mM Tris, pH 8.0 with 1 mM PMSF and sonicated.  Following 
sonication, the cell lysate was boiled for 30 min prior to centrifugation for 20 min at 
30,000 x g, 4 °C.  The cleared lysate was dialyzed overnight against 20 mM Tris, pH 8.0 
at 4 °C prior to loading on a Superdex 200 column (25 cm).  FPLC fractions were 
dialyzed against 20 mM Tris, pH 8.0 at 4 °C and further purified using a HiTrap Q HP 
column (GE Healthcare).  Fractions were dialyzed against Milli-Q water and stored at 4 
°C.  Protein was concentrated using 3 KDa Amicon Ultra-0.5 mL centrifugal filters 
(EMD Millipore) and adjusted to 500 μM by BCA assay.  Protein was then stored at -80 
°C until further use.  SDS-PAGE analysis was performed to analyze the purity of αS. 
 
Trypsin Digest Analysis of Acd Mutants 
Protein (CaM-L113δ, αS-Y39δ, or αS-F94δ) was precipitated using 1:4 8.75 M 
trichloroacetic acid/protein sample and incubated at 4 °C for 15 minutes.  The precipitate 
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was centrifuged for 15 min at 13,200 rpm to pellet protein.  The protein pellet was then 
washed three times with cold acetone to remove trace trichloroacetic acid.  Trace acetone 
was removed by incubating protein pellets in a 95 °C water bath for 5 min open to the 
atmosphere.  Protein pellets were then re-suspended in 6 M guanidinium hydrochloride 
with 50 mM Tris pH 8.0, and denatured by boiling at 95 °C for 10 minutes.  Protein 
samples were then diluted to 0.75 M guanidinium hydrochloride with 50 mM Tris pH 7.6 
and 1 mM calcium chloride.  Sequencing grade modified trypsin (0.6 μg, Promega) was 
used to digest samples for 24 hours at 37 °C.  Trypsin digest aliquots (1 μL) were 
combined with α-cyano-4-hydroxycinnamic acid (1 μL of a saturated solution in 1:1 
H2O/CH3CN with 1 % TFA) and analyzed by MALDI MS. 
 
 
Figure 2.35: MALDI MS of Trypsinized Proteins.  Asterisks indicate the absence of peaks corresponding 
to Tyr incorporation at the site of interest.  CaM-L113δ107-115: Calcd m/z (M+H)+ 1179.3, found 1179.5; αS-
Y39δ35-43: Calcd m/z (M+H)+ 1052.5, found 1052.5; αS-Y94δ81-96: Calcd m/z (M+H)+ 1595.8, found 1595.8.  
No evidence of Npf incorporation is observed. Reprinted with permission from Speight, L. C.; Muthusamy, 
A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. A.; Petersson, 
E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent Amino Acid for 
Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy Transfer Studies. 
Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright (2013) American 
Chemical Society. 
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Calmodulin Circular Dichroism Measurements   
Mutant stability was evaluated using temperature-dependent circular dichroism (CD) 
spectroscopy.  Since calcium-bound CaM (holo-CaM) is thermostable (Tm > 90 °C), we 
specifically examined the thermal unfolding of the apo-enzyme.  To compare the apo- 
and holo-forms, purified protein was dialyzed against 2 mM EDTA in 50 mM 4-(2-
hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) pH 6.70, or 10 mM CaCl2 in 50 
mM HEPES pH 6.70.  CD data were obtained from 20 µM protein samples diluted in the 
appropriate buffer monitoring at 222 nm, between 5 and 95 oC, using the variable 
temperature module provided with the Aviv 410 CD spectrometer.  Protein 
concentrations were determined by using the BCA assay.  Data were collected with a 1 
°C/min temperature slope, 30 s averaging time, 2 min temperature equilibration time, 5 s 
response time, and 1 nm band width.  The resulting raw ellipticity (θD) measurements 
were transformed to molar residue ellipticity values (θ) using 
θ =θD /(clnR )  (11) 
where c is concentration (M), ℓ is the path length (cm), and nR is the number of residues.  
To determine fraction folded (ff) for the apo-enzyme, linear baselines were fit to the low 
temperature (θF = mFT + bF) or high temperature (θU = mUT + bU) data.  The full data 
range was then fit to equation (12) where K = e-(ΔH – TΔS)/RT, ΔH and ΔS are adjustable 
parameters and R = 8.3145 J•mol-1•K-1.  Plots are shown for each mutant in Figure 2.12 
θ =θF (T)(1− ff (T))+θu (T)ff (T)               ff = K/(1+ K)  (12) 
Since the holo-enzyme did not melt, only the molar residue ellipticity as a function of 
temperature is shown for each mutant (Figure 2.12). 
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Calmodulin Peptide Binding Measurements from Steady-State Fluorescence 
All peptide binding experiments shown on the following pages were conducted in 15 mM 
HEPES buffer, 140 mM KCl, and 6 mM CaCl2, pH 6.70.  Dry peptides were brought up 
in a minimal amount of buffer to make fresh concentrated stock solutions for each 
experiment. Protein concentrations were determined by use of Thermo Scientific’s Pierce 
BCA protein assay kit using known concentrations of bovine serium albumin as the 
standard.  Peptide concentrations were determined on the following basis: for pOCNC, 
Phe absorbance was used (ε 257 = 600 M-1•cm-1); for Trp-pOCNC, Trp absorbance at was 
used (ε270 = 5237 M-1•cm-1), and for Mcm-pOCNC, methyl coumarin absorbance was 
used (ε 325 = 12,000 M-1•cm-1).111, 124  For each mutant, solutions were prepared that 
contained approximately 10 µM protein and a variable amount of peptide, ranging from 0 
to 15 µM and representing at least seven distinct concentrations.  Each sample was 
prepared in triplicate. 
Corrected fluorescence measurements of each sample were taken on a Cary Eclipse 
fluorometer at 25 °C using quartz fluorometer cells with 1 cm path lengths for 
experiments with pOCNC binding to CaM-G41δ.  Fluorescence spectra were obtained 
using a Tecan M1000 plate reader and a UV transparent 96 well plate for experiments 
with CaM- F13δ, CaM-Y100δ, CaM-L113δ, Trp-pOCNC, and Mcm-pOCNC.  The 
excitation wavelength was 385 nm and emission spectra were collected from 400 to 550 
nm for pOCNC and Trp-pOCNC or from 350 nm to 550 nm for Mcm-pOCNC binding. 
For pOCNC binding to CaM-G41δ experiments on the Cary instrument, the excitation and 
emission slit widths were 5 nm, the scan rate was 120 nm/min, the averaging time 0.5 s, 
and the data interval 1.0 nm.  For the Tecan M1000 plate reader: excitation and emission 
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bandwidths were 5 nm, 50 flashes at 400 Hz, 20 ms integration time, a manual gain 
setting of 75, and a 20 mm Z-position.  For CaM/peptide pairs for which no significant 
change in fluorescence was observed in the presence of 15 µM peptide, representative 
spectra are shown in Figure S17. 
Calmodulin Binding Data Fitting  
All peptide binding affinities were calculated using Equation 13 as previously 
described.125   
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TIM Unfolding Measurements from Steady-State Fluorescence  
Fluorescence spectra were obtained using a Tecan M1000 plate reader and a UV 
transparent 96 well plate with settings as described above.  Acd was excited at 386 nm 
and emission monitored between 400 -550 nm.  The fluorescence intensity at 450 nm was 
used to monitor the dynamics of Acd fluorescence relative to the addition of urea. 
TIM Unfolding from Fluorescence Lifetimes   
Fluorescence lifetimes for TIM or Acd solutions in urea were recorded and fit to 
Equations 2 – 4 as described for the Stern-Volmer experiments.  Amplitude-weighted 
exponential fit data are shown in Figures 2.36 – 2.38 and Table 2.9. 
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Figure 2.36. Lifetime TIM-F74δ Urea Denaturation Experiments.  Fits to TIM-F74δ fluorescence lifetime data 
with varying concentrations of urea in 100 mM sodium phosphate buffer, pH 7.00 (λex = 405 nm; λem = 450 
nm) at 25 °C.  Biexponential fit parameters are given in Table 2.9. Reprinted with permission from Speight, 
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L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, 
R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent 
Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy Transfer 
Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright (2013) 
American Chemical Society. 
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Figure 2.37. Lifetime TIM-Y101δ Urea Denaturation Experiments.  Fits to TIM-Y101δ fluorescence lifetime 
data with varying concentrations of urea in 100 mM sodium phosphate buffer, pH 7.00 (λex = 405 nm; λem = 
450 nm) at 25 °C.  Biexponential fit parameters are given in Table 2.9. Reprinted with permission from 
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Speight, L. C.; Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, 
B. F.; Mehl, R. A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a 
Fluorescent Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance 
Energy Transfer Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright 
(2013) American Chemical Society. 
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Figure 2.38: Lifetime Acd Urea Experiments.  Fits to Acd fluorescence lifetime data with varying 
concentrations of urea in 100 mM sodium phosphate buffer, pH 7.00 (λex = 405 nm; λem = 450 nm) at 25 °C.  
Exponential fit parameters are given in Table 2.9. Reprinted with permission from Speight, L. C.; 
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Muthusamy, A. K.; Goldberg, J. M.; Warner, J. B.; Wissner, R. F.; Willi, T. S.; Woodman, B. F.; Mehl, R. 
A.; Petersson, E. J., Efficient Synthesis and In Vivo Incorporation of Acridon-2-ylalanine, a Fluorescent 
Amino Acid for Lifetime and Forster Resonance Energy Transfer/Luminescence Resonance Energy Transfer 
Studies. Journal of the American Chemical Society 2013, 135 (50), 18806-18814. Copyright (2013) 
American Chemical Society. 
Table 2.9: Exponential Fits to Lifetime TIM Urea Denaturation Data. 
Sample [Urea] (M) τ1 (ns) % τ1 τ2 (ns) % τ2 τavg (ns) 
TIM-F74δ 0 8.85 ± 0.07 37.6 ± 0.7 2.68 ± 0.05 62.4 ± 1.5 5.0 ± 0.1 
 2 10.51 ± 0.07 45.5 ± 0.8 3.04 ± 0.07 54.5 ± 1.4 6.4 ± 0.1 
 3 12.92 ± 0.07 61.0 ± 1.0 3.22 ± 0.11 39.0 ± 1.2 9.2 ± 0.2 
 4 13.99 ± 0.07 83.6 ± 1.6 2.65 ± 0.28 16.4 ± 1.4 12.1 ± 0.3 
TIM-Y101δ 0 14.32 ± 0.09 56.4 ± 1.0 3.23 ± 0.10 43.6 ± 1.4 9.5 ± 0.2 
 2 13.54 ± 0.08 61.6 ± 1.0 3.44 ± 0.12 38.4 ± 1.3 9.7 ± 0.2 
 3 13.37 ± 0.07 78.8 ± 1.4 2.83 ± 0.21 21.2 ± 1.3 11.1 ± 0.3 
 4 14.61 ± 0.07 85.7 ± 1.4 3.89 ± 0.36 14.3 ± 1.1 13.1 ± 0.3 
       
Sample [Urea] (M) τ1 (ns) % τ1 τ2 (ns) % τ2 τavg (ns) 
Acd 0 15.82 ± 0.08     
 2 15.87 ± 0.08     
 3 15.99 ± 0.08     
 4 15.70 ± 0.08     
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BACKGROUND AND PRIOR STUDIES 
Many aspects of ribosomal translation have been rigorously studied,126 including  
examinations of native aaRS permissivity127, EF-Tu binding49, and accommodation of 
ternary complexes into the A-site of the ribosome128. However, another structural facet of 
the ribosome, the nascent peptide exit tunnel, is a potential steric gate that could govern 
the kinetics or permissivity of incorporation of amino acids bearing large side-chains or 
side-chain modifications. As noted by T. Steitz, who shared in the 2009 Nobel Prize in 
Chemistry for his work studying the ribosome, the intricacies of the nascent peptide exit  
tunnel are poorly understood, despite the overall structural elucidation of the ribosome129. 
First confirmed to exist along with early cryo-electron microscopy images of the 
ribosome in 1995 (and hypothesized to exist in the mid-1980s130), the exit tunnel and its 
role in peptide synthesis have perplexed biophysical researchers131. Aside from 
facilitating the exit of polypeptides from the macromolecular machine, it has been shown 
that this region of the ribosome plays an important part in attenuation of the rate of 
ribosomal peptide synthesis; there are specific sequences that can interact with the walls 
of the tunnel and stall peptide synthesis132, 133, macrolide and ketolide antibiotics bind to 
the tunnel134, also stopping peptide synthesis, and antibiotic resistance to macrolides is 
achieved by translation of peptide sequences that are capable of removing the bound 
macrolide135, 136. However an understanding of the exact physiology of the tunnel and 
how its dynamics may influence the final conformation of polypeptides that emerge from 
the tunnel remains elusive137.  
The 80 - 100 Å long peptide exit tunnel-measuring from the peptidyl transfer center 
(PTC) to bulk solvent at the end of the tunnel-of the ribosome was initially thought to be 
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a static fixture of the ribosome’s overall architecture, which although varying in diameter 
throughout its length, is too small and rigid to allow nascent peptide chains to fold 
beyond an entropic adoption of α-helical conformations129. In 2006 P. Moore, T. Steitz, 
and coworkers published a molecular dynamics study of the exit tunnel that aimed at 
mapping the geometry of the tunnel. While mainly examining the ability of the tunnel to 
accommodate water and ions, the study did note the work of others in which it was found 
that 30 – 40 residues of nascent peptides are protected from protease cleavage138. 
Consequently, the average distance allocated to each residue is 2 – 2.7 Å, a significant 
compaction from the 3.5 Å each residue would require if the nascent polypeptide chain 
was in a completely elongated conformation and a significant elongation from the 1.5 Å 
per residue distance typical of α-helices139. These previous observations, in conjunction 
with P. Moore and colleagues’ finding that the accessible volume of the tunnel decreased 
dramatically when they used probes with radii of greater than 3.0 Å, led the group to 
postulate that there is no regular ordered folding of nascent polypeptide chains as they 
traverse the tunnel. Despite these findings, the role of the exit tunnel and its impact on the 
folding of nascent peptides is still controversial and alternative hypotheses exist140-144.  
 
ARREST PEPTIDES AS REGULATORY MECHANISMS 
The findings of this molecular dynamics study notwithstanding, the translation of specific 
peptides and sequences involved in cellular regulation and antibiotic resistance does 
imply that the ribosomal exit tunnel is capable of responding to stimuli. For example, 
certain peptide sequences have been shown to stall the ribosome during their translation 
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in the absence of certain protein or small molecule cofactors. Common examples of this 
phenomenon include SecM, part of the protein secretion pathways in E. coli, and TnaC, 
the leader peptide of the operon coding for tryptophanase (Tna), responsible for Trp 
degradation in E. coli. The mechanisms by which these peptides interact with the 
ribosomal exit tunnel and consequently arrest translation differ significantly. SecM bears 
a C-terminal sequence that induces pronounced ribosomal stalling in the absence of other 
Sec proteins at the exit of the tunnel. This binding was shown to be a property of the 
peptide sequence (FXXXXWIXXXXGIRAGP, where X is any amino acid) as mutation 
of Pro to azetidine, a Pro UAA analog consisting of a 4-membered ring, greatly reduces 
the arresting properties of the sequence133. These observations have been corroborated by 
others leading to a hypothesis in which the bound nascent peptide skews the orientation 
of the PTC in such a manner that only Pro, the most conformationally inflexible amino 
acid, cannot proceed into the tunnel145. SecM translation can continue through one of two 
postulated mechanisms: either binding of the N-terminal domain of SecM (that, at the 
time of translation of the arresting C-terminal sequence has completely traversed the 
tunnel) by other elements of the Sec protein machinery ‘pulls’ the stalled peptide from 
the tunnel or binding of the Sec machinery to the ribosome induces a conformational 
change that allows translation to continue.  The lab of K. Ito believes that experimental 
evidence supports the ‘pulling’ hypothesis as the translation of as many as 50 residues 
upstream from the stalling sequence is necessary for effective arrest cancellation133. This 
shows that the binding of the signal sequence to the walls of the tunnel is too tight to be 
released with a moderate conformational change but instead requires physical force to 
dislodge it from the tunnel. This is proposed to be accomplished by the high affinity 
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binding of an out-of-tunnel element to the N-terminal portion of SecM which pulls on the 
nascent peptide in addition to the translation of numerous residues which do not interact 
with the tunnel walls following the arresting sequence. Further supporting the ‘pulling’ 
hypothesis, the laboratory of G. von Heijne has shown using force microscopy that co-
translational insertion of SecM into the translocon does in fact produce a pulling force 
that may be responsible in part for the cancellation of SecM mediated translation 
arrest146.   
On the other hand, proponents of the induced conformational change theory in the 
laboratory of A. Yonath found that L22, a ribosomal protein, extends a β-hairpin motif 
into the exit tunnel147. From their study of the large ribosomal subunit from the organism 
Deinoccus radiodurans (D50S), they hypothesized that L22 acts as a gate capable of 
moving about two hinges. However this hypothesis has not been corroborated in the 
literature and computational work by K. Schulten and coworkers concerning the 
mechanism of TnaC mediated ribosomal stalling supports the pulling hypothesis 
proposed by Ito and von Heijne132.  
Translational regulation of TnaC is coupled to cellular Trp concentrations. When cellular 
Trp concentrations are low, the ribosome translates the TnaC gene without any atypical 
behavior. Yet when cellular Trp concentrations are high, translation is markedly 
attenuated. High Trp concentrations lead to binding of the amino acid by the TnaC 
nascent polypeptide/ribosomal complex, most likely proximal to the PTC. This Trp 
binding effectively stalls the ribosome at the TnaC stop codon (just after translating the 
Pro in the TnaC arrest sequence), which inhibits Rho factor binding, its interaction with 
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the RNA polymerase complex, and subsequent transcription termination which is 
necessary for ribosomal read-through of the stop codon. Physiologically, the structural 
shifts necessary to facilitate binding of Trp to the TnaC nascent polypeptide/ribosomal 
complex still remain unclear; however interactions between the TnaC nascent 
polypeptide and the exit tunnel have been proposed. Combining methods of 
computational analysis and cryo-electron microscopy images of the E. coli 70S/TnaC 
complex, K. Schulten’s group revealed that Arg92 of L22 makes a cation-π interaction 
with Trp12 of the nascent TnaC peptide132. This residue is critical for TnaC regulation 
and thus it is well conserved among TnaC variants. Furthermore, Asp16, another 
conserved residue in the TnaC stalling sequence, makes salt bridges with ribosomal 
proteins. Neither of these interactions involve gate-like movements of the L22 β-hairpin 
or any associated residues in the tunnel as postulated by others. However these 
interactions modeled by Schulten still require the tunnel to actively respond to and 
interact with unique residues on a nascent polypeptide chain.  
 
‘RESCUE’ PEPTIDES PROVIDING ANTIBIOTIC RESISTANCE TO 
MACROLIDE AND KETOLIDE ANTIBIOTICS 
As previously alluded to, the most striking example of the exit tunnel harboring nascent 
peptide structural dynamics lies in the observation that the translation of specific short 
peptide sequences grants resistance to the macrolide and/or ketolide antibiotics. Several 
groups have shown that resistance to these antibiotics arises from the translation of 
proteins bearing unique N-terminal sequences that either evict the bound antibiotic or 
154 
facilitate the threading of a polypeptide around the exogenous compound135, 136, 148, 149. 
Macrolide and ketolide antibiotics are thought to inhibit ribosomal peptide synthesis by 
blocking nascent peptides from traversing the exit tunnel (the ‘plug-in-the-bottle’ model). 
Evidence for this lies primarily in the fact that in cell-free protein translation experiments 
conducted in the presence of macrolides, no full length protein is made, rather only 6 – 10 
amino acid long peptidyl tRNAs are observed. Thus it is thought that peptide synthesis in 
the presence of these compounds continues until the nascent N-terminus contacts the 
antibiotic, sterically clashes, and propagates the clash to the PTC where the peptidyl 
tRNA moves into a conformation in which peptidyl transfer cannot occur (Figure 3.1)150, 
151. The relative location of binding does differ from the macrolides to the ketolides as the 
use of the former yields 6 – 10 amino acid long peptidyl tRNAs while the use of the latter 
allows the synthesis of longer 9 – 10 residue species. In line with these observations, it 
has been shown that ketolides bind upstream in the tunnel while macrolides bind 
downstream near the PTC, adjacent to ribosomal proteins L4 and L22 and one specific 
nucleobase: A2062135, 149. 
A. Mankin and colleagues have closely studied the mechanisms by which ‘resistance’ 
peptides are able to render ribosomes resistant to macrolide or ketolide antibiotics. 
Mankin’s initial hypothesis, called the ‘bottle brush’ model, invokes the concept that the 
translation of a specific peptide (the ‘brush’) interacts either directly with the bound 
antibiotic and forces it out of the tunnel or with the walls of the tunnel, inducing 
conformational changes in the rRNA and/or ribosomal proteins that lead to a dramatic 
decrease in affinity for the antibiotic135. It is important to note that these pathways are not 
mutually exclusive; ‘resistance’ peptide induced conformational changes could facilitate 
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a direct interaction with the antibiotic. However, both the models of inhibition and 
resistance rely on the assumption that the ribosomal exit tunnel cannot accommodate both 
the antibiotic and a nascent peptide chain. Recent findings by the Mankin group indicate 
that the tunnel actually is much more plastic than previously thought. In line with other 
groups’ observations, they found that the N-terminal sequence of a nascent peptide 
dictates whether or not translation can proceed past a few residues in the presence of 
macrolide antibiotics. However, their novel discovery was that they saw translation of 
polypeptides without extrusion of the bound macrolide antibiotic136. As this finding was 
surprising, they appended the N-terminal sequence responsible for macrolide bypass onto 
well-studied proteins whose translation has been shown to not be resistant to ketolide 
antibiotics: elongation factor G (EF-G) and luciferase. In both cases, complete translation 
inhibition was not observed, but rather translation stalling in the middle of the protein 
sequences occurred after translating a significant portion of the rest of the proteins: 
yielding either a 40 kDa or 20 kDa truncated protein respectively. These results led the 
group to postulate that antibiotic-induced ribosomal stalling depends strictly on the amino 
acid sequence of the nascent peptide. Initially, translation in the luciferase experiments 
terminated at Pro189 to yield the aforementioned 20 kDa truncated protein. When this 
residue was mutated to a less conformationally-constrained amino acid, translation 
stalling occurred at the next Pro residue, 199. Crystallographic analyses of ribosome-
macrolide complexes help to justify these results; many show that the exit tunnel is not 
completely blocked134. In fact, the narrowest portion of the tunnel with an antibiotic 
bound has an opening controlled by a highly flexible nucleobase: adenosine (A) 2062. As 
this nucleobase juts out into the tunnel and is held in place by a single carbon-nitrogen 
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bond, it can adopt several conformations without significantly altering the overall 
structure of the ribosome. It is possible that the N-terminal ‘resistance’ peptides force 
A2062 into a conformation conducive to a flexible nascent peptide snaking past, yet upon 
the appearance of bulky or structurally inflexible residues (i.e., Pro), A2062 restricts 
passage. Thus, translation arrest following successful antibiotic bypass occurs when there 
are structurally demanding residues or sequences. This suggests that the ribosomal-
nascent peptide complex harbors residues or nucleobases capable of discriminating the 
structural landscape of polypeptides that traverse it.  Furthermore, the binding of an 
antibiotic to this tunnel hypersensitizes it to the structural facets of nascent chains by 
constraining the movements of discriminating moieties such as A2062. The importance 
of A2062 as a discriminating moiety in the tunnel is highlighted further by other findings 
of the Mankin group in which resistance to the macrolide erythromycin is achieved by 
methylation of A2062, presumably precluding efficient antibiotic binding151.  
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Figure 3.1: Models of Modes of Action for Macrolide AntibioticsThree major scenarios are possible if the 
macrolide does not leave the tunnel. Top: The macrolide can obscure the tunnel and block all protein 
synthesis. Middle: The nascent chain can traverse a portion of the drug blocked tunnel but then become 
arrested early in its translation. Bottom: N-terminal bypass can occur in which the nascent chain bypasses 
the antibiotic. Two scenarios are possible in this case. First (top far right), the N-terminal bypass can result 
in late state arrest leading to abortion of complete translation. Second (bottom far right), the entire protein 
can snake past the macrolide resulting in complete translation. Adapted from Kannan et al.136 with 
permission from Elsevier.  
 
TOWARDS AN UNDERSTANDING OF THE PHYSIOLOGY AND FUNCTION 
OF THE RIBOSOMAL EXIT TUNNEL 
Many questions arise from these findings: what are the structural features of the nascent 
peptide exit tunnel that discriminate peptides traversing it? For what purpose does the 
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tunnel scan the topology of newly synthesized peptides? Do interactions of the tunnel and 
nascent peptides affect the rate of translation? In light of these questions, several groups 
have postulated that the ribosomal exit tunnel is a conduit in which nascent polypeptides 
begin to fold140, 142, 143. The laboratory of C. Deutsch has carefully studied this hypothesis 
by examining the exit tunnel and its functional response to the chemical and physical 
properties of nascent polypeptides.  
The most basic type of protein fold is the formation of secondary structures such as α-
helices. As such, a systematic study of the propensity of nascent polypeptide chains in the 
exit tunnel to form defined structures should start with an examination of helix formation. 
To this end, the Deutsch lab created a molecular ruler in which they could probe the 
relative compaction of peptide chains143. Using a Kv1.3 T1 domain sequence, modified to 
remove two small α-helical segments, the group created a peptide platform that, 
according to prior studies has been shown to be completely extended. Additionally, a 
BstEII-digestion site was placed after Arg101 so that the peptide would effectively be 
stalled on the ribosome after translation of this residue. By placing single Cys residues at 
various locations in this peptide sequence (at various distances from the PTC) and post-
translationally probing the accessibility of these residues with the mass-tagging reagent 
PEG-MAL (a polyethyleneglycol polymer functionalized with a maleimide that is 5 kDa 
in size), the group was able to ascertain the accessibility of each residue relative to the 
free peptide in solution. Accessibility was found to be a monotonic function of distance 
from the PTC in the last 20 Å of the tunnel next to the exit port. After these proof-of-
principle experiments, the group then engineered helical segments at various locations in 
the nascent polypeptide. Ala has the highest helical propensity of all the amino acid 
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residues, and α-helices are more compact than completely extended peptides. Thus, 
insertion of Ala repeats was expected to induce overall compaction of the previously 
extended peptide139. Using the same Cys / PEG-MAL tagging methodology, they probed 
the accessibility of three Cys residues engineered within this Ala-substituted ruler. Their 
results are consistent with the hypothesis that insertion of a helical domain into the 
molecular ruler would compact and axially retract the ruler into the ribosomal exit tunnel.  
These molecular ruler experiments allowed the group to verify three previously 
postulated parameters inferred from other functional studies and imaging data for the 
ribosomal exit tunnel, including cryo-EM images of α-helical nascent polypeptides in the 
exit tunnel152. First, testing with this method verified that compact structures can exist 
within the nascent polypeptide exit tunnel as shown by their comparison of reactivity 
with PEG-MAL from the all-extended to the compacted molecular ruler. To verify that a 
difference in accessibility was a function of steric hindrance of the large PEG-MAL 
probe entering the tunnel and not a measure of the relative chemical reactivity of the Cys 
residues, they also used the small molecule probe N-ethylmaleimide (NEM). Reaction of 
NEM with the single Cys molecular rulers, followed by ribosomal release, and then 
attempted reaction with PEG-MAL did not produce a significant population of 
PEGylated peptides, suggesting that the Cys residues, regardless of location, were 
reactive and their relative reactivities with PEG-MAL were a function of the accessibility 
of the residue while the construct was still in the tunnel. Second, the tunnel is largely 
exposed to bulk aqueous solvent. As the reaction between the Cys residues and PEG-
MAL requires ionization of the sulfhydryl moiety and a relatively high dielectic 
environment, it is fair to attribute this to an aqueous environment. Finally, comparison of 
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the length of the molecular ruler and the sites of Cys accessibility match well with a 
tunnel length on the order of ~100 Å, in line with estimates from structural 
determinations. These data provided the group with a verified means to test the formation 
of secondary structure within the ribosomal exit tunnel. However, the questions as to how 
secondary structure formation is facilitated by the tunnel, as well as whether or not the 
tunnel actively responds to diverse structural landscapes of various nascent peptides, 
remained ambiguous.  
To address the question of how secondary structure formation could be facilitated by the 
ribosomal nascent peptide exit tunnel, the Deutsch lab extended their molecular ruler 
methodology by the creation of several molecular rulers with Ala repeats located at 
various locations in the nascent peptide sequence. Using Ala repeats of either 5, 10, or 15 
residues and locating these sequences at various distances from the PTC, they determined 
whether if there are preferred locations for helix formation141. While these experiments 
did show locations in the tunnel that are particularly conducive to helix formation, they 
did not identify the exact mechanism or moieties responsible for this phenomena. Is the 
exit tunnel actively responding to the sequence-specific structure of the nascent 
polypeptide or is it merely providing an entropic trap in which helices can form?  
Eager to answer these questions, the Deutsch lab began a new series of experiments to 
probe the response of the ribosomal exit tunnel to probes with varying steric bulk. To do 
this, steric probes constructed from tetraalkylammonium-decorated maleimides of 
increasing volume (from trimethyl, triethyl, tripropyl, to tributyl functionalized probes) 
were used to modify a single Cys engineered at different locations along the molecular 
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ruler spanning the length of the tunnel142. The kinetics of modification at each location 
was used to obtain modification rate constants. This study demonstrated that the tunnel is 
capable of discriminating between exogenous probes of volumes from 220 Å3 (TMA) to 
388 Å3 (TBA). However the most interesting findings of these experiments arose when 
they examined the ability of the tunnel to discriminate between differently sized residues 
on the nascent peptide itself. By placing either an Ala or a Trp residue C-terminally 
adjacent to the Cys site of labeling and comparing the solvent accessible, the Deutsch 
group showed that at locations 22, 20, and 18 residues away from the PTC, solvent 
accessibility is sensitive to the identity of an adjacent residue; that is, accessibility 
increases with increasing the van der Waals’ volume of an adjacent side-chain, 
suggesting that when a nascent polypeptide chain has a bulky residue at these locations 
either the tunnel changes conformation to accommodate it, or the nascent peptide itself 
rearranges to account for the larger moiety. This scenario was not detected at the 
vestibule, nor at the constriction site within the tunnel153.  
All of the discussed experiments by the Deutsch lab carry one important caveat: they are 
probing the contours of the ribosomal nascent peptide exit tunnel by examining the 
ability of various reagents to enter via the exit tunnel and react with a Cys residue on a 
stalled peptide, after translation has ceased. To examine movement of a nascent peptide 
and its impact on the tunnels’ contours (or conversely, the impact of the tunnel’s contours 
on the transit of a nascent peptide), one would need a steric probe to be incorporated into 
a nascent chain at the PTC and traverse the length of the tunnel. 
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AMINOACYLATION AND IN VITRO SENSE REPROGRAMING STRATEGIES 
One strategy to study the contours of the ribosome nascent peptide exit tunnel is to create 
a nascent chain containing UAAs of systematically increasing size. Based on the studies 
of modified Cys residues in the tunnel (above), the Deutsch laboratory chose to 
incorporate Cys modified UAAs to accomplish this task. The first step in beginning such 
experiments was to implement an efficient method to derivatize Cys and attach the 
resulting amino acid derivative to a tRNA bearing an anticodon that would allow for site-
specific incorporation of the resulting probe. Derivatization of Cys residues with 
maleimide probes occurs via a three step mechanism in which the thiol is deprotonated to 
reveal the nucleophilic sulfhydryl which then attacks one of the alkene carbons in the 
maleimide ring. This results in a keto-enol tautomerism that reverses upon protonation of 
the carbon adjacent to the newly formed thioether and yields the final succinimide 
product. Commonly, this transformation is referred to as a thia-Michael reaction. 
However, a variety of reaction conditions aimed at mimicking these conditions on a 
protected Cys to form a NEM-Cys adduct failed to produce the desired product. Instead, 
it was observed that the resulting succinimide ring is prone to hydrolysis during the 
reaction, work-up, and/or purification.  Atypical conditions, such as the use of boric acid 
as a catalyst154, were also employed, however we were unable to replicate the reported 
results under conditions in our laboratory (Figure 3.2). We were concerned with this 
hydrolysis as the ring-open form of the derivative has many more degrees of freedom and 
as such would be less likely to be sampling the same steric space of the tunnel in each 
experiment as opposed to a more rigid ring structure. The lability of the succinimide rings 
made it clear that mild thia-Michael reaction conditions were necessary and, ideally, 
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should be done late in the synthesis of the amino acid derivative to minimize hydrolysis. 
As such, a new synthetic plan was needed.  
 
Figure 3.2: Conditions Tested for the Thia-Michael Reaction Between NEM and a Protected Cys. 
As previously discussed in this document there are two main strategies that have been 
used to create aminoacyl tRNAs bearing UAAs: semi-synthetic tRNAs and the use of an 
o-aaRS/tRNA pair. Each of these methods has its benefits and complications: semi-
synthetic tRNA requires the production of both a truncated tRNA and an aminoacylated 
dinucleotide while an o-aaRS/tRNA pair requires either evolution or robust screening. 
Intrinsic to both methods is the use of significantly modified tRNA species. Semi-
synthetic tRNA methods yield an aminoacyl tRNA with a deoxycytidine at the 75 
position of the tRNA while the use of an o-aaRS/tRNA pair necessitates the use of a 
tRNA that cannot be charged by any endogenous aaRSs. It is not uncommon for the 
tRNAs used in o-aaRS/tRNA pairs to have significantly perturbed binding to the host 
ribosome, a disadvantage the Schultz group often notes and has published efforts to 
alleviate63. As all of the Deutsch laboratory experiments are in vitro translations in a 
rabbit reticulocyte extract kit, it would be ideal to use a Cys tRNA carrying a modified 
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Cys UAA to more closely imitate the natural process of ribosomal translation. 
Fortunately, H. Suga has devised a general method for the acylation of any tRNA species 
with virtually any amino acid using an evolved RNA catalyst155.  
Noting that other groups have discovered RNA molecules capable of aminoacylating 
tRNA like structures (RNA sequences bearing the 3’ CCA aminoacyl- acceptor structural 
hallmark of a tRNA) and that such RNAzymes are a crucial facet of the RNA world 
hypothesis, H. Suga was inspired to explore the in vitro evolution of such a RNA 
catalyst156. Using the 5’ leader sequence of pre-tRNAs that is cleaved in vivo by RNase P, 
H. Suga used random mutagenesis and in vitro selection to identify a RNA sequence 
capable of charging in cis the 3’ acceptor stem of a pre-tRNA157. By activating the 
carboxylate of Phe with a cyanomethyl ester (CME) and 15 rigorous rounds of in vitro 
selection, the group was able to evolve the 5’-leader sequence to recognize the aromatic 
ring of Phe and aminoacylate the activated amino acid onto the 3’ end of the tRNA. 
Further refinement of this RNA aminoacylation catalyst allowed the group to cleave the 
5’-leader sequence and aminoacylate tRNAs in trans as well as show that the catalyst 
selectively aminoacylates the 3’ hydroxyl of tRNAs, a specificity feature common to one 
class of aaRSs158. Suga and coworkers named this RNAzyme flexizyme (Fx) for its 
ability to aminoacylate any tRNA. 
Optimization of the original Fx that recognizes Phe led to the publication of eFx, a Fx 
variant with enhanced aminoacylation properties, but it only recognizes the aromatic 
amino acids (Phe, Trp, and Tyr) activated with a CME. Of most interest to chemical 
biologists however was the development of a Fx in which the specificity for the aromatic 
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side-chain of Phe was transferred to the activating ester moiety. Other Fx catalysts have 
been developed by the Suga group to recognize distinct aromatic moieties positioned off 
the carboxylate as either esters or thioesters. Interestingly, eFx has been shown to work 
with all tested amino acids functionalized with a p-chlorobenzyl thioester, showing that 
the RNAzyme truly is flexible not only with regards to its tRNA substrate scope, but also 
to its method of recognizing an activated amino acid. However the use of the thioester 
activating group appeared problematic to us as we desired to use Cys derivatives and the 
possibility of transthioesterification with the Cys thiol posed an unwanted complication. 
However, the Suga group did identify a Fx they called dFx due to its ability to utilize any 
amino acid functionalized with a 3,5-dinitrobenzyl ester (DBE)159. The broad substrate 
scope of this Fx appealed to us and was thus chosen as our tRNA aminoacylation 
catalyst. 
Thus, we sought to develop synthetic routes to the DBE-activated amino acids. Since the 
test reactions with NEM and Cys revealed the necessity of attaching the maleimide 
probes at the latest stage possible in the synthetic scheme, a new retrosynthetic analysis 
was conducted (Figure 3.3). It was envisioned that the route could start with cystine. The 
use of this homodisulfide was chosen as a late-stage reduction to the free thiol would 
yield 2 equivalents of reactive Cys-DBE for each molecule of starting homodisulfide. 
This procedure increases the efficiency of the process because a protecting group is 
necessary to prevent undesired reactions with the nucleophilic thiol and the use of any 
other protecting groups would result in those moieties being discarded as waste or 
reacting with the maleimide probes.  
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Figure 3.3: Retrosynthetic Analysis of Succinimide Functionalized Cys-DBEs. 
In practice, the route began with protection of the two amines of cystine with t-butyl 
carbamates (Boc) to yield N, N’-diboc-cystine (2). Attachment of the dinitrobenzyl 
moiety was markedly more difficult than in any of Suga’s reports, presumably because in 
this case we are forming a bis-DBE. Cross-reaction of one carboxylic acid with a formed 
DBE on the other half of the molecule could result in a cyclic anhydride, which would 
then decompose into the starting bis-acid. Two routes were explored to optimize this step 
and both nucleophilic and electrophilic dinitrobenzyl reagents were tested to provide the 
most efficient transformation of N,N’-diBoc-cystine into N,N’-diBoc-cystine-bis-DBE 
(3). Since the use of DNB-Cl afforded the desired product in 62.4 % yield and the use of 
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DNB-OH yielded considerably less (18.8 %), all future reactions were conducted using 
DNB-Cl and the appropriate reaction conditions. Efficient synthesis in hand, compound 3 
was then used as the scaffold to create all of the succinimide derivatized Cys-DBE 
compounds. 
As previous experiments highlighted the tendency of the succinimide ring to hydrolyze 
under basic conditions, it was envisioned that the use of the hydrochloric salt of (TCEP-
HCl) would allow generation of the free thiol from the homodisulfide 3 under acidic 
conditions. Additionally, it was envisioned that these conditions could still facilitate the 
thia-Michael reaction between the newly revealed thiols and maleimides of interest, 
despite the low pH. Fortunately, this strategy worked and provided the desired attachment 
of the steric probes to the Cys-DBE. Removal of the Boc group from the α-amine was 
accomplished with a 30 min treatment with trifluoroacetic acid on ice. Test reactions with 
NEM were conducted in neat DMF, however the use of the tetraalkylammonium 
derivatized maleimides required a water/DMF mixture to completely solvate all reactants. 
Since these compounds were then going to be used in an in vitro flexizyme charging 
reaction, purity was of the upmost concern. As previous test reactions showed that the 
succinimide ring was labile to hydrolysis during an aqueous work-up or on silica 
columns, they were purified to homogeneity by reverse-phase (RP) HPLC under acidic 
conditions (0.1% trifluoroacetic acid (TFA)) (Scheme 3.1). Preliminary results with 
collaborators at Thomas Jefferson University show that compounds 4 and 5 are substrates 
for flexizyme aminoacylation reactions. 
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Scheme 3.1: Synthetic Route to Succinimide Derivatized Cys DBEs. 
To use the tRNACys harboring our modified Cys UAAs in the rabbit reticulocyte in vitro 
translation system we needed to develop a strategy to inhibit endogenous Cys aaRS 
activity. This is important because the Fx reaction does not go to completion, leaving 
some unacylated tRNACys that co-precipitates with our desired UAA-tRNACys. To avoid 
aminoacylation of this material, we needed to inhibit the endogenous Cys aaRS. The 
group of D. Tan has published the synthesis and use of nonhydrolyzable 
aminosulfonamides (AMS) as inhibitors of aaRSs and other adenylating enzymes and we 
sought to replicate their results. Following literature procedures160, 161, we were able to 
synthesize Cys-AMS in 6 steps and 25 % total yield following HPLC purification of the 
final product (Scheme 3.2). Gratifyingly, this compound shows significant inhibition (75 
– 85 %) of Cys incorporation in the rabbit reticulocyte in vitro translation system and 
thus provides a means for us to site-specifically incorporate our Cys derivatives. 
Furthermore, preliminary results show that incorporation of compounds 4 and 5 is 
possible in the presence of Cys-AMS.  
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Scheme 3.2: Synthesis of the Cys aaRS Inhibitor: Cys-AMS. 
Using these steric probe amino acids and Cys aaRS inhibitors, the process of probing the 
transit rates of probe-containing nascent peptides through the ribosomal exit tunnel has 
begun. These experiments will use a slightly modified version of the Kv1.3 protein 
sequence in which a single Cys codon has been engineered immediately N-terminal to a 
polyArg sequence. This polyArg sequence is predicted to pause the nascent peptide in the 
tunnel162. Synthesis of the remaining residues of the nascent chain after the Cys and 
polyArg sequences allows the Cys derivatives to move along the distal 60 – 80 Å of the 
tunnel. Thus the kinetics of translation of the Cys derivatives can be compared to 
ascertain the difference in transit time between the different steric probes without 
worrying about the probes different interactions with species such as EF-Tu.  
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EXPERIMENTAL METHODS 
General Information 
2’,3’isoproylidene adenosine, tert-butyldimethylchlorosilane (TBDS-Cl), tetrahydrofuran 
(THF), N,N-dimethylformamide, imidazole, tetrabutylammonium fluoride (TBAF) (1 M 
in THF), chlorosulfonyl isocyanate, N-(tert-butoxycarbonyl)-S-trityl-L-cysteine (Boc-
Cys(Trt)-OH), trifluoroacetic acid (TFA), L-cystine, 3,5-dinitrobenzyl alcohol (DNB-
OH), 3,5-dinitrobenzyl chloride (DNB-Cl), triethylamine, tributylamine, N-(2-
bromoethyl)phthalimide, N-methoxycarbonylmaleimide, (2-
aminoethyl)trimethylammonium chloride hydrochloride, N, N-diisopropylethylamine 
(DIPEA), 4-methylmorpholine (NMM), sodium iodide (NaI), isobutyl chloroformate 
(IBCF), N-ethylmaleimide, di-tert-butyl dicarbamate (Boc2O), and sodium hydroxide 
(NaOH) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Triisopropyl silane 
was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC-HCl) was purchased from 
AnaSpec, Inc. (Fremont, CA, USA). (Tris(2-carboxyethyl)phosphine) hydrochloride 
(TCEP-HCl) was purchased from CalBioChem, a subsidiary of EMD Chemicals, Inc. 
(San Diego, CA, USA). All other reagents and solvents were purchased from Fisher 
Scientific (Pittsburg, PA, USA).  
Matrix-assisted laser desorption ionization (MALDI) mass spectra were collected with a 
Bruker Ultraflex III MALDI-TOF-TOF mass spectrometer (Billerica, MA, USA). NMR 
spectra, 1H and 13C, were collected with a Bruker DRX 500 MHz instrument.  CDCl3 was 
calibrated at δ 7.27 for 1H and δ 77.2 for 13C. DEPT-135 Carbon NMR notation as follows: 
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no signal is designated by (np), a positive signal is designated by (+), and a negative signal 
is designated by (-).  High-resolution mass spectra (HRMS) were obtained on a Waters LC-
TOF mass spectrometer (model LCT-XE Premier) using electrospray ionization in positive 
mode (Milford, MA, USA). 
 
Synthesis of Tetraalkylammonium Maleimides 
 
Synthesis of these compounds was conducted according to procedures previously 
reported by the Deutsch laboratory. Characterization by low resolution liquid 
chromatography/mass spectrometry (LR-LCMS) and reverse phase (RP) HPLC matched 
those in the cited reports142, 163.  
Synthesis of (2R,2'R)-3,3'-disulfanediylbis(2-((tert-
butoxycarbonyl)amino)propanoic acid) (2) 
 
50 mL of 1:1 water : dioxanes was added to a round bottom flask (RBF) and cooled to 0° 
C under an Ar atmosphere. 1.33 g (33.29 mmol) NaOH was added to the flask and 
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allowed to stir 5 min. 2.0 g (8.32 mmol) L-cystine and 4.54 g (20.81 mmoles) di-tert-
butyl dicarbamate were then added to the flask. After 4 hours, the mixture was acidified 
to pH 3 by dropwise addition of 3 M hydrochloric acid (HCl). The product was then 
extracted from the aqueous solution with ethyl acetate (EtOAc) (3 x 100 mL), dried with 
magnesium sulfate (MgSO4), and concentrated in vacuo. The compound was then used 
without further purification. 3.25 g (88.8 % yield) of pure product were retrieved using 
this method. 1H NMR and LR-LCMS matched that of a previous report164.  
Synthesis of bis(3,5-dinitrobenzyl) 3,3'-disulfanediyl(2R,2'R)-bis(2-((tert-
butoxycarbonyl)amino)propanoate) (3) 
 
Route A:  
1.0 g (2.27 mmol) of (2R,2'R)-3,3'-disulfanediylbis(2-((tert-
butoxycarbonyl)amino)propanoic acid) (2) was added to 5 mL of dry THF in an oven 
dried RBF and cooled to 0° C under an Ar atmosphere. 0.46 g (500 µL; 4.54 mmol) 
NMM was added dropwise via syringe. 1.24 g (1180 µL; 9.08 mmol) IBCF was then 
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added dropwise via syringe and the resulting solution was allowed to stir at 0° C for 30 
min. 1.01 g (4.54 mmol) DNB-OH was then dissolved in 7 mL dry THF and added to the 
solution dropwise via syringe. After 1 hour at 0° C the reaction was allowed to warm to 
room temperature (RT) and 0.46 g (500 µL; 4.54 mmol) additional NMM was slowly 
added to the RBF via syringe. After 16 hr, the reaction was washed with 50 mL saturated 
ammonium chloride (NH4Cl), extracted with EtOAc (3 x 100 mL), dried with MgSO4, 
and concentrated in vacuo.  
Route B:  
1.0 g (2.27 mmol) of 2, 1.97 g (13.17 mmol) NaI, and 1.62 mL (9.31 mmol) DIPEA were 
added to 2.5 mL dry DMF in a RBF under an Ar atmosphere and the mixture was 
allowed to stir for 10 min. 1.97 g (9.08 mmol) DNB-Cl was then added to the flask and 
the reaction was allowed to stir overnight at RT. After 16 hr, the mixture was diluted with 
50 mL methylene chloride (DCM), washed with 50 mL water twice (which was back-
extracted with 20 mL DCM each time), dried with MgSO4, and concentrated in vacuo.  
Purification and characterization for both routes: 
The resulting crude yellow-orange oil was then subjected to flash column 
chromatography (FCC) for purification. Rf = 0.26 in (7:3 Hexanes/EtOAc). Route A 
yielded 0.34 g (18.8 %) while route B yielded 1.13 g (62.4 %) and was thus this route 
was used for all subsequent syntheses of this compound. 1H NMR (500 MHz, CDCl3) δ 
9.02 (s, 2 H), 8.60 (s, 4 H), 5.4 (br. s, 6 H), 4.71 – 4.65 (m, 2 H), 3.24 – 3.14 (br. s, 4 H), 
1.42 (s, 9 H); 13C NMR (125 MHz, CDCl3): δ 170.6 (np), 155.2 (np), 148.9 (np), 139.3 
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(np), 128.3 (+), 119.0 (+), 81.0 (np), 65.2 (-), 53.2 (+), 40.8 (-), 28.4 (+); HRMS (ESI) 
m/z calcd for C30H36N6O16S2Na [M+Na]+ 823.1527, found 823.1520.  
General Method for the Syntheses of Succinimide Functionalized Cys-DBEs (4 – 7)  
Homodisulfide 3 (0.053 mmol) was combined with 0.117 mmol NEM, compounds 8, 9, 
or 10 and 0.265 mmol of TCEP-HCl in 1 mL of 80 % DMF / 20 % water. The mixture 
was allowed to react at rt for 2.5 hrs then 20 mL of water with 0.1 % TFA was added and 
the resulting solution was lyophilized to dryness. The solution was redissolved in 2 mL 
TFA and allowed to react on ice for 30 minutes before being concentrated in vacuo. Each 
compound synthesized utilizing these methods was purified by RP-HPLC as described 
below using a C18 HPLC column. 
HPLC Tables for Purification of 4 – 7  
Table 3.1: Purification of 4.. (Buffer A is 100 % H2O, 0.1 % CF3CO2H. Buffer B is 90 % Acetonitrile, 10 
% H2O, 0.1 % CF3CO2H) 
Time (min) % Buffer B 
0.01 1 
5 30 
30 50 
35 100 
40 100 
45 5 
Rf = 18.23 min 
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Table 3.2: Purification of 5.. (Buffer A is 100 % H2O, 0.1 % CF3CO2H. Buffer B is 90 % Acetonitrile, 10 
% H2O, 0.1 % CF3CO2H) 
Time (min) % Buffer B 
0.01 1 
30.00 50 
35.00 100 
40.00 100 
45.00 20 
Rf = 19.14 min 
Table 3.3: Purification of 6.. (Buffer A is 100 % H2O, 0.1 % CF3CO2H. Buffer B is 100 % Acetonitrile, 0.1 
% CF3CO2H) 
Time (min) % Buffer B 
0.01 1 
7.00 25 
15.00 35 
28.00 45 
32.00 55 
34.00 100 
38.00 100 
40.00 2 
Rf = 11.25 min 
Table 3.4: Purification of 7. (Buffer A is 100 % H2O, 0.1 % CF3CO2H. Buffer B is 90 % Acetonitrile, 10 % 
H2O, 0.1 % CF3CO2H) 
Time (min) % Buffer B 
0.01 1 
50.00 65 
55.00 100 
60.00 100 
65.00 5 
Rf = 18.85 min 
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MS Table for the Characterization of 4 – 7  
Table 3.5: MS Analyses of Cys-Succinimide-DBEs. 
Compound 
Calculated Ion 
Mass  
Observed Ion 
Mass 
4 427.09 427.24  
5 484.15 484.12 
6 610.29 610.22  
7 526.20  526.18 
 
Synthesis of Cys-AMS 
The synthesis of this compound was conducted as described in a report by the laboratory 
of D. Tan160. Of note, sulfamoyl chloride, a necessary reagent for this synthesis, was also 
made in-house according to another literature procedure161. All characterizations matched 
those of prior reports160, 161.  
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